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Abstract 
Mitophagy allows for the removal of damaged and dysfunctional mitochondria 
from the cell thereby attenuating any deleterious, potentially tumorigenic 
effects malfunctioning mitochondria may cause. Mitophagy is a specific from of 
macro-autophagy whereby mitochondria are selectively degraded. What controls 
this specificity is an area of active research. The translocation of various 
proteins such as PINK1 and PARKIN, to the mitochondria prior to mitophagy is 
thought to act as signals for recruitment of the autophagosome to the 
mitochondria. However what is the initiating signal for mitophagy that causes 
these proteins to act remains unclear. Damaged and dysfunctional mitochondria 
generate increased levels of reactive oxygen species and we hypothesized that 
these cause the oxidation of the mitochondrial membrane poly-unsaturated 
lipid, cardiolipin (CL), which acts as an indicator of mitochondrial health and as 
an initiating signal to the mitophagic machinery.  
Using human fibroblasts (derived from Barth’s syndrome patients) deficient in 
functional tafazzin (Taz), the enzyme responsible for CL maturation (poly-
unsaturation), and control fibroblasts created by re-introducing a fully functional 
Taz gene into the parental Barth’s syndrome cells. The frequency at which 
mitophagy occurs in these deficient and revertant cell lines was analysed under 
different oxidative stress conditions, in conjunction with other factors known to 
affect the occurrence of mitophagy; such as mitochondrial morphology, 
dynamics, mass, membrane potential and function.  
We observed that not only were mitochondrial morphology, dynamics and 
function affected by the levels of polyunsaturated CL, but that indeed 
mitophagy is abrogated in cells lacking expression of functional TAZ and 
therefore lacking mature polyunsaturated CL. Further to this initial experiments 
have confirmed reduced levels of oxidized CL in the Barth’s syndrome cells, 
which combined with the evidence of reduced mitophagy suggests this could 
indeed be the initiating signal for mitophagy. Thus the data presented within 
this thesis provides evidence of the role of polyunsaturated CL, in mitophagy and 
suggests that through its oxidation it provides the initiating signal for mitophagy. 
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1.1 Mitophagy 
Mitophagy is the quality control process by which mitochondria are removed 
from cells. In addition to quality control mitophagy can be a protective 
response, or a developmental response. In this first section we will present and 
discuss the process of mitophagy; what stimulates, regulates and controls 
mitophagy. First we must briefly discuss the more general process of autophagy 
of which mitophagy is a specific subset. 
1.1.1 Autophagy 
Autophagy means “self-eating” or “self-digesting”. It is, in the cellular context, 
a process by which the cell degrades organelles proteins and other 
macromolecules, such that they may then either be removed from the cell 
altogether or recycled and used to synthesise new cellular components. The 
intricacies of this process will only be described briefly here, for more detail see 
reviews (1-5). 
The role of autophagy in cells can be considered as three fold:  
1. A response to nutrient stress; a cell induces autophagy to break down cellular 
components to use as fuel until the nutrient stress is removed. 
 2. A quality control process; removing damaged, dysfunctional cellular 
components and re-cycling the building blocks from which they are made.  
3. Tissue specific roles; such as removal of all mitochondria from developing 
erythrocytes.  
Autophagy is continually on-going at background levels in the cell through its 
role in cellular quality control. However upon various stress stimuli the rate of 
autophagy is increased. Under nutrient stress any protein or organelle (other 
than mitochondria (6)) may be subject to autophagic degradation to provide fuel 
for the cell. Obviously, this is only a temporary solution and prolonged nutrient 
starvation will result in autophagic cell death (1). As a consequence it is highly 
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regulated and involves a dedicated set of proteins encoded for by the autophagy 
genes commonly known as the ATG or APG genes. These genes encode the 
autophagic machinery required for initiation, progression and conclusion of the 
autophagy process. Figure 1:1 shows how each of these ATG proteins interacts 
with the signalling machinery and each other to control the autophagy response. 
Whilst we will not dwell on each component of this pathway; four key 
components warrant further explanation due to their function in mitophagy.  
Firstly p62/SQSTM1 (p62 sequestosome, here after referred to as p62) and NBR1, 
two proteins with similar function have been identified as cargo receptor 
proteins, binding to and identifying cellular components for autophagosomal 
degradation. Autophagosomal cargo is usually ubiquitinated and both p62 and 
NBR1 have ubiquitin binding domains through which they recognise and bind 
target components. Once bound to the potential cargo NBR1 and p62 can form 
aggregates of cargo by forming p62/p62, NBR1/NBR1 and p62/NBR1 interactions 
via the PB1 domains present in both proteins. The LIR (LC3 interacting region) 
domain also present in each protein allows interaction with LC3, recruiting the 
autophagosome to the awaiting cargo (7). Neither p62 nor NBR1 require each 
other for their function and their mode of action is similar suggesting 
redundancy in the pairing. They may act in tandem to amplify the autophagic 
response binding different forms of ubiquitination, or as others suggest are 
tissue specific in their function (7).  
Prior to autophagy LC3 (microtubule associated protein light chain 3) or ATG8 as 
it is known in yeast, is cytosolic in a delipidated form known as LC3I. Upon 
formation of the autophagosome it becomes lipidated by conjugation with the 
phospholipid phosphatidylethanolamine (PE) on the autophagosomal membrane 
forming LC3II. LC3II can act as a receptor for autophagic cargo, interacting as 
mentioned above with p62 and NBR1, bringing the autophagosome into contact 
with its intended cargo. The conversion of LC3I to LC3II can be used as a 
measure of autophagy (and mitophagy) induction. The observance of LC3II 
punctae by microscopy allows for the identification of autophagosomes (as LC3 
decorates the autophagosomal membrane) within cells.  
Finally LAMP2 (lysosomal associated membrane protein -2) is found on the 
lysosomal membrane, it mediates the lysosomal uptake of the chaperone HSC73 
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bound to cargo proteins and is required for the lysosomal destruction of 
autophagic vacuoles, it can be used to identify the lysosome and therefore in-
conjunction with LC3 labelling the whole autophagy process can be tracked.     
The function of all the ATG proteins is to modulate the formation and 
interactions of the two vesicles that are essential for autophagy; the 
autophagosome and the lysosome. The autophagosome is a double membrane 
enclosed structure that engulfs the organelles or proteins to be degraded. It 
then fuses with the lysosome, forming the autolysosome (an acidic single 
membrane bound structure), at which point LC3II disassociates. The Cargo now 
enclosed in the acidic autolysosome is broken down and degraded by the 
lysosomal enzymes. 
 
Figure 1:1- The Autophagy pathway and machinery 
Illustration reproduced courtesy of Cell Signalling Technology, Inc. (www.cellsignal.com). 
Illustration details the pathway and components involved in autophagy. 
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Whilst starvation induced autophagy appears indiscriminate regarding the 
organelles and proteins it degrades, not all forms of autophagy are as random in 
their choice. Specific forms of autophagy exist whereby a particular organelle or 
protein is targeted for autophagy above all others. It is proposed that in these 
cases the organelle or protein has a particular mechanism to signal to the 
autophagic machinery that it is “ready” for degradation. One such case is that of 
mitophagy, first defined by J.J. Lemasters in his 2005 paper “Selective 
mitochondrial autophagy, or mitophagy, as a targeted defence against oxidative 
stress, mitochondrial dysfunction and aging.”  where the selective and specific 
degradation of mitochondria was observed above all other cellular components 
in the form of a quality control process (8).  
1.1.2 Specific degradation of mitochondria by mitophagy 
Mitophagy can be stimulated by a variety of different factors: Loss of 
mitochondrial function and with it decreased ATP production (9); generation of 
reactive oxygen species (ROS), ROS levels are known to increase when cells are 
placed under many stress conditions (10); cellular differentiation signals (11-13) 
and changes in oxygen availability e.g. hypoxia versus normoxia (14-20). The 
stages of mitophagy are illustrated in Figure 1:2, with reference made to the 
various proteins both mitophagic and autophagic that are involved at each stage. 
Following mitophagic stimuli, mitochondria become depolarised and undergo 
fission from the remaining mitochondrial network (21). Daughter mitochondria 
generated following a fission event that are not depolarised may re-join the 
network through fusion Figure 1:2. Where a daughter mitochondrion is 
depolarised a specific set of proteins called the “mitophagy proteins” or 
machinery is activated and recruited to the target mitochondria which in turn 
allow the recruitment of the autophagic machinery Figure 1:2. Initially this may 
begin with stabilisation of PINK1 upon the mitochondria and PARKIN recruitment. 
PARKIN ubiquitinates targets upon the mitochondria which in turn recruit the 
cargo receptors p62 and NBR1 and they recruit the autophagosome to the target 
mitochondria. The PINK1/PARKIN system represents only one of several potential 
routes for mitochondrial degradation via mitophagy, other proteins are also 
observed to act on mitochondria instigating a mitophagy response and these will 
be discussed in more detail later.   
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As a relatively new field of research, much of these specifics remain unclear, 
and the role of Mitophagy in cell survival or death is hotly debated. Through its 
importance in many disease areas such as cancer, ageing, metabolic disorders 
and neurodegenerative disease it has become the subject of much interest and 
research, the majority of which has focused on the proteins involved (22-31).  
Another area for consideration which appears to have been overlooked is the 
role of the biological membranes in mitophagy, more specifically the lipids these 
membranes are composed of. 
 
Figure 1:2- The process of mitophagy 
The Above schematic details all the various steps in the process of mitophagy as discussed in this 
chapter. It has been split into two sections: In the top section the processes and components that 
are specific to mitophagy are indicated; whilst the lower section details the processes and 
components that are shared between mitophagy and autophagy. It should be noted that whilst not 
shown here there is nothing to prevent mitochondria that have fused following fission being subject 
once again to further damage and fission events leading to mitophagy. In addition whilst PINK1 and 
PARKIN are shown as representatives of the mitophagy machinery, NIX, BNIP3 etc. are also 
involved. 
Further discussion about the specificity of the mitophagy machinery is detailed 
in later sections. However, before we delve more deeply into mitophagy, the 
association of mitophagy with mitochondrial dynamics and the role of mitophagy 
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in disease, the origins and functional role of the mitochondria  will be reviewed 
as this will have a bearing on our understanding of mitophagy.  
1.1.3 Mitochondrial Ancestry, its role within the cell and 
mitophagy 
About two billion years ago pre-eukaryotic cells did not contain mitochondria. 
Far back in the evolution of the first eukaryotic cell an aerobic eubacteria was 
engulfed by or infected an early eukaryotic cell. Rather than employing 
defensive strategies to remove the foreign pathogen a symbiotic relationship 
developed between the two cell types allowing each to effectively utilize the 
rising oxygen concentrations in the earth’s atmosphere, at the time, to generate 
energy. This gave these cells a selective advantage over other cell types lacking 
such a relationship, resulting in the evolution of the eukaryotic cell complete 
with mitochondria as we observe today (32). Mitochondria are efficient energy 
converters; they convert metabolic substrates into adenosine triphosphate 
(ATP), the energy molecule of the cell, through oxidation. This process is known 
as oxidative phosphorylation (OXPHOS) the basis for which, chemiosmotic 
theory, was described in 1961 earning its founder Peter Mitchel his Nobel Prize 
(33). However, much of the dogma that lead to development of this theory had 
been well established for some time due to the work of a large number of 
individuals including such as  Belitzer, Tsybakova, Ochoa, Harden, Lipmann, 
Friedkin and Lehninger (34-38) among others. Altogether these individuals, 
including Peter Mitchel, described how metabolites such as sugars, fats and 
amino acids could be broken down initially through glycolysis (a process localised 
in the cytosol) and then subsequently through TCA cycle (taking place within the 
mitochondria), with both process generating the required co-factor NADH which 
is essential for the final stage of metabolism OXPHOS where the transfer of 
electrons through four protein complexes, positioned in the inner mitochondrial 
membrane, could generate a proton gradient across that membrane which could 
be utilized by the fifth and final complex in the electron transport chain (ETC) 
to generate ATP.    
ATP is generated at only two stages of the metabolic pathway described above; 
firstly in glycolysis, and secondly and far more efficiently during OXPHOS. 
OXPHOS is the highest oxygen consuming process in a cell relying completely on 
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mitochondrial function and integrity and takes place entirely within the 
mitochondria. Five dedicated enzymes found on the inner mitochondrial 
membrane work together, Complex I (NADH dehydrogenase), Complex II 
(succinate dehydrogenase), Complex III (cytochrome C reductase) and Complex 
IV (Cytochrome C oxidase). NADH (produced during the TCA cycle) binds complex 
I where it donates two electrons which reduce the co-enzyme ubiquinone to 
ubiquinol. NAD+ is then released in conjunction with the export of four protons 
through complex I into the intermembrane space. Ubiquinone is a lipid soluble 
compound found within the inner mitochondrial membrane, it acts as an 
electron and proton acceptor working with complexes I, II and III to allow the 
flow of electrons between complexes as well as the movement of protons. In 
addition to its role in OXPHOS Complex II also functions within the TCA cycle. It 
catalyses the conversion of succinate to fumarate (during the TCA cycle) 
producing FADH. FADH is then the oxidized by complex II releasing electrons 
which are used to reduce another ubiquinone molecule, to ubiquinol, no protons 
are pumped to the intermembrane space by this complex. Complex III has the 
important role of transferring the electrons carried by ubiquionol molecules, 
generated by complexes I and II, to cytochrome C. Cytochrome C is a water 
soluble electron carrier protein; a heme group within the protein makes it an 
ideal for this task. It works with complex III and VI moving electrons between the 
two complexes allowing the energy transfer that will ultimately lead to protons 
being pumped out of the mitochondrial matrix. Cytochrome C can only take up 
one electron and ubiquinol carries two electrons thus, two molecules of 
cytochrome C are required for oxidation of one molecule of ubiqunol. As such 
complex III catalyses a two stage process which culminates in the transfer of two 
electrons from ubiquinol to two separate molecules of cytochrome C with the 
concomitant release of four protons to the intermembrane space. The reduced 
molecules of cytochrome C now move to complex IV of the chain for the final 
transfer of electrons to occur. Complex IV catalyses the transfer of electrons 
from cytochrome C to oxygen, this produces water and simultaneously allows the 
pumping of a further four protons to the intermembrane space. Oxygen is the 
final acceptor of electrons in OXPHOS and in addition to facilitating the pumping 
of protons to the intermembrane space by complex IV the reduction of oxygen at 
this stage further contributes to the proton gradient by the removal of protons 
from the matrix to form the water generated upon electron transfer to oxygen. 
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It is known that cardiolipin (CL, a mitochondrial membrane lipid discussed in 
section 1.3.1) is required for stability of the complexes and formation of 
supercomplexes (where the complexes of the ETC oligomerize increasing the 
efficiency of the OXPHOS), as well as the efficient function of cytochrome C (39-
43). It has also been suggested that CL acts as a proton trap during OXPHOS, 
shuttling protons between the ETC complexes (for review see(33)). 
The electrical energy is utilized to pump hydrogen ions out of the mitochondrial 
matrix and into the intermembrane space, converting the electrical energy to 
potential energy in the form of a proton gradient. This energy is utilized by the 
fifth and final complex in OXPHOS Complex V, ATP synthase. ATP synthase allows 
protons to flow through its Fo subunit back into the mitochondrial matrix. In 
doing so the Fo subunits rotates converting the potential energy of the proton 
gradient into kinetic energy. This rotation forces conformational changes upon 
the F1 subunit resulting in the conversion of ADP and Pi into ATP.  
Although mitochondria are very efficient at producing ATP they are not 100% 
effective and as with other energy converting process they generate by-
products, namely reactive oxygen species (ROS). ROS is the term given to a 
group of chemicals including super oxide, hydrogen peroxide and hydroxide. 
Mitochondria are the major source of ROS within a cell. They are generated as a 
result of premature termination of the ETC, i.e. in a small number of cases the 
transfer of electrons through the ETC to Complex IV is not completed and the 
electron is prematurely transferred to the awaiting oxygen molecule by a 
complex other than complex IV. This results in the production of superoxide. 
Under stable conditions this type of premature termination occurs for 0.1-2% of 
all electrons passing through the ETC. However, when mitochondria become 
damaged or the individual complexes fail to form supercomplexes with one 
another this percentage increases resulting in increased ROS levels. Under 
normal conditions the cell and indeed the mitochondria themselves have 
mechanisms for dealing with ROS and the damage they cause for example, ROS 
scavenging enzymes like SOD1/2 and cellular antioxidants such as glutathione 
(GSH). These mechanisms may be able to keep background levels of ROS at bay 
but when mitochondria become damaged and dysfunctional the levels of ROS can 
increase dramatically. These increased levels then exacerbate an already poor 
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situation causing further damage and potentially deleterious effects if allowed 
to remain which is when a mitophagic response may be necessary. 
Despite its now excessively long-standing association with eukaryotic cells the 
mitochondria still represents at the most innocuous levels a separate entity 
within the cell independent in its own genome; replication, transcription and 
translational machinery, allowing for the generation of the specialized proteins 
it requires for its function. At a more sinister level mitochondria are still 
invading pathogens, foreign bodies, and perhaps the cell recognises this at 
times, such as during mitophagy, and employs its innate immune defence system 
to deal with the invader. It is possible that what we observe as a quality control 
mechanism in general terms actually has its roots in a primordial immune 
response (autophagy) to an invading pathogen, albeit that this pathogen has 
remained hidden for some two billion years. With this in mind we should look at 
what remains of the mitochondria’s pathogenic past that may be under certain 
conditions still be recognised by the cell as an antigen of an invading pathogen 
facilitating its removal from the cell by autophagy, this may be the key to the 
specific nature of mitophagy.  
1.1.4 Mitochondrial Dynamics 
As previously mentioned all forms of mitophagy initially require fission along 
with mitochondrial depolarisation. Mitochondria most often exist in cells in long 
filamentous networks. Under certain conditions these filaments can either 
fragment, producing shorter rods or spheres, or they can elongate and branch, 
becoming more filamentous and interconnected in a mitochondria web. These 
changes in mitochondrial morphology are governed by two distinct groups of 
proteins; those involved in fragmentation, the fission proteins, and those 
involved in elongation and branching, the fusion proteins. The interplay between 
the processes of fission and fusion allows for the maintenance of mitochondrial 
morphology and the segregation of damaged and dysfunctional mitochondria 
through fission from the healthy mitochondrial filaments, allowing for removal 
by mitophagy (17, 30). 
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1.1.4.1 Fission 
Mitochondrial fission is mediated by dynamin related protein 1(DRP1) 
mitochondria fission protein 1 (FIS1), mitochondria fission factor (Mff) and 
contacts with the endoplasmic reticulum (ER) (44-50). All are found to interact 
with the mitochondria bringing about constriction of both inner and outer 
membranes allowing for the eventual division of the mitochondrial tubule. 
Activation of DRP1 is dependent upon its phosphorylation. DRP1 is cytosolic 
when phosphorylated, by protein kinase A (PKA), which prevents its 
translocation to the mitochondria and therefore prevents fission (51, 52). 
Activation of DRP1 requires its dephosphorylation by calcineurin, upon which 
DRP1 will translocate to the mitochondria where it is stabilised by SUMOyaltion 
(53, 54). Once there it is believed it works in conjunction with FIS1 and Mff to 
induce fragmentation of the mitochondrial network while concurrently 
accumulation of autophagosomes occurs (45). For fission to occur DRP1 must 
form a proteins helix around the mitochondrial tubule at the point at which 
fission will occur. However the average diameter of a mitochondrial filament is 
larger than the internal diameter of the DRP1 helix, i.e. mitochondrial tubules 
are too large for DRP1 to enclose, which left the question of how DRP1 was able 
to bind mitochondria. Recently it was discovered that mitochondrial contact 
with the ER induced mitochondrial tubule constriction, giving the mitochondria a 
smaller diameter around which the DRP1 helix could form (44).  
Mitochondrial/ER interactions are well documented, with extensive contact 
points dependent upon ER movement along acetylated microtubules,(47). These 
contact sites mark out areas of potential mitochondrial fission. In the majority 
of mitochondrial fission events ER contact with the mitochondria is observed, 
and the mitochondrial diameter was noted to be reduced. The ER network 
actually encircles or crosses the tubule were mitochondrial diameter is reduced, 
bringing about constriction by physically pinching or squeezing the mitochondrial 
tubule. DRP1 punctae were observed to co-localise to these sites of ER-driven 
mitochondrial constriction, suggesting that the ER causes the constriction of 
mitochondrial tubules allowing the formation of the DRP1 helix required for 
fission to occur (44).  
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1.1.4.2 Fusion 
Fusion is the process by which mitochondria join together and branch forming 
long interconnected filamentous networks. As with fission, fusion has its own 
dedicated protein machinery: Optic atrophy protein 1 (OPA1 or Mgm1 in yeast) 
on the inner membrane and mitofusin 1 and 2 (MFN1 and MFN2, Fzo1 in yeast) on 
the outer mitochondrial membrane (55-60). OPA1/Mgm1 also has a role in 
mitochondrial cristae remodelling and inner membrane tethering (61, 62). The 
function of these fusion proteins appears in some cases to require mitochondrial 
specific lipids, CL and mitochondrial phosphatidylethanolamine (mPE).  
OPA1/Mgm1 requires interaction with CL and mPE for its function in 
mitochondrial fusion and cristae maintenance and re-modelling (39, 63, 64). Loss 
of mPE and CL results in increased mitochondrial fragmentation and reduced 
levels of the fusion protein Mgm1p/OPA1 (39). In yeast there are two isoforms of 
Mgm1, l-Mgm1p and s-Mgm1p, which both require CL to assemble into the fully 
functional Mgm1 protein (64). The S-Mgm1p isoform associates with CL in the 
inner membrane activating its GTPase domain. The l-Mgm1p also preferentially 
binds CL, but in contrast does not possess any GTPase activity and it is therefore 
likely the membrane anchor of the Mgm1p complex (64). The two isoforms can 
interact with one another within the same inner mitochondrial membrane, 
mediating cristae structure or bridging the gap between two adjacent inner 
membranes and thus facilitating the inner membrane fusion between two 
mitochondria (62). The same is also true for the mammalian form of Mgm1, 
OPA1, which requires binding to CL in the inner mitochondrial membrane to 
allow activation of its GTPase domain and the formation of OPA1 oligomers (63). 
mPE can compensate for loss of CL although not with the same degree of 
efficacy and loss of both CL and mPE prevents mitochondrial fusion in yeast 
(39).Both CL and mPE are predominantly synthesised and localised in the inner 
membrane. Loss of both lipids (as observed in Barth’s syndrome (65)) affects the 
assembly and function of the Mgm1 protein.  
Fusion followed by fission segregates dysfunctional mitochondria for degradation 
by mitophagy (21). Fission generates two daughter mitochondria, usually one of 
is depolarised whilst the other will be hyperpolarised, due to the segregation of 
dysfunctional components into one daughter and functional components into the 
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other respectively, this results in the formation of two mitochondria one healthy 
and hyperpolarised and one dysfunctional and depolarised. The hyperpolarized 
daughter mitochondria will inevitably re-fuse with other mitochondria within the 
mitochondrial network, whilst the depolarised mitochondria will not (Figure 
1:2). Following fission and depolarisation OPA1 and MFN levels are reduced 
which prevents re-fusion of the damaged mitochondria with the remaining 
healthy network and allows degradation of the isolated damaged mitochondria 
through mitophagy (21, 66). High levels of fusion proteins reduced mitophagy by 
64%, suggesting fusion prevents mitophagy while fission promotes it (21). 
Mitochondrial fission and depolarisation are the first steps in the mitophagy 
process, following which mitophagy specific proteins are recruited or stabilised 
on the mitochondria to ensure mitochondrial recruitment of the autophagosome. 
Which mitophagy proteins are involved seems to depend on the mitophagic 
stimulus.   
1.1.5 The Mitophagic Machinery 
Mitophagy like autophagy has several different roles: tissue specific removal of 
mitochondria, for functional reasons in the tissue concerned; Quality control, 
removal of old worn out dysfunctional organelles; or finally extensive damage 
control or response to stress; where stressors cause extensive damage to the 
mitochondrial network or invoke an environmental change whereby maintenance 
of mitochondrial presence is toxic to the cell. Each ‘type’ of mitophagy involves 
specific “mitophagy proteins” that regulate mitochondrial sequestration to the 
autophagosome. In the following section we will discuss the various forms of 
mitophagy and the key regulatory proteins than control the process.  
1.1.5.1 PINK1 and PARKIN; the principal characters of mitophagy 
PINK1 and PARKIN are two proteins whose role in targeting depolarised 
mitochondria for mitophagy appears key in almost all cases. They were first 
brought to the attention of researchers due to their role in neurodegenerative 
disease (section 1.4.2). PINK1 (PTEN-Induced Kinase 1) encodes a mitochondrial 
located Ser/Thr kinase and PARKIN encodes an E3 ubiquitin ligase. The evidence 
suggests that PINK1 acts upstream of PARKIN, since loss of PINK1 results in 
failure of PARKIN to translocate to the mitochondria following depolarisation 
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(22-24, 27-29). PINK1 is continually cleaved to its inactive form in healthy 
polarized mitochondria. Upon mitochondrial depolarisation this is prevented and 
PINK1 remains active linking its activity to mitophagy post depolarisation (24, 
28). Once PINK1 is stabilised on the mitochondrial surface it recruits and 
activates PARKIN by phosphorylation of ser65 of PARKIN (27, 67, 68).   
It has been noted that whilst PARKIN is initially cytosolic PINK1 resides on the 
mitochondria. How PINK1 brings about PARKIN phosphorylation and indeed its 
translocation to the mitochondria is a subject of much debate. It has been 
suggested that PINK1 may indirectly activate PARKIN by activation of an as yet 
unidentified cytosolic kinase which in turn activates PARKIN. Alternatively, 
PARKIN could be directly activated by PINK1 at the mitochondrial surface. 
However recent evidence suggests that PINK1 mediated phosphorylation of Mfn2 
prior to mitophagy may act as the recruitment signal and in addition inhibit 
fusion which is important in preventing re-fusion of damaged mitochondria into 
the healthy network (66).  
Earlier work demonstrated how overexpression of fission proteins were able to 
rescue mitochondrial morphology defects observed in PINK1/PARKIN mutants 
implicating PINK1 and PARKIN in mitochondrial fission directly (69, 70). 
However, it was recognised that this could also result from failure to supress 
fusion (69, 70). In Drosophila PINK1 and PARKIN were shown to act in synergy to 
promote mitochondrial fission by inhibition of mitochondrial fusion through 
selective proteasomal degradation of fusion machinery, thus tipping the balance 
in favour of fission and thereby enforcing segregation of damaged/dysfunctional 
mitochondria (66, 69-71). 
Following recruitment to the mitochondria PARKIN is in range to be acted upon 
directly by PINK1; phosphorylating and activating PARKIN as suggested previously 
(68). Mfn2 is not the only possible method for PARKIN recruitment to the 
mitochondria other mechanisms have also been suggested; PINK1 
phosphorylation of MIRO (a component of the motor/adaptor complex that links 
mitochondria to kinesin), VDAC1 and Mfn1 have all been observed to recruit 
PARKIN to the mitochondrial surface (27, 71, 72).  
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Once activated PARKIN adds poly-ubiquitin chains to various substrates upon the 
mitochondrial surface, priming the mitochondria for degradation through the 
autophagic pathway. The poly-ubiquitin chains are associated with lysosomal and 
autophagic degradation through the proteins p62 and NBR1. p62 connects the 
ubiquitin system to autophagic machinery (27). It acts as an adaptor protein in 
PARKIN mediated mitophagy, binding the PARKIN added ubiquitin chains through 
its UBA domain and recruits the autophagosome through its LIR domain by 
binding LC3 (7). In addition to p62 a second adaptor protein NBR1 has a similar 
role. NBR1 has been seen to associate and co-localise with p62 and together 
both are observed to interact with GABARAP (a protein found to be associated 
with the autophagosome) and LC3 (7, 73, 74). p62 and NBR1 may bind one 
another by virtue of their respective PB1 domains, however neither one alone is 
essential for mitophagy suggesting a degree of redundancy or tissue specificity 
between the pairing (7, 75).  
The PB1 domain of p62 and NBR1 not only allow these proteins to bind each 
other but also for p62 to bind other p62 proteins and the same for NBR1. This 
ability to from oligomers causes the formation of mitochondrial aggregates. The 
formation of aggregates appears to strengthen the segregation effect of 
damaged mitochondria from the remaining network which is in the first instance 
initialised by fission from the network. It is also of interest that this clustering is 
reminiscent of the aggregates of cellular components observed in 
neurodegenerative diseases like Parkinson’s disease (PD). These aggregates are 
not thought to be the cause of such diseases but merely the cells protective 
response, and the role of p62/NBR1 appears to be the generation of aggregates 
in order that they are effectively quarantined and removed from the cell,(76). 
Along with aggregate formation p62 also causes perinuclear localisation of 
mitochondria prior to mitophagy further quarantining damaged mitochondria 
from the rest of the healthy network (76). p62 depletion fails to bring about 
perinuclear localisation but does not inhibit mitophagy; in-fact depletion 
accelerates mitophagy indicating perinuclear localisation is not essential for 
degradation of mitochondria by mitophagy. Perhaps the maintenance of 
mitophagy and its accelerated rate in p62 depleted conditions results from 
NBR1, or the recently discovered role of HDAC6 in mediating the interaction of 
the autophagic machinery with the damaged mitochondria (76-78). However, 
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although p62 is required for mitochondrial movement to the perinuclear region it 
is believed that PARKIN, and not p62 is responsible mediating that movement, 
using dynein motors to bring about movement along microtubules (76). This 
movement is retrograde, moving the mitochondria to the perinuclear region, 
mitochondria are also capable of anterograde movement using kinesin motors on 
the microtubules however this is prevented through proteasomal degradation of 
the mitochondrial component of the motor adaptor complex MIRO as already 
mentioned (72). This Suggests PARKIN induces retrograde movement of 
mitochondrial aggregates to the perinuclear region by preventing anterograde 
movement, tipping the balance in favour of retrograde movement. The function 
of p62, HDAC6 and NBR1 is simply to form the aggregates and possibly facilitate 
interaction with dynein motors allowing for movement and accumulation of 
damaged mitochondria in one region of the cell. HDAC6 has a further mitophagy 
relevant function, it is able to activate the cortactin actin remodelling 
machinery which promotes the formation of autophagosomes and lysosomes (77, 
78). Therefore HDAC6 may also instigate the formation of the autophagosome 
around the damaged mitochondrial aggregates to which it is bound. 
As mentioned initially PINK1 and PARKIN appear to play roles in almost all forms 
of mitophagy, i.e. they are the key components of the mitophagic machinery. 
However others appear to be more specific in terms of the type of mitophagy 
they help regulate. Below we will discuss some more specific mitophagic stimuli 
and how other mitophagic proteins regulate mitophagy, often in conjunction 
with PINK1 and PARKIN. 
1.1.5.2 Mitochondrial clearance in reticulocytes; a tissue specific form of 
mitophagy 
Mature erythrocytes do not contain mitochondria. As mitochondria are oxygen 
consumers if not removed mitochondria would consume the oxygen carried by 
the erythrocyte before it could be distributed through the body. In addition as 
erythrocytes are continually taking up and releasing oxygen, the cellular 
environment is highly oxidative. In such highly oxidative conditions mitochondria 
(and other organelles) would be continually damaged and this may induce an 
apoptotic response. Therefore in order that erythrocytes may function correctly 
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and avoid pre-mature cell death removal of mitochondria, (and other cellular 
components) is a vital stage in erythrocyte maturation.  
Reticulocytes are the developmental precursors to erythrocytes. During 
reticulocyte maturation into erythrocytes mitochondria are completely removed 
from the cell via a tissue specific form of mitophagy. NIX has been identified by 
several groups as the key protein responsible for reticulocyte specific mitophagy 
(11-13).  Although other organelles are also removed during maturation NIX was 
only seen to affect mitochondrial removal. Loss of NIX results in shorter lifespan 
of red blood cells (RBCs), increased apoptosis and increased levels of ROS (12). 
Mitochondrial membrane potential is maintained when NIX is absent, although 
the accumulation of autophagosomes is increased (12). This suggests that NIX has 
a role in induction of mitochondrial depolarisation and facilitating mitochondrial 
engulfment by the autophagosome. Indeed direct interaction of NIX with LC3 and 
the GABARAP proteins of the autophagosomal membrane suggest an adaptor 
protein like role for NIX in autophagosome recruitment to the intended 
mitochondrial cargo (11). NIX may also regulate induction of the autophagic 
machinery through its role in increasing ROS levels in cells dramatically prior to 
mitophagy. This increase inhibits the suppressive action of mTOR upon the 
autophagy pathway allowing for the activation of the autophagic machinery (16). 
The function of NIX in reticulocyte maturation is a highly specific form of 
mitophagy unique to the developing red blood cell. However this does not 
preclude NIX from roles in other less specific forms of mitophagy, indeed it has 
been observed to work in tandem with PINK1/ PARKIN (16). NIX expression is also 
induced under hypoxic conditions and therefore may have a role in hypoxia 
driven mitophagy, in conjunction with or instead of BNIP3 (see below) (79). 
1.1.5.3 BNIP3 and Hypoxia; a mitophagic response to toxicity 
Hypoxia describes an environmental state where there is a deficiency in the 
amount of oxygen reaching a tissue below normal physiological levels. Such an 
environment is often observed in cancer where the centre of a solid tumour is 
hypoxic due to lack of access to a reliable blood supply. This causes low oxygen 
and nutrient delivery to the centre of the mass. The role of mitophagy in such an 
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environment will be discussed in greater detail in section 1.4.1. Here we will 
focus upon the regulation of mitophagy in such an environment. 
When oxygen is limited the removal of mitochondria is critical to prevent ROS 
formation and DNA damage. Removal of mitochondria under hypoxia relies on 
the action of BNIP3. BNIP3 (Bcl2/adenovirus E1B 19kDa-interacting protein 3), is 
known to be involved in mitochondrial mediated cell death and autophagy. Its 
expression is induced by hypoxia inducible factor 1α (HIF1α) and repressed by 
retinoblastoma protein (Rb) (13-15, 79, 80).  
Overexpression of BNIP3 leads to loss of mitochondrial membrane potential, as 
well as inducing the formation of the autophagosome. BNIP3 targets the 
complexes of the ETC for degradation by mitochondrial proteasomes impairing 
mitochondrial function and reducing membrane potential which, as a result 
triggers mitophagy (81). It also, like NIX, shows co-localisation with LC3 
indicating it may act as a receptor on the mitochondria for the autophagosome 
(13, 14, 79). As a consequence of this it reduces ROS levels mitigating some of 
the damaging effects of hypoxia, preventing mitochondrial mediated apoptosis 
thereby promoting cell survival in a hypoxic environment. However prolonged 
BNIP3 expression can result in necrotic cell death and as such is only a 
temporary measure for dealing with a hypoxic environment (14, 19). 
1.1.5.4 Energetic stress as an inducer of mitophagy 
Hypoxia and the developmental signals observed in reticulocyte maturation are 
highly specific events relevant to only a few tissue types. However energetic 
stress can occur in all tissue types and cells. Energetic stress can be separated 
into two types: stress resulting from low nutrient levels in the cell, meaning 
fewer nutrients are available for conversion to ATP; or stress resulting from 
mitochondrial dysfunction; where despite plentiful nutrients the mitochondria is 
incapable of generating enough ATP for cellular function. 
In the case of nutrient starvation, mitophagy appears to be abrogated. Under 
starvation induced autophagy mitochondria avoid degradation by elongation 
which prevents engulfment by the autophagosome (6, 82). As cAMP levels are 
increased during nutrient starvation Protein kinase A is activated which in turn 
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phosphorylates DRP1, thereby preventing its translocation to the mitochondria 
and effectively preventing mitochondrial fission. This is essentially the reverse 
of what is observed upon PINK1 and PARKIN activation (66). This ensures that 
mitochondria remain large and tubular, and elongate due to the unbalanced and 
unchecked function of the fusion proteins. The large size of the mitochondria 
renders them too big to be engulfed by the autophagosome.  
This response to starvation ensures that the mitochondria remain and are thus 
capable of utilizing the fruits of autophagy for energy production. Failure to 
prevent mitochondrial fission upon starvation results in increased ATP 
consumption by the mitochondria as the ATPase works in reverse, resulting in 
apoptotic cell death and mitochondrial removal by mitophagy (6). If this 
occurred the autophagic breakdown of cellular components to provide fuel to 
cells in times of nutrient starvation would be pointless as there would be little 
or no mitochondria present to convert the autophagy derived nutrients into ATP. 
Therefore mitophagy is abrogated in times of nutrient starvation induced 
energetic stress. However the reverse is true when mitochondrial dysfunction is 
the cause of energetic stress.  
The energetic status of a cell is directly related to the health and efficiency of 
mitochondria. Therefore it is no surprise that the energetic status of a cell can 
regulate mitophagy. The role of mitochondria in the cell is to make ATP 
(energy), if they fail to do this effectively, or start to generate too high a level 
of ROS then it is likely that they are malfunctioning and as such removal by 
mitophagy is desirable. The rate of OXPHOS is often increased under energetic 
stress to compensate for reduced ATP levels; this inevitably exacerbates an 
already bad situation increasing mitochondrial damage and dysfunction through 
increased ROS levels. Evidence suggests that PINK1 and PARKIN have a role in the 
response to energetic stress by promoting the turnover of respiratory chain 
complexes, (83). This turnover of respiratory complexes will in the first instance 
reduces OXPHOS activity as complex number is reduced which marks the 
mitochondria as dysfunctional due to the reduced level of ATP they generate. 
This will up-regulate the mitophagic response to remove the now inefficient 
mitochondria, and in the second instance will stimulate the biosynthesis of 
replacement complexes which will be much more efficient and relieve the 
energetic stress (83). Whilst the PINK1 and PARKIN pathway is known to promote 
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mitophagy, it is not through mitophagy that it mediates the turnover of the 
respiratory complex proteins. Perhaps turn over occurs through PINK1/PARKIN 
mediated proteasome degradation of the affected complexes, or (to be 
discussed in more detail later) through formation of mitochondrial derived 
vesicles which transport affected complexes directly to the lysosome for 
degradation (84). Neither has been ruled out currently, and both degradative 
pathways have been observed in other settings to degrade components of 
mitochondria either prior to or as an alternative to all out mitophagy. However 
for PINK1 and PARKIN to function in this manner firstly requires mitochondrial 
depolarisation to allow stabilisation of PINK1 upon the mitochondria (67). This 
appears in this context to be instigated by the action of NIX and a small 
farnysalated GTPase Rheb.  
Both NIX and Rheb expression are increased under energetic stress and Rheb is 
observed to be recruited to the outer mitochondrial membrane where it recruits 
and forms a complex with NIX (85).  NIX has the ability to induce mitochondrial 
depolarisation and this may lead to the stabilisation of PINK1 mentioned above. 
In addition this complex interacts with LC3 recruiting the autophagosome to the 
mitochondria allowing mitophagy to proceed. Mitophagy of this sort is also 
observed to induce biogenesis and as such Rheb mediated mitophagy not only 
removes the offending damaged and dysfunctional mitochondria but also 
stimulates biogenesis supplying the cell with new healthy mitochondria thereby 
alleviating the energetic stress (85).  
However whilst Rheb and Nix appear to regulate the mitophagic machinery, no 
role for Rheb was observed in activating the autophagic machinery as observed 
by its inability to inhibit mTOR. To understand this phase of the mitophagic 
response to energetic stress we must look back to the master regulators of 
autophagy (Figure 1:1). Under energetic stress, ATP levels are reduced as 
mentioned above, but also AMP levels are increased. This activates AMP- 
activated protein kinase (AMPK) a known suppressor of mTOR. AMPK also 
activates two initiating members of the autophagic machinery ULK1 and ULK2. 
ULK1 and ULK 2 have four AMPK phosphorylation sites, serving to activate these 
proteins upon phosphorylation (9). Once activated, and unsuppressed, ULK1 and 
2 can stimulate the autophagic machinery and the development of the 
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autophagosome, which is required for the mitophagic response initiated by Rheb 
and NIX.  
All of the different mitophagic responses, stimuli and machinery described in the 
section above, (1.3.5) describe how the mitochondria is primed for recognition 
by the autophagosome allowing for its degradation. It has focussed on the 
mitochondrial end of mitophagy and the proteins involved. However mitophagy 
also involves the autophagic machinery and it has been suggested that the site of 
formation for the autophagic membrane may relate to the type of cargo it will 
eventually degrade. For this reason it is also important to consider the formation 
of the autophagosomal membrane as a potential marker of the specificity of 
mitophagy. 
1.1.6 The role of lipids and membranes in mitophagy and 
autophagy 
The role of biological membranes and the lipids they are composed of has 
warranted little research in the field of mitophagy, with most of the limited 
investigations focusing on the source of the autophagosomal membrane rather 
than roles of the mitochondrial membrane and mitochondrial lipids in 
mitophagy. However it has been suggested that the origin of the autophagosomal 
membrane may have a bearing on the specificity of the autophagosome for a 
particular cargo,(86). The role of mitochondrial lipids in mitochondrial dynamics; 
for example, Phosphatidyllinositol (4, 5) bisphosphate (PI (4, 5) P2) and CL in 
mitochondrial fusion, may also have an effect on mitophagy initiation. The 
effect of lipids in the formation of the autophagosomal membrane and in 
mitochondrial membrane dynamics may be crucial to the initiation and 
progression of mitophagy. 
The mitochondrial lipid PI (4, 5) P2 has been observed to play a role in 
mitochondrial fragmentation (87). Reducing the levels of PI (4, 5) P2 on the OMM 
increased mitochondrial fragmentation. The entire mitochondria network was 
found to be fragmented after 24 hours and following 48 hours only a few 
mitochondria remain in the cell. Confocal microscopy identified co-localisation 
of lysosomes with the fragmented mitochondria suggesting mitochondrial 
removal by autophagy/mitophagy (87). The downstream effector of PI (4, 5) P2 
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was identified as protein kinase Cα (PKCα, a mitochondrial isoform of PKC). 
Reduced levels of PI (4, 5) P2 reduced the activity of PKCα resulting in 
mitochondrial fragmentation (due to disrupted fusion) and mitophagy. The role 
of PKCα has yet to be identified although it is thought that the presence of PKC 
phosphorylated proteins on the mitochondria may be crucial for mitochondrial 
integrity, perhaps in a similar way to PINK1 function. This gives lipids a 
functional role in mitophagy.  
CL is also implicated in mitochondrial dynamics (39, 63, 64). Found almost 
exclusively on the mitochondrial membrane, it affects the structure of the outer 
mitochondrial membrane (OMM) and inner mitochondrial membrane (IMM) during 
various processes. Upon mitochondrial fusion, CL synthesis is severely down 
regulated for 12 hours as a result of reduced phosphatidylglycerophosphate 
synthase (PGPS) activity, after which synthesis is significantly up-regulated along 
with PGPS and TAZ activity (discussed later) (88). There is no indication of the 
functional relevance of these changes in CL synthesis, yet since CL is a specific 
mitochondrial lipid such marked changes in its abundance may have functional 
implications for mitochondrial dynamics and mitophagy. 
In addition to the effects lipids have on mitochondrial dynamics and mitophagy, 
they also have an important role in forming the autophagosomal membrane 
required for degradation of mitochondria through mitophagy. Much controversy 
surrounds the question of where the autophagosomal membrane originates. The 
absence of any organelle specific proteins on the autophagosomal membrane 
suggests the membrane could originate from any single or a combination of all 
organelles within the cell (89). Three potential candidates for membrane 
donation exist, the mitochondria, the Golgi apparatus and the ER, which have 
membranes of the same thickness, 6-7nm thick, as an autophagosome. In 
contrast the plasma membrane is 9-10nm  thick, making an unlikely; though not 
impossible, source for the autophagosomal membrane (90). 
Mitochondria are sites of phosphatidylethanolamine (PE) synthesis (reviewed, 
(91)); PE is essential in autophagosomal membranes for the binding of LC3 (92), 
making mitochondria a potential source of this lipid for the autophagosome. 
Under starvation conditions, transfer of lipids between the mitochondrial 
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membrane and autophagosome have been observed (93). The transfer of 
fluorescently tagged phosphatidlyserine (PS) was traced from the ER to the 
mitochondria and then on to form the autophagosomal membrane. Blocking the 
transfer of PS from the ER resulted in failure to form autophagosomes. Further 
to this, and in contrast to the findings of other, Hailey et al 2010 showed co-
localisation of OMM markers with autophagosomes were observed whilst other 
organelle markers failed to co-localise. It is noted that this process could be 
confused with mitophagy, however no IMM or mitochondrial matrix markers were 
found to co-localise with the emerging membrane suggesting engulfment by the 
emerging membrane is not occurring. Electron microscopy (EM) and 
photobleaching studies support the theory of membrane biogenesis from the 
mitochondria demonstrating evidence of membrane sharing. However this 
sharing was limited which was suggested to indicate that this was a transient 
phase in the process, perhaps early on in autophagosomal development. In this 
case it may be that other organelles are involved in the later stages of the 
membrane maturation. 
Two elegant studies show evidence that the Golgi and trans-golgi network are 
involved in provision of lipids for the autophagosomal membrane, both 
implicating secretory proteins localised to the golgi (94, 95). Loss of function of 
secretory protein Sec2, under starvation conditions results in decreased 
autophagy and reduced numbers of autophagic punctae and reduced recruitment 
of atg9 to the phagophore assembly site (PAS) (94). Furthermore protein 
secretion from the golgi is reduced under nutrient starvation; perhaps due to the 
hijacking of the golgi network to derive autophagic membranes. A second 
secretory protein Sec7 has also been implicated along with its downstream 
effector Arf. It is localised to the trans-golgi compartments and remains there 
upon autophagic induction (95). Its role is in membrane sorting and thus it is 
logical that it could play a similar function in autophagic membrane production. 
Blockage of Sec7 activity results in reduced Arf activity and reduced prevalence 
of autophagic punctae. The PAS still forms as normal but immunoelectron 
microscopy shows it fails to expand and mature, suggesting a later stage role of 
sec7 in autophagosome development. In conjunction with this the Ypt31/32 
proteins (required for vesicle exit from the golgi) have been seen to play a role 
(94). Disruption of Ypt31/32 activity once again reduces the numbers of 
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autophagic punctae observed, suggesting the exiting vesicles may provide or 
carry lipids required for membrane development.  
As mentioned above it may be that the stimulus or type of autophagy determines 
the origin of the autophagic membrane. Recently the autophagic response to 
unfolded protein was investigated (86). Following the ER response to unfolded 
proteins the abundance of autophagosomes increased. These autophagosomes 
were often observed to be directly connected with the ER. The outer 
membranes were densely covered in ribosomes and usually contained ER 
contents. This was not observed as during autophagic response to starvation only 
in the context of unfolded proteins. These observation could be considered ER-
phagy (specific degradation of the ER by the autophagosome), and indeed the 
authors do state that the role of these autophagic punctae to sequester excess 
ER and unfolded protein and eventually degrade them. Direct connections 
between the ER and autophagosomes, as well as the presence of ribosomes 
suggest perhaps this is not straightforward ER-phagy. In support of this 3D EM 
tomography under starvation conditions showed the ER and emerging autophagic 
punctae side by side with connections between the two membranes visible (96, 
97). Contacts at multiple sites, not just at the open edges of the emerging 
autophagic punctae (where it might be supposed ER-phagy would progress from), 
indicate that the ER is contributing to the lipid membrane of the autophagic 
punctae rather than being engulfed by it(96). These contacts were observed not 
only with the outer leaflet of the autophagic punctae membrane but also the 
inner leaflet (96, 97). The ER forms a cradle like structure surrounding the 
emerging autophagic punctae, with a membrane extension visible emerging from 
the autophagic punctae into the ER (97) perhaps acting like a supply chain to 
transfer lipids for the developing membrane from the ER.  
Whilst the evidence for any of these organelles being the site of autophagosomal 
membrane generation is compelling the following should be considered.  In all 
but a few cases described here the inducing signal for autophagosome 
development is starvation. Whilst this is a well-recognised inducer it is not the 
only stimulus for autophagy, hypoxia, oxidative stress and mechanical stress 
among others also induce autophagy. The source of the autophagic membrane 
may differ depending on the initiating stimulus. It should also be noted that the 
intended cargo may influence the origin of the autophagic membrane. Bernales 
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et al 2006 hinted in their study at this, observing ER-derived autophagic 
membrane development, which then proceeded into ER-phagy which failed to 
occur under starvation induced macroautophagy (86). However, Hailey et al 
show that although the mitochondrion donates membrane under starvation that 
the donating mitochondria is not then degraded (93).  
The most obvious source of membrane however is the golgi network. Its role in 
the cell is to secrete protein and lipid for use elsewhere inside and outside the 
cell. As discussed above the golgi network has been implicated in lipid supply, 
via the secretory proteins, but there is no evidence of direct membrane sharing, 
no contact sites have been observed as seen for the ER and mitochondria. 
Perhaps the golgi does not require direct contact donating lipids via vesicles that 
bud off from the golgi and fuse at the PAS to form the autophagosome. 
 One point that is hinted at in various articles is that in actuality the membrane 
may be derived from multiple organelles. The data regarding each organelle is 
compelling, so perhaps each organelle under different stress conditions or at 
different stages of autophagosome development donates membrane. Hailey et al 
showed the transfer of the lipid PS from the ER to the mitochondria and then 
onto the autophagosome (93). Evidence of the mitochondria’s involvement in 
autophagosome development it is compelling, however it also indicates 
involvement of the ER, as blocking PS transport from the ER blocked 
autophagosome development implicating both organelles in autophagosome 
formation whilst suggesting lipid sharing between the ER and mitochondria is 
necessary also. Indeed recent evidence highlights the role of mitochondria 
associated ER membrane (MAM’s), ER mitochondria contact sites that occur 
within cells (98). Under starvation Atg14 and ATG5 two proteins required for 
autophagosome formation are observed to be recruited to MAM sites followed by 
autophagosome formation, with the ER snare protein syntaxin 17 being 
instrumental in the recruitment of ATG14. Upon disruption of MAM sites by 
knockdown of both Mfn2 and PACS-2 (genes required for maintenance of MAM’s) 
autophagosome formation was observed to be significantly reduced (98). Perhaps 
further investigation of lipid trafficking and organelle membrane sharing or 
contact sites may reveal further co-operative relationships between the 
organelles which enable the formation of the autophagosome under various 
different autophagic stimuli. It has been suggested  that the golgi in its role as 
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protein and lipid distributor for the cell may affect how membranes are donated 
from other organelles as they are dependent on the lipids they receive from the 
golgi (95).  
Overall it seems apparent that there is still much to be resolved in relation to 
the role of lipids in mitophagy and the development of the autophagosomal 
membrane. Further information on the origins of the autophagosome may prove 
invaluable if we can isolate one form of autophagy form another (i.e. mitophagy 
from ER-phagy) based on membrane donation sites and perhaps inhibit or 
promote one form of autophagy over another. 
1.1.7 The Lysosome and Digestion 
The formation of the autophagosome and its engulfment of mitochondria does 
not represent the end of the mitophagy process. Breakdown of the mitochondria 
into its constituent parts requires fusion of the autophagosome with the 
lysosome, thereby forming the autolysosome, which contains various lysosomal 
enzymes capable of degrading the mitochondrial content Figure 1:1. 
The Lysosome is an acidic vesicle that is crucial to the final stage of mitophagy it 
contains a variety of degradative enzymes; glycosidases, lysosomal proteases and 
sulfatases. Which are all involved in the degradation of autolysome content. It 
has recently been shown that direct lysosomal digestion of mitochondrial 
components can occur without the requirement of the intermediary 
autophagosome (84).  
Mitochondrial derived vesicles (MDV’s) represent a mitophagy and autophagy 
independent method of mitochondrial quality control. MDV’s form upon 
oxidative stress when damaged elements (protein and lipid) of the mitochondria 
bud off from the main mitochondrial body and are transported directly to the 
lysosome for degradation. This process requires neither mitochondrial 
depolarisation or the involvement of LC3 and the autophagosome, (84). The 
budding of damaged components precedes any greater mitophagy response and 
is not brought on by mitochondrial fission and fragmentation, suggesting perhaps 
a first line of defences against oxidative stress. It may also be a useful ‘back-up’ 
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strategy for removal of damaged mitochondria and mitochondrial components 
under conditions where mitophagy and autophagy are dysfunctional.  
The fusion of the mitochondria containing autophagosome with the lysosome 
marks the final stage in the degradative process, with the lysosomal enzymes 
breaking down the contained mitochondria and re-cycling its basic constituents. 
With an understanding of the process, signals, proteins and lipids that govern 
mitophagy, and an insight into its function at the rudimentary level (as detailed 
in the above sections), we can explore some of the roles mitophagy has in 
various diseases, including its role in cancer and how it may represent a 
potential target for cancer therapeutics and treatment in other forms of disease. 
1.1.8  The use of dyes and probes to monitoring mitophagy 
Three organelles are involved in the mitophagic process: the mitochondria, the 
autophagosome and the lysosome. Fluorescently labelling these organelles 
allows the monitoring of various aspects of mitophagy. Currently there are a 
variety of commercially available dyes and probes available for live cell imaging, 
and these can prove very useful when undertaking studies into mitophagy. 
However, caution should always be used when interpreting the results they 
generate due to uncertainties regarding the specificity, mechanism of action and 
mis-localization of the dyes upon treatment with mitophagy inducing agents like 
CCCP.  
To label mitochondria the mitotracker dyes are routinely used. These dyes are 
marketed by Invitrogen life technologies and include: Mitotracker FM, 
Mitotracker CMTMRos and Mitotracker CM-H2-TMRos probes in various colours. 
The ‘FM’ dyes are for use in live cells only whilst the ‘CMTMRos’ and ‘CM-H2-
TMRos’ are also marketed for use in fixed cell imaging (99, 100).  
The ‘CMTMRos’ probes are cationic and continually fluorescent whilst ‘CM-H2-
TMRos’probes are only fluorescent upon oxidation. Both dyes depend on an 
intact mitochondrial membrane potential for their specificity. They are 
supposedly retained within the mitochondria through interaction of their 
chloromethyl group with thiol groups within the mitochondria. Despite this upon 
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mitochondrial depolarisation specific mitochondrial localized fluorescence from 
these dyes is lost (99). 
The ‘FM’ dyes are specifically for live cell imaging only. As with the ‘CMTMRos’ 
and ‘CM-H2-TMRos’ dyes the ‘FM’ dyes segregate to the mitochondria based upon 
the membrane potential of the mitochondria and their cationic nature, despite 
initial claims by the manufacture that these dyes segregated independently of 
mitochondrial membrane potential (100). The fluorescence intensity of the 
mitotracker green FM probe was observed to increase upon loss of mitochondrial 
membrane potential, however upon investigation of the localization of the probe 
following mitochondrial depolarization it was seen to be non-specific and 
certainly not retained within the mitochondria again contradicting the 
manufactures claims and that of one other group (50, 100). It appears likely that 
all the mitotracker probes are dependent (perhaps to varying degrees) upon 
mitochondrial membrane potential.  
Thus, whilst the mitotrackers make excellent tools for the study of functional 
(polarized) mitochondria, they are rendered uninformative upon mitochondrial 
depolarization. As one of the key steps in mitophagy prior to engulfment by the 
autophagosome is the loss of mitochondrial membrane potential, these dyes and 
probes do not represent a reliable tool for labeling mitochondria to enable 
tracking them through the mitophagy process. An alternative to use of dyes or 
probes could be to fix and permeabilize cells and stain with mitochondria 
specific antibodies. This will not perhaps give indication of functional status of 
the mitochondria or allow monitoring of dynamic mitochondrial processes like 
mitochondrial movement, mitochondrial fission and fusion, but it will allow for 
identification of mitochondria regardless of the polarity of the mitochondria. 
Alternatively for live cell imaging perhaps introduction and stable expression of 
a fluorescently labelled protein specific for the mitochondria e.g. the 
mitochondrial targeting sequence of cytochrome C, which is not dependent upon 
membrane potential could allow for monitoring mitochondria in live cells 
regardless of their membrane potential.  
The dependency of the mitotrackers on mitochondrial membrane potential 
makes them of little use when labelling depolarized mitochondria; it does make 
them useful for monitoring mitochondrial depolarization. The mitotrackers along 
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with the classically used tetramethylrhodamine ethyl ester (TMRE) can be used 
to monitor mitochondrial membrane potential (56). These dyes are rapidly and 
selectively taken up by live cells and sequestered to polarised mitochondria 
where they fluoresce. Upon the mitochondrial depolarisation both dyes lose 
their mitochondrial localisation, and TMRE ceases to fluoresce. Therefore 
mitochondrial membrane potential can be assessed either through localisation of 
the mitotracker dye and, in the case of TMRE, can be quantified by measuring 
the fluorescence intensity. As mentioned above mitochondrial depolarisation is a 
recognised stage in mitophagy initiation, as such when attempting to induce 
mitophagy it can be useful to ascertain the exposure time and concentration 
required for a mitophagic stimuli to cause mitochondrial depolarisation as this 
will be the conditions under which mitophagy is most likely to occur, and for this 
purpose TMRE would be an ideal candidate. 
The second organelle that is essential for mitophagy is the autophagosome. One 
dye that has been touted as an autophagosome specific marker is 
monodansylcadaverine (MDC). This probe has been continuously described as 
specific to the autophagosome; however on closer inspection this appears not to 
be the case (101). Despite being labelled as a marker of the autophagosome MDC 
in fact appears to be more specific than this labelling not autophagosomes but 
autolysosomes, the late stage vacuole of the autophagy pathway formed upon 
fusion of the lysosome with the autophagosome (Figure 1:1) (101). This is 
suggested to result from the supply, by the lysosome, of transporters required 
for MDC import to the autophagosome upon fusion. However, it could also result 
from specific sequestration of MDC to the lysosome which upon fusion with the 
autophagosome is also observed inside the autolysosome. Due to uncertainty 
over the mechanism of MDC accumulation and its association with autolysosomes 
not autophagosomes it should not be used as a marker for specific labelling of 
autophagosomes. Currently the most reliable methods for labelling the 
autophagosome are either to fix and stain cells with antibodies specific for 
proteins found on the autophagosome or introduce and stably express a 
fluorescently tagged version of an autophagosomal protein e.g. LC3. 
The third and final organelle involved in mitophagy is the lysosome. As with the 
mitochondria and autophagosomes these organelles can be easily labelled 
through fixation and the use of appropriate antibodies or introduction and 
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expression of a fluorescently tagged version of a lysosomal specific protein e.g. 
LAMP2. However there also exists, as for the mitochondria, a set of 
commercially available probes (Invitrogen Life Technologies) called the 
lysotrackers and lysosensors which can be used to label and monitor the 
lysosomes in live cells. The lysotrackers are weak bases which are permeable to 
cells and segregate to the acidic compartments of the cell. Their mechanism of 
action is not clearly established but it is suggested by the manufactures to 
involve protonation of the probe upon sequestration into acidic vacuoles i.e. 
lysosomes, which results in the retention in the lysosome. The lysosensor probes 
appear to have the same mechanism of action with reference to their 
accumulation in the lysosome; however their fluorescence is dependent upon the 
pH of the lysosome. As such they may be useful for monitoring the acidity of the 
lysosome, and perhaps investigations into lysosome biogenesis maturation and 
acidification.  
The use of any of these probes when studying mitophagy should be carefully 
considered in conjunction with the method of mitophagy induction. CCCP is 
commonly used as an inducer of mitophagy due to its ability to depolarize 
mitochondria. It is a protonophore which is negatively charged and as such is 
drawn into the mitochondria due to the positive charge of the mitochondrial 
intermembrane space as well as other positively charged organelles such as the 
lysosome. Once inside the mitochondria combines with protons found in the 
intermembrane space and is neutralized. This allows it to move across the inner 
mitochondrial membrane (taking the proton with it) into the mitochondrial 
matrix. Once inside the matrix the proton dissociates from the CCCP molecule 
making it negatively charged and therefore it moves back through the inner 
membrane to the positively charged intermembrane space where it then re-
combines with another proton and the process is repeated. This effectively 
destroys the proton gradient across the inner mitochondrial membrane by 
moving protons from the intermembrane space back to the mitochondrial 
matrix, effectively depolarizing the mitochondria. In the lysosome CCCP appears 
to act in a similar fashion as observed in the mitochondria, inside the lysosome it 
combines with the protons present again becoming neutral and then moves out 
of the lysosome taking the proton with it. Following which the proton dissociates 
from the CCCP again making it negatively charged and therefore it can move 
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back into the lysosome where it then re-combines with another proton and the 
process is repeated. This effectively destroys the acidic nature of the lysosome 
which inhibits its degradative function thus affecting the progression of 
mitophagy (102). 
In addition to the effect that CCCP has on these organelles it also affects the 
specificity of the probes mentioned above, specifically the localization of the 
mitotracker dyes. It has been shown that upon treatment with CCCP mitotracker 
dyes lose association with the mitochondria and instead segregate to the 
lysosome (102).  This is believed to result from CCCP driven dissipation of the 
mitochondrial membrane potential, and concurrent establishment of a 
membrane potential across the lysosomal membrane. This lysosomal membrane 
potential results from the abolition of the proton gradient across the membrane 
leaving the ionic counter gradients the lysosome imposes to compensate for the 
high internal proton concentration unbalanced. In summary CCCP abolishes the 
membrane potential of the mitochondria whilst imposing a membrane potential 
on the lysosome. As mitotracker probes rely on membrane potential for their 
specific localization upon CCCP addition they leave the mitochondria and enter 
the lysosome. This localization of mitotracker to the lysosome could be 
interpreted as the end stage of mitophagy (degradation of the mitochondria in 
the autolysosome). However it was noted that the mitochondria themselves 
were not always found to be localized to the mitochondria, indicating 
mitotracker localization to the lysosome can be independent of mitophagy (102). 
In summary the use of dyes to study mitophagy must be performed with caution 
due to uncertainties regarding specify and mode of action. Furthermore great 
consideration should be given when choosing the method to induce mitophagy 
due to off target effects on other organelles and/or the probes being used to 
study mitophagy.  
1.2 Disease associated with autophagy and mitophagy  
1.2.1 Cancer and Autophagy 
The role of autophagy in tumourgenesis is highly dependent upon the stage of 
cancer cell development; tumour initiation, tumour maintenance or progression 
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to malignancy. During the early stages of tumour development autophagy can 
offer a protective role, removing damaged and dysfunctional organelles and 
excess cellular components which could release or have potentially tumorigenic 
effects if allowed to persist within a normal cell, such as dysfunctional 
mitochondria releasing damaging ROS. Autophagic removal of p62 is highly 
important to prevent tumorgenesis.  p62 as mentioned previously is a known 
cargo receptor in autophagy, it binds and forms aggregates with the autophagic 
cargo prior to engulfment by the autophagosome and degradation. Failure of 
autophagy results in the accumulation of p62 aggregates which have been 
observed to cause liver damage and tumourgenesis (103, 104). Accumulation of 
p62 resulting from reduced autophagy has been linked to regulation of NF-κB 
activity in liver and lung cancer (104, 105). In this context it would appear 
beneficial to up-regulate autophagy and thereby reduce cancer initiation and 
progression; indeed anti-cancer drugs such as rapamycin specifically target the 
master inhibitor of autophagy mTOR leading to activation of autophagy with the 
goal of preventing these effects. 
However in an established cancer cell increased autophagy can actually be 
beneficial for tumour progression. Cancer cells tend to have much higher levels 
of metabolic stress compared to normal cells due to increased nutrient stress 
and hypoxia resulting from inadequate blood supply and increased metabolic 
demands to support increased growth and proliferation. One avenue of action 
cancer cells take to deal with these stresses is to activate autophagy to provide 
nutrients by breakdown of cellular components and using their basic constituents 
to generate ATP, which allows cell survival under these unfavourable conditions. 
However this must be coupled with defects in apoptosis as in apoptotic 
competent cells sustained nutrient deprivation and autophagy would result in 
cell death (106, 107). RAS driven cancers are observed to be reliant upon 
autophagy for survival (108, 109), their growth and proliferation rates are such 
that autophagy is essential to provide the nutrients required. However this 
makes them highly sensitive to autophagy inhibition; inhibition of autophagy in 
RAS driven tumours either results in growth arrest or more dramatically cell 
death. This would suggest that inhibition of autophagy in these tumour types 
could be exploited as therapeutic target. Hypoxia, has been shown to induce 
autophagy, through HIF1α activation, autophagy then reduces p62 levels 
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reducing its suppressive effect on RAS and ERK1/2 promoting cell survival under 
hypoxia (110). In such an environment it seems that inhibition of autophagy 
would also be an effective cancer treatment; reducing the nutrient supply to the 
hypoxic cells even further, forcing them into cell death. 
Based on this supporting role of autophagy in cancer progression therapeutic 
agents such as chloroquine are in clinical trials as a potential treatment for 
cancer. Chloroquine was originally developed as an anti-malarial drug, but was 
observed to affect the degradative power of the autolysosome making it relevant 
in the disruption of the autophagy pathway (111, 112). It enters the lysosome 
and becomes protonated and as a consequence reduces the acidity within the 
lysosome which reduces the function of the lysosomal enzymes. This prevents 
the completion of autophagy resulting in abolition of the nutrient supply through 
autophagy, which effectively starves a cancer cell that is dependent on 
autophagy for nutrients.  
However in many cancers autophagy is actually supressed, in breast, ovarian, 
hepatocellular carcinoma, lung adenocarcinoma, lymphoma and prostate cancers 
the function beclin1 a key pro-autophagy protein is frequently found to be lost 
(113-115). In addition it is also common to observe constitutive activation of PI-3 
kinase in cancer cells leading to activation of mTOR and thus inhibition of 
autophagy. It is understood that in this context PI-3 kinase mutations uncouple it 
from nutrient and growth factor availability allowing unchecked cell growth and 
proliferation (106). As a consequence the cell is unable to induce autophagy; this 
may in fact highlight a selective “Achilles heel” for cancer cells with PI-3 kinase 
mutations of this sort. These types of cells are balanced on a knife edge: any 
further increase of nutrient stress in cells unable to activate autophagy will 
result in cell death through nutrient starvation; yet normal cells able to activate 
autophagy should survive. However loss of autophagy in established cancer cells 
can increase the malignancy of the tumour. If autophagy is abrogated damaged 
and dysfunctional organelles will be allowed to persist within cancer cells. This 
would result in the release of damaging agents which can cause further 
tumorigenic mutations increasing the malignancy or perhaps metastatic ability of 
a cancer cell. Thus up-regulation of autophagy may again be an attractive 
therapeutic approach to prevent tumour progression or metastasis.  
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Autophagy represents a dichotomy in cancer treatment: on one hand in the 
initial stages of cancer, up-regulation of autophagy would allow for removal of 
damaged and dysfunctional organelles which would otherwise cause further 
tumorigenic mutations through release of damaging agents. However in later 
stages up-regulation of autophagy can provide the cancer cell with the nutrients 
it requires for further growth and proliferation, which would suggest inhibition 
of autophagy as a therapeutic approach in this case. However, autophagy is 
already down regulated in some types of cancer, and whilst this may represent 
an “Achilles heel” of sorts it also allows retention of mutagenic agents which 
could increase the aggressiveness of a tumour cell; in which case it is unclear if 
up-regulation or down-regulation of autophagy would be the most beneficial. 
The role of autophagy in cancer is clearly dependent on the type and stage of 
cancer. This highlights the complexity that must be addressed to target 
autophagy therapeutically.  
1.2.2 Mitophagy and Disease 
Mitophagy has been implicated in several disease pathologies; indeed much of 
the initial work in elucidating the regulatory stages and components behind 
mitophagy has its origins in disease models. Most notable is the discovery of the 
role of PINK1 and PARKIN in mitophagy; two proteins first identified through 
their tendency to be dysfunctional in neurodegenerative disorders such as PD. 
Mutations in both PINK1 and PARKIN have been implicated in PD, in addition 
mutations in PARKIN have also been observed to affect the susceptibility to 
leprosy, cancer and Alzheimer’s disease (AD) (OMIN 602544 & 608309 (116)). PD 
is a movement disorder characterized by bradykinesa, resting tremor, rigidity 
and postural instability. Pathological presentation includes degeneration of 
dopaminergic neurons and formation of Lewy bodies. It is generally a sporadic 
genetic disorder although rare familial cases have allowed for insight into the 
molecular events that give rise to this disease. Identifying mutations in several 
genes that appear to be involved in the disease presentation, PINK1 (PARK6) and 
PARK2 (encoding PARKIN) among them. Mutations in PINK1 and PARK2 that are 
associated with PD have been observed to reduce the incidence of mitophagy 
(117). One class of mutations observed to affect the RING1 domain of PARKIN, 
effects its ability to translocate to the mitochondria and its function (118). 
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Several chaperone proteins, such as HSJ1a, appear to be able to correct, to 
some level, the defects in mitophagy caused by mutations in the RING1 domain 
of PARKIN observed in PD, and as such represent interesting targets for the 
treatment of PD (118). The RING domains of PARKIN are important for protein 
structure and stability, therefore it is unsurprising that chaperone proteins with 
roles in protein folding, translocation and cellular response to mis-folded 
proteins effect the stability, location and activity of PARKIN, particularly for 
mutant forms of PARKIN that fail to fold correctly (118). 
PINK1 and PARKIN have been studied in mitophagy following a catastrophic 
failure of mitochondria (brought on by CCCP treatment for example). However in 
age related diseases such as PD and AD, mitochondrial damage will be slow and 
progressive (116). In this physiological setting PINK1 and PARKIN were observed 
to perform the same function as observed under the dramatic induced conditions 
of CCCP damage. Whilst this supports a role for PINK1/PARKIN in mitophagy 
under a more physiologically relevant setting, recent evidence suggests 
otherwise (119). Utilizing a mouse model which, due to loss of the mitochondrial 
transcription factor TFAM gives, depletion and abolition of expression of 
mitochondrial DNA (medina) and disrupting the ETC. This causes a progressive 
neuro-degeneration over time, reminiscent of that observed in PD patients. Both 
mitochondrial fragmentation and formation of mitochondrial aggregates were 
observed in dopaminergic neurones of the substantia nigra (those primarily 
affected in PD); however no mitochondrial localisation of PARKIN was detected. 
Indeed upon knockdown of PARKIN the expected worsening of the phenotype of 
the TFAM knockdown was not observed. This suggests that whilst PARKIN may be 
required for mitophagy in cultured cells it is not required in vivo (119). However, 
whilst this is an improved system in comparison to the use of cell lines it is not 
without its pitfalls and these may account for the differences observed. Knock 
out of TFAM not only affects transcription of the genes encoding proteins of the 
respiratory chain but as it is an essential protein to the mitochondrial basal 
transcription machinery it will affect transcription of all genes encoded upon the 
mitochondrial DNA. Although several mitochondrial proteins have already been 
identified as potential ‘receptors’ for PARKIN recruitment to the mitochondria 
(27, 66, 72) there may be others that are yet unidentified and encoded by the 
mitochondria DNA. Which may be if not essential, at least required in 
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combination with those already identified, and as such this global inhibition of 
mitochondrial derived protein synthesis may be preventing expression of such a 
crucial receptor. In relation to this it has been observed ex-vivo that PARKIN 
binds to and ubiquitinates complexes of the ETC targeting them for degradation 
by the proteasome (83). Perhaps the binding of PARKIN to defective ETC 
complexes as observed here not only serves to target them to the proteasome 
but also enables PARKIN recruitment to the dysfunctional mitochondria. The 
abolition of transcription of the mtDNA in this model prevents transcription of 
the ETC complexes and thereby may prevent such a recruitment occurring. In 
essence the complete abolition of mtDNA transcription does not in my opinion 
represent a physiologically representative scenario in which to study PARKIN 
recruitment to the mitochondria.  Furthermore, the availability of stabilised 
PINK1 upon the mitochondrial membrane was not investigated, and therefore it 
may be that the lack of mitochondrial recruitment in this model was due to lack 
of PINK1, which prevented PARKIN recruitment.   
In addition to reduced mitophagy in PD, ATP synthesis and mitochondrial 
network branching are significantly reduced when PARK2 is mutated, whilst 
levels of oxidative stress and mitochondrial mass are increased (120). It has been 
suggested that this is due to the secondary function of PARKIN in regulating 
mitochondrial function and morphology, (120). However these other effects 
could be the result of reduced mitophagy and consequential maintenance of 
damaged and dysfunctional mitochondria due to failure in PARKIN mediated 
mitophagy preventing them being degraded. As such mitophagy represents a 
potential target for therapy in PD patients.  
PARKIN has also been implicated in other disease pathologies. It has recently 
been identified as a key regulator of mitophagy in cardiac tissue. The heart is 
one of the highest energy consuming organs in the body, and as a consequence 
its cells are packed full of mitochondria. Due to this constant high energy 
demand the mitochondria deteriorate quickly through excessive use. As such 
cardiac tissue requires continuous mitophagy and mitochondrial biogenesis to 
remove and replace worn out damaged and dysfunctional mitochondria. 
Reduction in the incidence of mitophagy with time has been linked to cardiac 
aging and dysfunction (121). In cardiac dysfunction p53 is observed to bind 
cytosolic PARKIN at its RING0 domain and prevents translocation to mitochondria 
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and mitochondrial clearance by mitophagy (121). p53 inhibition of PARKIN has 
been observed in heart disease and cardiac aging indicating that inhibition of 
p53 could aid in the treatment of these conditions, and may affect the incidence 
of heart failure. However such a treatment obviously comes with risks; p53 is a 
powerful and crucial tumour suppressor, its indiscriminate inhibition would lift 
this suppressive effect allowing cancer initiation. However it does not preclude 
suppression of p53 interaction with PARKIN as a treatment. One possibility would 
be a therapy specifically targeting the p53 interaction with PARKIN whilst 
leaving its tumour suppressive capabilities untouched. Alternatively, perhaps 
through focusing on PARKIN enhancing its activities or expression to counteract 
the p53 effect would be more viable. 
Mitophagy in PD and cardiac aging, occur in organs of high energy demand, the 
brain and heart respectively, where it is logical that issues with the energy 
producing centres, mitochondria, would be influential in disease presentation 
and progression. The same is also true in diabetes mellitus type II, where 
increased glucose levels result in excessive mitophagy and cell death (122). Here 
insulin insensitivity results in high glucose levels pushing the mitochondrial 
respiration rate higher. This results in increased levels of mitochondrial 
damage/dysfunction and ROS etc. leading to mitophagy induction, the level of 
which will determine if the cell in question survives or is targeted for mitophagic 
cell death. However mitophagy also has roles in diseases where energy demand 
or production is not at the heart of the disease.  
Systemic lupus erythematosus SLE is an autoimmune condition resulting from 
abnormal T-cell activation. Accumulation of dysfunctional mitochondria has 
been identified as a cause for abnormal T-cell activity in SLE, which suggests a 
defect in mitochondrial quality control (123). HRES1/Rab4 is found to be over-
expressed in SLE patients and it promotes the lysosomal degradation of DRP1, 
preventing mitochondrial fission which is required for mitophagy to progress; as 
such over-expression (as observed in SLE) of HRES1/Rab4 results in abrogation of 
mitophagy and accumulation of damaged and dysfunctional mitochondria (123). 
Inhibition of HRES1/Rab4 in mice prevents DRP1 degradation, allowing fission to 
occur and damaged mitochondria to be removed by mitophagy resulting in 
reduced disease presentation (123). In this case it is the effect of the damaged 
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mitochondria upon the T-cell that results in disease (not energy demand) due to 
insufficient mitophagy.  
By contrast in Crohn’s disease high levels of mitophagy are responsible for 
disease manifestation. Crohn’s disease is a form of inflammatory bowel disease. 
It arises from a variety of mutations which appear to affect the immune 
response to bacterial attack. Crohn’s is an episodic disorder meaning that an 
individual can be unaffected one day and severely affected the next, it is not 
solely dependent upon genetics but also environment, with episodes of Crohn’s 
often linked to increased bacterial presence in the gut. Immunity related GTPase 
M (IRGM), is responsible for initiating an autophagy response to invading 
intracellular pathogens. Mutations within the IRGM gene which affect function 
have been identified as a risk factor in the development of Crohn’s disease (43). 
Recently affinity of IRGM for CL has been identified. IRGM translocates to the 
mitochondria binding CL, following which it is internalised and is found on the 
inner membrane or matrix (124). It can affect mitochondrial dynamics, 
mitochondrial polarity, mitophagy and ultimately cell death by apoptosis or 
necrosis. IRGM1 is the only IRG found in humans and its expression is very low 
and tightly regulated. It represents an archaic immune defence system of the 
cell, highlighted by its affinity for mitochondria specifically CL. This suggests, 
given the origins of mitochondria (section 1.3.3), that IRGM drives a primordial 
immune response against any invading microbe. Mutations in IRGM linked to 
Crohn’s appear to cause an over-reaction to bacterial attack by IRGM, triggering 
high levels of mitophagy, inflammation and necrotic cell death. All of which are 
ordinarily tightly controlled in unaffected individuals. Inhibition of mitophagy in 
this case, or indeed binding of IRGM to the mitochondria, may reduce disease 
severity.  
1.2.2.1 Cancer and Mitophagy 
The role of mitophagy in cancer is unclear with few therapeutic approaches 
aimed at targeting mitophagy. Given that mitophagy is a subtype of autophagy it 
is probable that a similar dichotomy would arise where the timing of mitophagy 
could have either cancer promoting or inhibiting effects. To date little research 
has focused on mitophagy in cancer however some tentative investigations have 
been undertaken. 
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One key area in which mitophagy is implicated in a potentially tumour promoting 
role is in cell survival under hypoxia, as mentioned above (section 1.3.5.3). 
Hypoxic environments are frequently encountered by cancer cells in solid 
tumours as they outgrow the surrounding blood supply, resulting in a solid 
tumour mass with a hypoxic centre. This not only deprives the tumour cells of 
oxygen but the limited blood supply is also restrictive in terms of nutrients. In 
such environments cancer cells employ a multifaceted response, allowing cells 
to be maintained whilst simultaneously attempting to rectify this deadly issue by 
inducing the development of a more extensive blood supply. Mitophagy under 
hypoxia is found to be induced by activation of BNIP3. This causes the removal of 
the mitochondria preventing their cytotoxic affects resulting from increased ROS 
generation. ROS levels are increased due to the effect of the low oxygen 
concentration limiting the efficiency of mitochondrial respiration. This increase 
in ROS would also induce mitochondrial mediated apoptosis, see section 1.3.5.3 
and (14, 19, 110). Thus removal of mitochondria in cancer cells by mitophagy 
not only mitigates the damaging effects of ROS but also promotes cell survival by 
preventing induction of the mitochondrial cell death pathway. From this it would 
appear that inhibition of mitophagy would serve as an effective tool in cancer 
treatment, allowing persistence of mitochondria under hypoxia would elevate 
ROS to toxic levels which would lead to cell death. However, we should not 
forget that prolonged BNIP3 expression can cause necrotic cell death (14, 19). 
Thus up-regulation of BNIP3 mediated mitophagy may serve as a better 
treatment pushing cancer cells into necrotic cell death, however necrotic cell 
death itself can be tumourgeneic due to the release of potentially damaging 
agents to the extracellular environment and the inflammatory response it 
induces. 
The mitophagy protein PINK1 has been implicated in regulating the autophagy 
and apoptotic machinery in addition to its role in mitophagy (125, 126). It has 
been observed to bind beclin 1 and thus promote autophagy whilst also 
phosphorylating Bcl-xL preventing its pro-apoptotic cleavage, which together 
gives PINK1 a pro-survival role in cancer by inhibiting cell death and up-
regulating autophagy to provide nutrients.  Although in neither case was there 
observed an effect on mitophagy, it does not preclude a mitophagy response as 
part of PINK1’s pro-survival role. 
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As with autophagy mitophagy represents a double edged sword in terms of a 
target for cancer treatment, and further investigation and understanding of the 
role of mitophagy in cancer is required before it can be considered as a 
therapeutic target.  
1.3 Barth syndrome, Tafazzin and Cardiolipin 
1.3.1 Cardiolipin 
Cardiolipin (CL) is a phospholipid consisting of four acyl chains linked by a 
backbone of three glycerol groups. It was given the name cardiolipin as it was 
first isolated from cardiomyocytes taken from a bulls heart (127). CL is also 
known as bis-(1, 2-diacyl-sn-glycero-3-phospho)-1’, 3’-sn-glycerol and is 
exclusively within the mitochondrial membrane within mammalian cells (128, 
129). CL is a unique type of phospholipid in that it is composed of phosphatidic 
acid (black in Figure 1:3) and phosphatidylglycerol (red in Figure 1:3) joined by a 
three glycerol groups to give cardiolipin Figure 1:3. 
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Figure 1:3- Structure of Cardiolipin 
Above is the structure of a mature cardiolipin, composed of four unsaturated acyl chains (linoleoyl) 
and a polar head group. 
The biosynthesis of CL occurs through the pathway detailed in Figure 1:4 (130, 
131). Synthesis begins with the conversion of phosphatidic acid (PA) to CDP-
diacylglycerol (CDP-DAG), by CDP-diacylglycerol synthase (CDP-DAG synthase).  
Phosphatidylglycerophosphate Synthase (PGP synthase) then adds one molecule 
of glycerol-3-phosphate to CDP-DAG generating phosphatidyl-glycerol-3-
phosphate (PGP) which is immediately dephosphorylated by PGP phosphatase to 
phosphatidyl-glycerol (PG). Cardiolipin synthase (CL synthase) an enzyme unique 
to cardiolipin synthesis (132), joins one molecule of PG to a molecule of CDP-
DAG forming cardiolipin (CL). This form of CL is described as immature and the 
enzymes that have aided in its synthesis to this point have no specificity for acyl 
chain length or degree of saturation. As such, remodelling of the immature CL 
moiety is required and this process is governed by phospholipase A and the 
specific CL remodelling enzyme Tafazzin (TAZ) (129). Phospholipase A removes 
one acyl chain from the immature CL moiety transforming it into 
monolysocardiolipin (MLCL); TAZ then preforms the re-acylation reaction using 
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its acyltransferase activity to transfer an unsaturated acyl chain from 
phosphatidylcholine (PC) to MLCL. This cycle of deacylation and re-acylation is 
repeated four times until all the acyl chains of the immature CL are replaced by 
polyunsaturated acyl chains by TAZ (129). 
CL has many functional roles within the membrane of the mitochondria, as 
mentioned in section 1.3.4 and 1.3.6. It is also instrumental to the pathology of 
the disease Barth syndrome which will be discussed in more detail in section 
1.5.3. Many of the symptoms of Barth syndrome result from reduced function of 
the ETC within the mitochondria, resulting in low production of ATP. The reason 
for this is that CL also has a functional role within the ETC, stabilising and 
increasing the efficiency of the respiratory complexes.  
The complexes of the ETC in mammals are often found to be organised into 
super complexes, (133, 134). It is believed that these super complexes confer 
greater efficiency on the ETC and reduce the production of ROS, compared to 
cases where super complexes are absent (18, 135-137). CL binding has been 
observed for each complex of the ETC, with identification of binding sites in 
critical locations on Complex III and IV, (42, 138-142). CL is believed to provide 
the critical interface between adjacent complexes within a supercomplex, and 
were CL is lacking the presence of supercomplexes are diminished. Complex II is 
the only component of the ETC which to date has not been shown to form CL 
dependant supercomplexes with the other enzymes in the ETC. 
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Figure 1:4- Biosynthesis of cardiolipin 
Above is a depiction of the pathway and enzymes involved in biosynthesis and maturation of 
cardiolipin, enzymes are highlighted in purple, products highlighted in green and chemical 
structures adjacent to each product. 
However CL is still critical to the function and formation of complex II. CL 
stabilises the subunits of Complex II allowing the complete Complex to form, 
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specifically the membrane bound heterodimer and the catalytic heterodimer. Its 
interaction with the catalytic subunit was also shown to be essential for the 
complex to operate at its full capacity (41). Its presence in the lipid bi-layer 
around this complex also has a role in the lowering ROS production from this 
enzyme, (41).  
In addition to its role in mitochondrial ATP production CL has also been 
implicated in mitochondrial driven apoptosis (143-145). During apoptosis CL acts 
as a binding platform for caspase-8 which translocates and embeds itself in the 
mitochondrial membrane upon the CL platform, allowing for its further 
activation enabling it to cleave Bid to form pro-apoptotic tBid. CL is also 
required for the release of cytochrome c, tBid binding to the mitochondria and 
BAX oligomerisation during apoptosis.  
1.3.2 Tafazzin 
As mentioned briefly above the synthesis of mature CL relies completely on the 
function of the acyltransferase tafazzin (TAZ) (129). It uses acyl groups 
(linoleoyl) from phosphatidylcholine (PC) and transfers them to 
monolysocardiolipin (MLCL). It can utilize acyl groups from 
phosphatidylethanolamine (PE) and phosphatidic acid (PA), although the use of 
these two lipids is much lower than the use of PC. It is also noted that the 
transfer can occur in reverse, from CL to PC but again the occurrence of this 
reaction is much reduced compared to the PC to CL reaction mediated by TAZ 
(129).  
The gene identified as encoding tafazzin was known as G4.5 and resides upon 
the distal region of the X-chromosome, Xq28 (146). This gene encodes a 
transcript which can be differentially spliced giving rise to twelve spliceforms, 
as seen in Figure 1:5, and these are translated into a variety of different 
isoforms of the TAZ protein (146). The functional significance of each isoform is 
still under investigation, they may have tissue specific functions or some 
isoforms have a preference for specific acyl groups over others and or catalyse 
the reverse reaction of CL to MLCL rather than MLCL to CL (147).  
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Figure 1:5- Twelve isoforms of TAZ. 
Above is a schematic showing initially the entire layout of the gene encoding for TAZ below which 
are given the representations of the various isoforms of TAZ generated by differential splicing of 
the transcript generated from the TAZ gene. The first six represent isoforms generated from the 
first open reading frame of the transcript, whilst the final six represent isoforms generated from the 
second open reading frame of the transcript. 
Six of the transcripts produced have been assessed in various different tissue 
types; full length, Δexon5, Δexon7, Δexon 5&7,Δexon 6&7 and Δexon 5,6 &7 
(148). All were observed to be present at similar levels to each other in each 
tissue type, with the exception of the Δexon 6&7 spliceform which was 
exceptionally low in all tissue types whilst the pancreas and spleen showed the 
highest levels of any TAZ transcript of all the tissue types tested (148). However 
this pattern of mRNA expression does not correlate with levels of puCL detected 
in each of the tissues. This indicates that there may be a difference between 
mRNA expression and protein expression or activity, and that further 
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investigations into tissue specific protein expression is required. All spliceforms 
of human TAZ localise to the mitochondria in drosophila, suggesting the 
targeting sequence for TAZ must be in the N-terminal section of tafazzin, (149). 
Only full- lengthTAZ and TAZΔexon5 have acyltransferase activity, with 
TAZΔexon5 having the greatest activity of the two, suggesting that exon7 is 
essential for function, and these two isoforms are the only functional isoforms in 
terms of mature CL synthesis (149, 150). Full- lengthTAZ can restore muscle 
activity in mutant TAZ Drosophila melanogaster fully, whilst this recovery was 
only partial upon TAZΔexon5 expression. Both isoforms restored male fertility, as 
well as defects observed in respiration, and rescued the CL profile from an 
abnormal profile of high MLCL and low mature CL to the wild-type profile with 
high mature CL levels and low MLCL. The TAZΔexon5 and full- lengthTAZ protein 
isoforms are found within large protein complexes within the mitochondria, with 
the full- length TAZ dissociating more readily than the TAZΔexon5 isoform 
suggesting that full- lengthTAZ is less integrated into the mitochondrial 
membrane than TAZΔexon5 (149). Interestingly only TAZΔexon5 can fully rescue 
the growth defect in yeast caused by loss of yeast TAZ expression (150), but 
both TAZΔexon5 and full- length TAZ could rescue the CL profile back to wild-
type; however the rescue by full- lengthTAZ was only partial in this case. Full- 
lengthTAZ is only present in higher organisms and as it is non- functional in 
yeast, (150) there is a suggestion that the exon5, absent in lower organisms, has 
an as yet unknown function in higher organisms. A polymorphism found in exon 5 
in 4% of African Americans has been linked to idiopathic cardiomyopathy and as 
such may indicate a role for exon5 in TAZ in the development and function of 
the human heart (149).  
Mutations in TAZ cause disruption to the CL profile prior to terminal 
differentiation of cells, however structural abnormalities such as distortion of 
mitochondrial morphology and structure only become apparent following 
differentiation (151). The cristae within TAZ mutant cells are found to be 
distorted and mitochondria are observed to be swollen (151). Such structural and 
functional defects associated with mutations in TAZ made it the prime candidate 
for the gene involved in Barth’s syndrome. 
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1.3.3 Barth Syndrome 
Barth’s syndrome is a human X-linked recessive genetic disease first 
characterized in 1983 by P.G. Barth, with patients presenting with clinical 
symptoms of dilated cardiomyopathy, ventricular hypertrophy, neutropenia and 
skeletal myopathy (152). All patients described were male, in line with an X-
linked recessive disorder, and all died in infancy or early childhood whilst female 
carriers appeared unaffected. Electron microscopy of cardiac tissue revealed 
enlarged sarcoplasmic space filled with swollen spherical mitochondria. The 
mitochondria showed intact outer membrane, whilst the cristae were severely 
disrupted and matrix observed to be of lower electron density than was usual. 
Lipid droplet number was found to be slightly increased, and the activity of the 
ETC was diminished in isolated skeletal mitochondria from Barth’s patients. The 
diminished activity of the ETC was found to result from a block in the respiratory 
chain following ubiquinone most probably due to the significantly reduced levels 
of cytochrome C (152). Further investigation indicated that the activity of 
Complexes III and IV were diminished in Barth syndrome patients and that this 
was the result of reduced stability and formation of both of these complexes 
which must be dependent upon the gene product that is mutated in Barth 
syndrome (153).  
Later it was discovered that the levels of CL in Barth’s syndrome patients were 
reduced, more specifically the levels of polyunsaturated CL (puCL) were 
significantly lower than that normally observed (55). This loss of mature puCL 
coincided with a reciprocal increase in MLCL, (59, 98). These discoveries quite 
clearly implicated TAZ as the gene involved in Barth’s syndrome, due to its 
function in conversion of MLCL to mature CL. TAZ was later identified as the 
gene involved in Barth’s syndrome, its X-chromosome location and reduced 
levels of mature CL all aligned with the presentation of the disease, whilst 
genetic linkage analysis confirmed this to be the case (146). Barth’s associated 
mutations in the TAZ gene did not always preclude transcription from the gene, 
indeed increased levels of transcripts have been observed in Barth’s patients 
perhaps as an attempt to compensate for reduced function of the enzyme 
however, this could not be correlated to protein levels at the time due to lack of 
reliable antibodies specific for TAZ (148). 
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Since the discovery of mutations in TAZ and reduced CL as the causal agents in 
Barth syndrome, much work has focused on how the loss of TAZ function and 
mature CL causes the phenotypic presentation of Barth syndrome.  
Many mutations within the TAZ gene have been observed to cause Barth’s 
syndrome, with varying degrees of severity, suggesting that how the TAZ protein 
is affected by mutation could have a bearing on disease severity. Three non-
catalytic defects can effect TAZ activity and hence puCL production: 1) 
Mutations in the localisation signal preventing TAZ localising to the 
mitochondria; 2) Mutations effecting expression levels such that reduced levels 
of TAZ are present in the cell; 3) Mutations affecting TAZ stability such that the 
protein is unstable and/or degraded at an accelerated rate by the proteasome 
(147). These three classes of mutation do not affect the activity of the TAZ 
protein directly, but affect its ability to reach the mitochondria, or be present in 
high enough concentrations to be effective. Catalytic defects in TAZ obviously 
affect its function; in this case localisation, expression levels and stability of TAZ 
are normal. However their lack of transacylase activity will clearly prevent TAZ 
function. This abolition can be 1) complete, with no residual TAZ activity, 2) or 
result in attenuated function where the MLCL to CL reaction does occur but to a 
significantly reduced level, or 3) where the activity of TAZ is biased to the 
lysoPC to PC reaction rather than the MLCL to CL reaction, i.e. the reverse 
reaction from that which generates mature CL (147).  
Whatever the mutation the effects, although varying in severity are the same. 
Recent research has investigated how mutations in TAZ and reduction of mature 
CL affect cellular function, with the aim of better understanding the disease 
pathology and deriving new treatments. Quite unsurprisingly, given the role of 
CL in the stability and function of the complexes and supercomplex in the ETC, 
Barth’s syndrome derived cells and models showed decreased complex and super 
complex number and OXPHOS activity, (40) with the exception of patient 
derived lymphoblasts which did not show decreased OXPHOS activity despite 
reduced levels of supercomplexes and individual complexes being observed 
(154). With reduced OXPHOS activity was observed reduced membrane 
potential, most probably resulting from inability to generate the proton gradient 
and electron leakage due to reduced supercomplex formation. Glycolysis is 
unable to compensate for reduced respiration in Barth’s like induced pluripotent 
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stem cells, although increased levels of lactate observed in these cells suggests 
the glycolysis rate is increased perhaps in an unsuccessful attempt to 
compensate (40).  
In addition to direct effects on energy production, defects in mitochondrial 
morphology, biogenesis and cell death have also been observed in Barth’s 
syndrome. Barth’s derived cells have more and larger mitochondria with 
disordered cristae and reduced surface area (154). Given the role of CL in OPA1 
cristae remodelling it is reasonable to think that this morphology results from 
lack of CL interaction with OPA1. However, no effect on OPA1 was seen in Barth 
syndrome cells, suggesting that for this interaction it is the head group of CL not 
the acyl chains that govern the interaction, since CL is still present in Barth’s 
syndrome only at its immature stage with invariably highly saturated acyl chains 
(154). Therefore some other function of CL causes this abnormal cristae 
presentation. Apoptosis is blocked, despite increased MLCL levels which would 
increase the ability of tBid to bind to mitochondria, suggesting the blockage is 
prior to Bid cleavage (119). Caspase 8 fails to bind mitochondria that lack 
mature cardiolipin (143). Therefore Barth cells cannot undergo mitochondrial 
driven apoptosis as they lack the Bid/Caspase8 activation platform due to 
reduced levels of mature CL which renders Bid cleavage by caspase 8 impossible.  
1.3.4 Cardiolipin and Mitophagy 
Barth’s syndrome causes a variety of mitochondrial malfunctions resulting in 
dysfunctional and damaged mitochondria, which should result in their 
degradation by mitophagy. However, as we can still observe these 
damaged/dysfunctional mitochondria within the cells of Barth’s syndrome 
patients it would suggest mitophagy is not occurring, or at least not to the level 
required to remove these dysfunctional mitochondria. How each mitochondrion 
is targeted for mitophagy is a continually evolving area of research. Most of the 
focus is upon the proteins that associate with the mitochondria prior to and 
during mitophagy, acting as signals to the autophagic machinery that the 
mitochondria is ready to be degraded. However, the signal that recruits and or 
activates these proteins is poorly understood. Most of the proteins associated 
with mitophagy interact with the mitochondrial membrane; therefore perhaps 
the primary signal for mitophagy is generated within the mitochondrial 
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membrane itself. The mitochondria have two membranes, the inner and outer 
membranes, which are made up of various different lipids. Yet Cardiolipin is the 
only lipid which is found exclusively within the mitochondrial membrane in 
mammalian cells, i.e. it is specific for the mitochondria.  
The remodelling of CL by TAZ produces a mature polyunsaturated form of CL. As 
an unsaturated lipid CL is a prime site for oxidation, attack by ROS will result in 
oxidised CL. Elevated ROS levels are a hallmark of a malfunctioning 
mitochondria, and would result in the oxidation of CL, i.e. oxidized CL (oxi-CL) 
levels would be greatly increased in dysfunctional mitochondria. Therefore the 
presence and level of oxi-CL would be an excellent indicator of mitochondrial 
health. The change in structure of CL brought about by oxidation may be 
recognised by as yet unknown binding motifs in some of the mitophagic proteins. 
oxi-CL may provide a binding platform for mitophagic proteins similar to that 
described for caspase-8 and tBid (143). Alternatively due to its functional role in 
mitochondrial processes such as OXPHOS CL may alter the activity of the ETC 
and given that reduced ETC activity is a known stimulator of the mitophagy 
response initiate mitophagy in this way. In addition the exclusive location of CL 
within the mitochondrial membranes makes it highly specific to mitochondria 
and thus mitophagy. As such it is possible that the oxidation of CL could be the 
initiating signal for mitophagy.  
The likelihood of CL as the mitophagy inducing signal has not gone unnoticed by 
others. As discussed above it has been shown to act as a binding partner for 
IRGM stimulated mitophagy in the innate immune response to bacterial infection 
in Crohn’s disease (124). More recently the activity of an enzyme called ALCAT1 
under oxidative stress upon CL has highlighted a potential role for CL in 
mitophagy (155).  
ALCAT1 is a lysocardiolipin transferase that remodels CL in response to oxidative 
stress and abrogates mitochondrial fusion through depletion of Mfn1 and 2 (156). 
It causes increased oxidative stress, lipid peroxidation and mitochondrial DNA 
depletion (155). ALCAT1 remodels CL to give it fatty acid chains that are highly 
polyunsaturated, with increased levels of DHA, (Docosahexanoic acid), instead of 
conventional tetralinoleoyl CL (TLCL), which makes it excessively prone to 
oxidative attack. Loss of conventional TLCL in many age related diseases has 
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been indicated as a cause of disease. ALCAT1 expression is found to be highly 
up-regulated in age related diseases; diabetes, obesity and cardiomyopathy. The 
remodelling of CL in this fashion increases ROS levels and mitochondrial 
dysfunction and damage, which in turn leads to CL peroxidation. The increase in 
oxi-CL present under elevated ALCAT1 expression and action induces a 
mitophagy response removing the damaged and dysfunctional mitochondria 
(155).  
Loss of TLCL is also noted in Barth syndrome, though in this case it results from 
loss of TAZ activity and decreased levels of unsaturated fatty acid components in 
CL, however strikingly the pathological presentations are similar to those 
observed in ALCAT1 over-expression. It appears that we observe here the two 
polar opposites in terms of saturation status of CL. In Barth’s syndrome where 
TAZ is non-functional we see low or non-existent levels of puCL, whilst diseases 
associated with ALCAT1 expression we see highly elevated levels of puCL above 
those expected in healthy cells and this causes many deleterious effects, but for 
us most notably are the highly elevated levels of mitophagy. In this scenario 
(ALCAT1 expression) high levels of mitophagy appears to be deleterious, as 
observed in many other cases of diseases where mitophagy levels are elevated 
(section 1.4). More importantly though it highlights that oxidation of CL is 
required for mitophagy to proceed; in Barth syndrome cells this is near 
impossible due to the lack of puCL to be oxidized. Therefore between these two 
situations we observe the need for puCL in cells in order that it may be oxidized 
upon mitochondrial damage and dysfunction and act as a signal to induce 
mitophagy; however we also observed that the level of puCL or unsaturation of 
CL is critical to the health of the mitochondria and cell. To little results in Barth 
syndrome with all its symptoms, which may also be related to reduced 
mitophagy levels, and too high and the results can be equally as devastating as 
observed on ALCAT1 expression.   
The effects of ALCAT1, clearly highlight the role of oxi-CL in mitophagy, 
however recent work suggests that the reverse may be true (157). In a mouse 
model of Barth’s syndrome strange ‘onion’ like mitochondria with densely 
packed layers of cristae were observed and believed to represent mitochondria 
undergoing mitophagy. However they also observed an increase in abundance of 
mitochondria and mitochondrial DNA, which does not align with increased levels 
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of mitophagy. They also observed increased levels of vacuoles in the cell from 
the mouse model, whilst these could be viewed as evidence of increased 
mitophagy levels, it could be that these vacuoles are increased in number due 
ever increasing attempts to induce mitophagy but, due to lack of the oxidized 
puCL signal discussed above they fail to engulf the mitochondria, giving 
accumulation of empty autophagic vacuoles. This could account for the large 
numbers of empty vacuoles observed and the increased mitochondrial and 
mitochondrial DNA, whilst the ‘onion’ like mitochondria could be the result of 
severe morphological abnormalities due to lack of puCL . However all other 
observations they make upon mitochondrial size, morphology and the gross 
pathology of tissues and the entire mouse are concurrent with a Barth’s 
syndrome phenotype as outlined above, (152, 157). The evidence from the 
mouse model regarding mitophagy appears self-contradicting, the maintenance 
of mitochondrial mass and mitochondrial DNA along with increased incidence of 
vacuoles within the cells seems to suggest a blocked mitophagy process yet the 
authors specifically state that mitophagy is indeed increased based on an 
observed onion like phenotype of mitochondria. Furthermore it directly 
contradicts the findings of others (discussed above) which suggests an absolute 
requirement of puCL for the formation of oxi-CL and initiation of mitophagy 
(155, 156). In either case it appears that puCL is important in mitophagy, 
although why it is important is currently unclear. Further investigation is 
required to clarify what role puCL has to play in mitophagy.    
1.4 Aims and Hypothesis 
The process of mitophagy is a new and developing area of research where the 
scientific community is identifying the key steps and components of the 
pathway, some of which are discussed above. However although a multitude of 
proteins have been identified as translocating to and acting upon damaged 
mitochondria prior to autophagosomal engulfment it is still unclear how a 
mitochondrion signals to each of these proteins of its damaged status. As 
mentioned above cardiolipin is involved in numerous mitochondrial processes. 
The nature of cardiolipin with multiple unsaturated acyl chains makes it a prime 
target for oxidative attack and oxidation, indeed it has be shown in vitro that CL 
is readily oxidized by hydrogen peroxide in the presence of the mitochondrial 
protein cytochrome C (105, 109). Damaged and dysfunctional mitochondria have 
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increased levels of ROS, which effectively create the same conditions described 
for oxidation of CL by cytochrome C in vitro; CL cytochrome C and ROS all 
together in the confined space of the mitochondria. It is possible therefore that 
this would result in CL oxidation making it a key indicator of mitochondrial 
health and function and thus a potential signalling molecule in mitophagy.  
The central hypothesis of this thesis is that the oxidation of Cardiolipin, resulting 
from oxidative attack by reactive oxygen species derived from damaged and or 
dysfunctional mitochondrial, acts as the initiating signal for mitophagy.  
To test this hypothesis comparisons were made of cells devoid of mature 
cardiolipin (derived from Barth syndrome patients) and therefore unable to form 
oxidized cardiolipin against cells containing a healthy complement of cardiolipin 
species and thus able to form oxidized cardiolipin, in an attempt to test the 
hypothesis five key aims were questions were addressed: 
1. Determine if mitophagy is affected by the lack of mature puCL 
2. Show an increase in oxidation of cardiolipin upon mitophagic stimuli in 
cells with a healthy complement of CL species and observe that this does 
not occur where cells lack mature puCL. 
3. Investigate if mitochondrial dynamics were affected by lack of mature CL 
which could affect mitophagy. 
4. Determine if mitochondrial morphology and function are affected by lack 
of mature CL and any associated lack of mitophagy.  
5. Develop methods by which imaging data may be quantitated to allow 
accurate measurement of mitophagy from microscopy data.  
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 Chapter 2 Materials and Methods 
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2.1 Materials 
2.1.1 Reagents 
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Table 1- Chemicals and Kits 
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2.1.2 Equipment 
 
Table 2- List of Equipment 
 
2.1.3 Antiserum 
2.1.3.1 Primary Antibodies 
 
Table 3- List of Primary Antibodies 
 
2.1.3.2 Secondary Antibodies 
 
Table 4- List of Secondary Antibodies 
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2.1.4 General buffers and solutions 
 
Table 5- List of General Buffers and Solutions 
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2.1.5 Vectors and Plasmid constructs 
 
Table 6- List of Vectors and Plasmids 
2.2 Experimental procedures 
2.2.1 Fibroblast Cell culture  
Four human fibroblast cell lines were provided by Frédéric M. Vaz from The 
Laboratory of Genetic and metabolic diseases at the University of Amsterdam: 
C106 and C109 (CONTROL_1 and CONTROL_2 respectively) as control cells and 
Taz001 and Taz003 (TAZMUT_1 and TAZMUT_3 respectively) fibroblasts isolated 
from Barth’s syndrome patients. These were immortalised by Zach Schug prior to 
my work through stable htert expression. From the TAZMUT cells two further cell 
lines were generated TAZREV_1 and TAZREV_3; giving in total six cell lines. 
The cells were routinely cultured in DMEM supplemented with 10% FCS and 1% L-
glutamine at 37°C under 5% CO2. The serum was heat inactivated at 56°C for 30 
minutes prior to use. Cells were grown to confluence in 15cm plates at which 
time they were split 1:2. To split cells, media was removed and cells washed 
once with pre-warmed PBS (10ml per 15cm plate), then cells were detached 
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with 1X trypsin (5ml per 15cm plate) and the plate returned to 37°C until the 
cells have completely detached. 
2.2.2 RetroPackTM PT67 cells 
The PT67 cell line is commercially available from Clonetech, and is designed to 
package retrovirus with an amphotropic envelope as described in section 
2.2.8.2. The cells were cultured in DMEM supplemented with 10% FCS and 1% 
glutamine and grown at 37°C at 5% CO2. Cells were always split at 80-90% 
confluence 1:10 in 10cm plates, using 1X trypsin to detach cells. Prior to 
transfection cells were seeded at 4x106 cells per 10cm plate. 
2.2.3 HEK293T 
HEK293T cells are packaging cells used for lentiviral production as described in 
section 2.2.8.4. The cells were cultured in DMEM supplemented with 10% FCS 
and 1% glutamine and grown at 37°C at 5% CO2. Cells were always split at 80-90% 
confluence 1:10 in T175 flasks, using 1X trypsin to detach cells. Prior to 
transfection cells were seeded at 4x106 per 10cm plate.  
2.2.4 Freezing and thawing cells 
Frozen cell stocks were created for all cell lines in the same fashion. Cells were 
detached using 1X trypsin and counted. For the fibroblasts counting was 
performed using a haemocytometer, other cell lines may be counted using an 
automatic cell counter. The cells are then pelleted by centrifugation at 500xg 
for 5 minutes. The pellet is then re-suspended in the correct volume of freezing 
media (Table 5)  to give 1x106cells/ml. 1ml of the resultant solution is aliquoted 
into cryovials and transferred into a cryo freezing container which is placed over 
night at -80°C before transferring the cryovials into a liquid nitrogen tank for 
long term storage. 
For reviving stocks, cells were thawed rapidly in a water bath at 37°C and then 
added to pre-warmed media before being centrifuged at 500xg for 5 minutes to 
pellet the cells allowing removal of the DMSO in the freezing media. The pellet 
was then re-suspended in fresh media and cells transferred to a 10cm plate for 
initial culturing.  
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2.2.5 Bacterial transformation 
Following site-directed mutagenesis a specialised bacterial transformation 
protocol is required for amplification of mutated plasmid and this is detailed in 
section 2.2.6.2. This method is the general method used to amplify all plasmid 
and vector DNA indicated in Table 6 for use in mammalian cell transfection. 
50µl of DH5α competent E.coli were incubated on ice until thawed, at which 
point 3µl of plasmid DNA was added. The E.coli was then incubated for a further 
30 minutes on ice, before heat-shocked at 42°C for 45 seconds, and returned to 
ice for 2 minutes. Then 950µl of L-Broth was added and E.coli cultured at 37°C 
for 1 hour in a shacking incubator at 180rpm. Following an hours growth two LB-
agar plates were inoculated with the transformed E.coli. One plate was 
inoculated with 100µl undiluted culture whilst the second plate was inoculated 
with 100µl of culture diluted 1:20. Plates were inverted and cultured overnight 
at 37°C. The following day colonies were picked from the agar plates and used 
to inoculate 4ml L-Broth starter cultures. These were grown for 4 hours at 37°C 
in a shacking incubator at 180rpm. These complete cultures were then either 
used directly to extract plasmid DNA using the Qiagen mini-prep plasmid 
purification kit or used to inoculate a larger 250ml L-broth culture which was 
grown over night at 37°C in a shacking incubator at 180rpm from which plasmid 
DNA was extracted the following day. Plasmid extraction was usually undertaken 
using the Beatson in-house plasmid purification service, although on occasion 
plasmids were extracted by me using the Qiagen Maxi-prep plasmid purification 
kit. 
2.2.6 Site-directed mutagenesis of pmCherry-LC3 
LC3-cherry was cloned into the lentivirus vector pLenti6 in order that LC3-Cherry 
expressing stable cell lines could be generated through lentiviral infection. The 
pLenti6 vector had very few restriction sites within its multiple cloning site, 
which limited those that could be used to excise the mcherry-LC3 fragment from 
the pmCherry-LC3 plasmid Figure 2:1 B. One site that matched in both plasmids 
was a BAMHI site found in the MCS of both plasmids, Figure 2:1A and B. However 
in order to excise LC3-Cherry (from pmcherry_LC3) and insert it into the pLenti6 
vector a second BAMHI restriction site needed to be added to the pmCherry_LC3 
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upstream of the mCherry sequence. This was undertaken using site directed 
mutagenesis to change the three base pairs upstream of the mcherry gene as 
described below (Figure 2:1).  
2.2.6.1 Mutagenesis of pmCherry-LC3 
The mutagenesis primers for pmCherry-LC3 were designed using the Agilent 
online primer design software and then ordered from Invitrogen, the sequences 
are given below Figure 2:1 C, with the 3bp difference between vector and 
primer highlighted in Figure 2:1 D. Mutagenesis was essentially performed using 
the QuikChange site directed mutagenesis kit as directed by the manufacturer; 
Agilent (Stratagene).  
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Figure 2:1- Cloning strategy for pLenti6_LC3-Cherry 
(A) and (B) give diagrams of each of the original plasmids used in this cloning approach. The 
BAMHI restriction site is highlighted in each plasmid at the MCS. (C) Gives the sequences for both 
the forward and reverse primers used in the site directed mutagenesis. The bases highlighted in 
purple indicate the three base pairs that differ from the sequence in the plasmid, and represent the 
change that was made. (D) Shows a magnified view of the section of pmCherry-LC3 that was 
changed during the mutagenesis. The top section shows the original sequence with the primer 
binding sites indicated in pink and the region to be changed to a second BAMHI site indicated in 
yellow. The bottom section shows the same sequence post mutagenesis with the change in 3bp 
and BAMHI site highlighted. 
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Four Mutagenesis reactions were set up with different amounts of DNA in each: 
5ng, 10ng, 20ng and 50ng. Each reaction mix was composed of the following: 5µl 
of 10X reaction buffer, 5µl of the forward primer (125ng), 5µl of the reverse 
primer (125ng), 1µl of dNTP mix and 1µl of PfuTurbo DNA polymerase (2.5U/µl). 
Varying volumes of DNA were added in each reaction to ensure the correct 
number of nanograms of DNA was present in each reaction. Based on the final 
volume after DNA addition, deionized water was added to make the final volume 
equal to 50µl.  
The PCR tubes containing each reaction where then transferred into the DNA 
Engine DYAD thermo cycler (Peltier) and the following PCR protocol set:  
1. 30 seconds at 95°C 
2. 30 seconds at 95°C 
3. 1 minute at 55°C 
4. 6 minutes at 68°C 
5. 4°C until programed ended by user. 
Steps 2-4 were repeated for sixteen cycles. 
Each reaction was the subject to Dpn1 digest to remove the unmodified 
template plasmid. Dpn1 selectively digests the template plasmid as it is 
methylated by virtue of its replication in bacteria. However, the newly modified 
plasmid has been synthetically generated by PCR and as such is not methylated 
and therefore not recognised by Dpn1 or digested. For Dpn1 digestion 1µl of the 
enzyme (10U/µl) is added to each reaction and incubated for 1 hour at 37°C. 
Each reaction was then used to transform XL-10 gold bacteria in order to amplify 
the altered plasmid. 
2.2.6.2 XL-10 gold bacterial transformation  
The transformation was performed in XL-10 gold bacteria as follows: 50µl (per 
reaction) of XL-10 gold competent E.coli were thawed on ice. 2µl of β-
mercaptoethanol was added to each 50µl and swilled to mix followed by a 2 
minute incubation on ice. Then 2µl of the Dpn1 treated reactions were added to 
each 50µl of E.coli and swirled to mix before incubation on ice for 30 minutes. 
The cells were then heat-shocked for 30 seconds at 42°C then cooled on ice for 
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2 minutes. 450µl of L-Broth was then added to the E.coli and incubated at 37°C 
for 1 hour. After 1 hour 100µl of this mini-culture was used to inoculate 
kanamycin selective LB-agar plates (kanamycin is the selective marker in the 
pmCherry-LC3 plasmid). Plates were incubated overnight at 37°C to allow 
colonies to grow. 
The following day twenty four colonies were picked from across the six plates 
(corresponding to the six original DNA concentrations used for mutagenesis). 4ml 
kanamycin selective L-broth starter cultures were inoculated with these 
colonies, i.e. twenty four starter cultures, and were cultured during the day on 
a shaking incubator at 37°C at 180rpm. The E.coli from each culture was then 
pelleted and plasmid DNA extracted using the Qiagen plasmid mini kit, as per 
manufacturer’s instructions. 
2.2.6.3 Restriction digest and Agrose gel electrophoresis 
To determine which of the colonies had yielded plasmid which had successfully 
undergone mutagenesis to include a second BAMHI site, a restriction digest using 
BAMHI restriction enzyme was performed for each plasmid prep as follows: 1µl of 
plasmid prep, 2.5µl of 5x enzyme buffer (Invitrogen), 1µl of BAMHI restriction 
enzyme (1U/µl, Invitrogen) and 20.5µl of deionized water. Each digest was 
incubated at 37°C for 1 hour. Plasmids which have successfully been changed to 
include the extra BAMHI site will yield two fragments from this digest; those that 
were not successful would produce one fragment representing the linearized 
original plasmid. The results of each restriction digest were subject to gel 
electrophoresis to resolve the fragments generated by the digest.  
A 0.8% agrose gel (in 1% TAE) was poured and set in a BioRad agrose gel caster. 
Once set it was placed in a BioRad agrose gel tank and the tank filled with 1% 
TAE buffer (Table 5). 10µl of each restriction digest was loaded into the gel with 
one well set aside for the DNA molecular weight marker (1kbp Quick Load DNA 
ladder Table 1). The results can be seen in Figure 4:18, Chapter 4. Two of the 
plasmids that returned positive results for mutagenesis were chosen and 
amplified further to give greater quantities of plasmid using the Beatson in-
house plasmid purification service and were used in the cloning described below.  
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2.2.7 Cloning of LC3-Cherry into pLenti6 
To clone mCherry-LC3 into pLenti6 the mCherry-LC3 fragment first had to be 
excised from the pmCherry-LC3 plasmid. The modified pmCherry-LC3 generated 
above was subject to further BAMHI restriction digest. The components of the 
restriction digest reaction are double those described for the BAMHI restriction 
digest in section 2.2.6.3. The digest was performed as described above and 
fragments resolved by agrose gel electrophoresis also described above. The band 
corresponding to the mCherry-LC3 fragment was cut from the gel and extracted 
from the agrose using the QIAEXII gel extraction kit (Table 1) as described in the 
manufacturer’s instructions. In parallel the pLenti6 vector was also subject to 
BAMHI restriction digest, again double the size of the digest described in section 
2.2.6.3. This opens the pLenti6 vector at the MCS in preparation for insertion of 
the mCherry-LC3 fragment. Since the vector was cut with only one restriction 
enzyme it could spontaneously re-ligate prior to the insertion of the mCherry-
LC3 fragment. To prevent re-ligation the digest was treated with Calf Intestinal 
Alkaline phosphatase (CIP, New England Bioscience) as per manufacturer’s 
protocol. This dephosphorylates the 5’ overhangs created by BAMHI digestion 
and prevents spontaneous re-ligation. 
With both vector and fragment prepared, the ligation reaction was performed as 
follows: 2µl 10x T4 DNA ligase buffer, 3µl of mCherry-LC3 (0.15mg/ml) 
fragment, 1µl cut pLenti6 vector (5.5mg/ml), 1µl T4 DNA ligase, and 13µl 
deionized water. This was incubated for 10 minutes at room temperature. The 
ligation mixture was then used to transform bacteria as described in section 
2.2.5, where ampicillin selective LB-agar plates (ampicillin is the selective 
marker for pLenti6) were used to select bacterial colonies that had successfully 
been transformed. The colonies generated were then amplified and plasmid 
extracted to give mini prep samples of plasmid DNA (plasmid extraction 
performed by the Beatson in-house plasmid prep service) and each was 
sequenced by the Beatson in-house sequencing service to check for the presence 
and orientation of the insert.      
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2.2.8 Transfection and generation of stable cell lines 
Various methods of transfection and infection were used throughout this thesis 
to generate stable cell lines and induce transient expression of desired 
constructs. Given below is a brief outline of the protocols used for each method.  
2.2.8.1 Lipofectamine 
Lipofectamine is a commercially available transfection reagent (Invitrogen); 
whilst it is generally very useful for most cell types, it proved ineffective in the 
transfection of the fibroblasts used in this thesis. However it was used to 
transfect PT67 packaging cells with retroviral constructs enabling them to 
generate retrovirus. Below is the method used to transfect these cell. 
PT67 cells were plated at 7x105 cell/plate in 10cm plates, and allowed to attach 
overnight before transfection. The following day the transfection mix was 
prepared as follows: 1ml RPMI media (unsupplemented) and 25µl Lipofectamine 
2000 (Invitrogen) is mixed separate to a 1ml RPMI (unsupplemented) and 15µg of 
DNA construct solution, for 5 minutes. The two solutions are then combined and 
left to mix for 20 minutes. The cell culture media was then removed from the 
pre-plated PT67 cells and replaced with the full transfection mix: 25µl 
Lipofectamine 2000 (Invitrogen), 2ml RPMI media (unsupplemented) and 15µg of 
DNA construct (per plate). Cells are incubated in this mix for four hours at 37°C 
5% CO2, following which transfection mix is removed and media replaced with 
DMEM culture media supplemented as detailed in section 2.2.2. The following 
day the media was again removed and replaced with 6ml fresh media in 
preparation for use in viral infection of fibroblasts.  
2.2.8.2 Retroviral infection 
Retroviral infection was used to generate the TAZREV cells, derived from the 
TAZMUT cells by re-introduction of full–length TAZ cDNA (Table 6). Attempts 
were made to re-introduce two further spliceforms TAZΔexon5, and TAZΔexon7 
(Table 6). Of these two only infections of the TAZΔexon7 construct were 
successful, TAZΔexon5 failed to generate any colonies. Whilst retroviral 
infection did succeed in introducing full –length TAZ cDNA generating the 
TAZREV cells, it is not the preferred method for generating stable cell lines in 
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the human fibroblasts. The fibroblasts are slow growing and divide infrequently, 
and as retroviral infection only occurs when a cell is undergoing division, this 
meant that the rate of infection for the fibroblasts was very low accounting for 
the low number of colonies produced or in the case of TAZΔexon5 the complete 
absence of colonies. The method applied to generate the TAZREV cells is as 
follows:  
Viral packaging cells (PT67’s) were seeded into eight 10cm plates at 
7x105cell/plate and allowed to attach overnight. The cells were transfected 
(using lipofectamine as detailed in section 2.2.8.1) with one of the following; 
pLHCX (empty vector control), pLHCX-TAZ_full length TAZ, pLHCX-TAZ_Δexon5 
or pLHCX-TAZ_Δexon7, two plates per construct (Table 6). 
The following day eight 6cm plates were seeded with TAZMUT fibroblasts at 
2x105 cells/plate, i.e. four plates for TAZMUT_1 and four plates for TAZMUT_3. 
Two days following transfection of the packaging cells the virus containing media 
from the packaging cells (6ml from each plate, all treated individually) was 
removed with a syringe and filtered using a syringe filter (0.45µm pore size), 6ml 
of fresh media was added to the PT67’s in order to generate more viral 
supernatant for the following day. To this filtered viral supernatant was added 
6µl of 5mg/ml hexadimethrine bromide (polybrene, Table 1), which increases 
the efficiency of viral infection. The culture media was removed from the 
fibroblast plates, and the 6ml supplemented viral supernatant added (one 
fibroblast plate for each viral supernatant). The plates were then placed at 32°C 
5% CO2 overnight. This process was repeated the following day to give the 
fibroblasts a second dose of virus. 
On the third day the viral supernatant was removed from the fibroblasts and 
replaced with fresh supplemented DMEM as described in section 2.2.1 The cells 
were then left to recover from viral stress for one day. The following day 
antibiotic selection was applied in the form of 200µg/ml hygromycin, to select 
cells with stable expression of the TAZ constructs. 
All clones generated from this protocol were assayed for construct expression by 
western blot for the FLAG tag present in all constructs. Those that returned 
positive results where then assayed for TAZ activity by mass spectrometry for CL 
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and those that gave recovery of the Barth’s syndrome CL profile were used for 
all future experiments as control cells for the TAZMUT cells.     
2.2.8.3 Nucleofection 
Nucleofection was initially used as a method to generate stable cell lines but 
this proved unsuccessful. However, this method was highly successful for 
inducing transient expression of constructs, and was used as the standard 
method for inducing transient expression throughout the thesis. 
35mm dishes (glass bottomed dishes for confocal microscopy, Mattek) were 
prepared for seeding cells post nucleofection by adding 2ml of DMEM 
+10%FBS+1%Glutamine, to each dish. The dishes were placed at 37°C and 5% CO2 
to equilibrate in order that when the cells are added conditions will be optimal.  
Cells were harvested from a 15cm plate, media was aspirated and cells washed 
once in PBS before being detached using 1X Trypsin (Table 5). Once detached 
cells were removed from the plate and a cell count obtained using a 
haemocytometer. From this cell count the volume of cell suspension required to 
obtain 0.3x106 cells is determined. This is the number of cells required for one 
nucleofection reaction. The volume calculated is transferred into a centrifuge 
tube, ensuring enough aliquots for the number of reactions being undertaken. 
These aliquots are pelleted by centrifugation at 600xg for 10mins. 
Following centrifugation the supernatant is removed and the cells re-suspended 
in 100μl Nucleofector solution (100μl per reaction). The nucleofector solution is 
provided in Lonza kit, but supplement (also provided) must be added prior to 
use.  
The DNA construct to be expressed is added to the re-suspended cells; the 
amount of DNA added depends on the construct used and requires to be 
optimized for each construct. For most constructs used in this thesis 3µg was 
sufficient. However for Mito-dsRED 0.5μg of DNA was used, any greater amount 
caused artefacts in the cells upon fluorescence microscopy. The 
DNA/cell/nucleofector solution was well mixed by pipetting up and down but it 
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is important to avoid creating bubbles in the mixture. Once sufficiently mixed 
the solution was transferred to the sterile cuvettes supplied in the kit. 
Various programs on the Amaxa nucleofector device are recommended by Lonza 
(T-016, U-012, U-023 & V-013); all were tried with the most efficient protocols 
for the fibroblasts used in this thesis being the U-023 & V-013 programs giving 
~60-70% of cells taking up the DNA. As the V-013 protocol caused more cell 
death in our cells the U-023 protocol was always used. The cuvette was placed in 
the Nucleofector machine, the programme set and initiated.  
As quickly as possible following completion of the programme 500μl of media 
was removed from the plate(s) set up at the beginning of the protocol and added 
to the cuvette. Then, using the sterile pipettes (supplied in the kit), the 
contents of the cuvette was transferred to the pre-equilibrated plate(s). The 
plates were gently shaken to evenly distribute the cells and then returned to the 
incubator overnight. The following day the media was changed to remove dead 
cells and left to recover for at least one day before they are used. 
2.2.8.4 Lentiviral infection 
As Lipofectamine and nucleofection had proved unsuccessful as methods for 
generating stable cell lines and retroviral infection, although having some 
limited success when generating the TAZREV cells, was not reliable due to its 
reliance of dividing cells for infection a further method of stable cell line 
generation was sought to generate LC3-Cherry stable expression in all fibroblast 
line. Lentivirus does not require a cell to be undergoing cell division for 
infection, thus it represented an attractive alternative and following the 
generation of a suitable construct (section 2.2.6) was the method used and is 
described here. 
As with retroviral infection virus is generated by packaging cells which are in this 
case HEK293T cells. These cells were transfected with three plasmids, two 
helper plasmids pLpVSVG-1 and psPAX-2 (as mentioned in Chapter 4 section 
4.4.2) and the lentiviral construct carrying the LC3-cherry construct 
pLenti6_LC3-Cherry (generation of which is described in section 2.2.6). 
Transfection of these constructs was carried out using the calcium phosphate 
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method as detailed here. The day prior to transfection the HEK293T cells were 
seeded in a 10cm plate at 4x106 cells/plate and incubated overnight in 10ml of 
media (detailed in section 2.2.3) at 37°C and 5% CO2 to allow cells to attach. 
Late afternoon the following day the transfection mix was prepared as follows: 
10µg pLenti6_LC3-cherry, 4µg pLpVSVG-1, 7.5µg psPAX-2 were added to 440µl of 
sterile H2O and thoroughly mixed. To this was added 500µl 2X HBS (Table 5) and 
60µl 2M CaCl (sigma) solution. The solution was then mixed and left to incubate 
at 37°C for 30 minutes. The solution was then mixed one final time and the 
entire 1ml applied to the HEK293T packaging cells (the media on these cells was 
not removed; transfection mix was added to the media already on the plate). 
The cells were then returned to incubate for ~18 hours (overnight) at 37°C and 
5% CO2.On the same day that the HEK293T cells were transfected, the target 
fibroblast cells were plated on 10cm plates 2x106 cells/plate.  
The following morning the transfection mix and cell media, on the HEK293T 
cells, was removed and replaced with 6ml fresh media and cells incubated in 
this media for one day. 
Infection of fibroblasts takes place the following day: the 6ml virus containing 
media from the HEK293T cells was removed using a syringe and filtered using a 
syringe filter (0.45µm pore size). Fresh media was added to the HEK293T’s in 
order to generate more viral supernatant for the following day. 6µl of 5mg/ml 
hexadimethrine bromide (polybrene, Table 1) was added to the filtered viral 
supernatant to increase the efficiency of viral infection. The culture media is 
then removed from the fibroblast plates, and the 6ml supplemented viral 
supernatant is added to each one (one fibroblast plate for each viral 
supernatant). The plates were then placed at 32°C 5% CO2 overnight. This 
process was repeated the following day to give the fibroblasts a second dose of 
virus. Following the second dose, the virus containing media was removed and 
replaced with fresh supplemented DMEM as described in section 2.2.1. 
2.2.8.5 Reverse transcriptase assay for viral presence post infection 
Prior to selection of pools of LC3-cherry expressing cells by FACS as described 
below, cells had to be tested for residual lentivirus presence or production. The 
lentivirus generated by this method is replication incompetent but can infect 
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any human cell i.e. it can infect your own cells. Therefore before using these 
cells in any other experiments where perhaps infection of self would be more 
likely it was important to confirm that there was no virus present in the cells. 
Once applied to the fibroblasts the virus will be able to infect the cells but once 
inside is incapable of replicating itself and as such overtime and with successive 
media changes any remaining virus will disappear from the media. However an 
assay can be performed that will give confidence that this is the case, this assay 
is the commercially available ENZchek reverse transcriptase assay (Invitrogen). 
The protocol for its use is given below. 
Samples to be tested are taken fresh on the day of assay straight from cells in 
culture. Frozen samples seem to give lower readings, and thus may not be a true 
representation of actual viral count in culture. A positive control sample is also 
taken fresh on the day and is in the form of media taken from virus producing 
cells, i.e. packaging cells. A negative control is also required and is taken fresh 
on the day of assay from the parental cells of those infected, i.e. cells that have 
not encountered  the virus, but in all other aspects the same as those that have 
been infected. 
The method used is for the most part the same as that supplied by the 
manufacture. The template and primer were annealed; 2.5ul of component D is 
mixed with 2.5ul component E (this is half of what is given in manufacturer’s 
protocol and should allow for 50 reactions- further reductions would result in 
inaccuracies due to the difficulties in correctly measuring volumes smaller than 
2.5µl ). It was then incubated for 1 hour at room temperature to allow the 
primer and template to anneal. 
Standard curve and samples were prepared while incubating the primer and 
template. The manufacturer’s protocol shows that different components of cell 
culture media affect the fluorescence signal generated: to normalise for this we 
ensured that the standard curve and samples contained the same concentrations 
of any components as far as possible to give the most comparative readings.  
The standard curve was generated using the M-MLV reverse transcriptase 
available from Invitrogen. This comes with its own 5X enzyme buffer and DTT 
which was added to both the standard curve and samples to ensure all 
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components were equal. Five eppendorfs were labelled 15U, 1.5U, 0.5U, 0.15U 
and 0U and a Master Mix made using the water, DTT and 5X Enzyme buffer as 
detailed below. 
Master Mix 
5µl DTT 
20µl 5X Enzyme Buffer 
75µl water 
 
88µl of Master Mix is enough to cover the standard curve, and 12 samples where 
1µl of master mix is required for each replicate of each sample. The following 
volumes of Master Mix were then added to the previously labelled eppendorfs: 
15U -18.5µl, 0.15U- 18µl, 0.5 -13.4µl, 0.15U -18µl and 0U- 20µl. After which the 
enzyme was added as follows to produce the enzyme standards which were used 
to generate the standard curve: to the 15U eppendorf 1.5µl of enzyme was 
added (stock of enzyme is 33U/µl, so will dilute to 15U/µl in this way). This was 
mixed well and then 2µl of the 15U/ul stock was added to the 1.5U tube, to give 
1.5U/µl stock. Again this was mixed and 6.67µl added to the 0.5U tube, to give 
0.5U/µl stock. To make the 0.15U/µl stock 2µl of the 1.5U/µl stock was added to 
the 0.15U tube. Nothing is added to the 0U tube. 
Each enzyme standard was then diluted 1:5 in cell culture media (section 2.2.1). 
The 0U stock was also diluted in media in the same way to provide the 
background control for the assay in the media. This step ensures that the 
standard curve and samples all have the same levels of any assay 
quenching/enhancing constituents. 
Samples were prepared by removing 20µl (5ul is required for the assay, so 
triplicate+1 for each sample = 20µl) of media from the cells to be tested as well 
as the controls (as described above) and transferred into appropriately labelled 
eppendorfs. To each sample 4ul of Master Mix was added, again to ensure 
samples and standard curve are representative of each other.  
To prepare the reaction mixture the template primer mix, prepared earlier, was 
diluted by adding 1ml of component F (Again this is half that described in 
original protocol, as the template primer mix was halved originally). 20ul of this 
newly made template primer mix was added to the required number of wells of 
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a microtitre plate. The standards including the 0U background control are then 
added to the plate. Each standard was represented in triplicate and 5µl of each 
standard was applied to the designated wells of the microtitre plate containing 
the template primer mix. Next, the samples and positive and negative controls 
were added to the plate, each was represented in triplicate and 5µl of sample 
was added to the designated well.  
The plate was sealed in a reversible manner and incubated at room temperature 
for 1 hour. The reaction was the stopped by adding 2µl of component G to each 
well and stored at 4°C. Next 1X TE was prepared from the 20X stock provided 
(Component B) by dilution of 0.5ml 20XTE in 9.5ml nuclease free water (again 
half that of the manufacturer’s protocol). A working stock of PicoGreen was also 
prepared, diluting the stock provided (Component A) in the freshly made 1XTE 
again at half the volumes given in the manufacturer’s protocol; 25µl PicoGreen 
in 8.6ul 1XTE. This was prepared in a tube protected from light since PicoGreen 
will degrade upon exposure to light. 
173ul of working stock of PicoGreen was added to each well of the assay plate 
which was then incubated at room temperature protected from light for 5 
minutes. PicoGreen fluorescence was then measured using the Tecan Sapphire 
with excitation set at 480nm and emission detected at 520nm. A single end point 
reading is all that is required. These fluorescent readings were converted to viral 
presence in the sample by using the standard curve generated from the 
fluorescence detected from the room temperature standards, also measured 
during the assay. 
The limit of the Assay is 0.01U any detection above that is deemed to be unsafe 
and assay must either be repeated at later date to determine if detection was 
due to residual virus in the media or actual production of virus by cells. If a 
positive read persists then cells may be producing replication competent virus 
and should be destroyed. Readings below 0.01U are undetectable and samples 
are deemed free from virus. 
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2.2.8.6 Cell selection by FACS 
Once the infected cells are observed to be free of virus, as determined by the 
above assay, cells were selected for stable LC3-cherry expression using 
Fluorescence Activated Cell Sorting (FACS) to separate cells into pools based on 
fluorescence intensity. 
 
Figure 2:2- Fluorescence assisted cell sorting (FACS) 
Schematic taken and adapted from abcam website, explaining the principles of FACS. 
Cells to be sorted are supplied in suspension to the sorter from which they are 
aspirated and hydrodynamically focused in sheath fluid into a single cell stream. 
This allows for one cell only to pass the laser interrogation and analysis at any 
given time. This is very important as it means that each cell is analysed 
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individually, where more than one cell enters the point of analysis at the same 
time all those cells will be discarded as the sorter cannot accurately analyse the 
cells present. Depending on the result of this analysis the cell is given a charge: 
negative, positive or no charge at all. This charge (if given) is applied to the cell 
just prior to breaking from the sheath stream of cells into a single cell droplet. 
This droplet forms as the sheath stream containing the analysed and charged 
cells enters and air filled space, and as is the nature of any fluid injected into an 
air filled space it forms droplets. These droplets then pass through an electrical 
field created by two charged deflector plates. Dependent upon the charge given 
to the cell in the droplet, the cell is deflected to one of several collection tubes, 
or if uncharged continues past the deflection plates and into the waste channel 
for unwanted cells.  
To sort cells based on LC3-Cherry fluorescence cells were treated with 200nM 
Bafilomycin A the night prior to sorting to amplify the fluorescent signal for 
detection during FACS. Cells were sorted based on fluorescent intensity; with 
cells with no expression being discarded, whilst the remaining cells were split 
into three pools of low, medium and high fluorescence intensity (as described in 
Chapter 4 section 4.4.2.2). All cell lines were subject to the same selection 
process, using the same sorting parameters in each case. Following further 
interrogation of each pool it was determined that the ‘low intensity’ pool 
represented the most suitable for the imaging of mitophagy.   
2.2.9 Preparation of Cell lysates 
For generation of cell lysates for SDS-PAGE/western blot, cells were grown until 
confluent in 10cm plates and then lysed using 200µl RIPA buffer, Table 5. Plates 
were scraped using a cell scraper to ensure as high a concentration of protein in 
lysate as possible. Protein concentration was quantified using Thermo Scientifics 
BCA protein assay kit, Table 1. 
2.2.10 Mitochondrial Isolation 
Mitochondria were isolated from fibroblasts for SDS-PAGE/western blot 
detection of TAZ. For each sample of mitochondria generated, four confluent 
15cm plates of fibroblasts were required. PBS, Homogenizer tubes and 
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mitochondrial isolation buffer ((MIB) Table 5) were chilled on ice whilst protease 
inhibitor cocktail was thawed prior to extraction. 
Cell media was aspirated from plates and each plate washed once with PBS. To 
the first of the four 15cm plates 20ml of ice cold PBS was added and cells 
detached using a cell lifter. The cell/PBS suspension was then transferred to the 
second plate and the process repeated to detach the cells in this plate. This was 
repeated until all cells in each of the four plates have been detached and the 
combined cell/PBS suspension from all plates is in the fourth plate. The 20ml 
cell/PBS suspension was then transferred to a 50ml falcon tube and cells 
pelleted by centrifugation at 600xg for 10 minutes at 4°C. 
During this time the re-suspension buffer was made consisting of 1ml/plate of 
MIB, 1:100 dilution of Protease Inhibitor cocktail (Table 1) and 1:1000 dilution of 
1mM dithiothreitol (DTT) and the homogenizer tube is washed out with MIB.  
After cells have been pelleted the supernatant was aspirated and cells re-
suspended in 2ml of the re-suspension buffer, and transferred into the chilled 
homogenizer tube and incubated on ice for 15 minutes, to allow the hypotonic 
solution to cause the cells to swell. The Homogenizer (RZR 2051 control 
homogenizer, Table 2) was set to 1600rpm and cell suspension was homogenized 
with 100 strokes. The homogenate was transferred to eppendorf tubes and 
centrifuged at 600xg for 10 minutes in a pre-chilled centrifuge at 4°C to pellet 
any remaining cells. The supernatant was taken off and kept on ice, and the 
pellet again re-suspended in another 2ml of re-suspension buffer and transferred 
back into the homogenizer tube. This cell suspension was again homogenized as 
previously described. The second homogenate was again transferred to fresh 
eppendorfs and centrifuged at 600xg for 10 minutes in a pre-chilled centrifuge at 
4°C to pellet any remaining cells and cell debris. Again the supernatant was 
extracted and kept whilst this time the cell pellet was discarded. To separate 
the mitochondria from other cellular components, the retained supernatants, 
were further centrifuged at 12000xg for 10 minutes in a pre-chilled centrifuge at 
4°C. The pellet generated from this centrifugation step represents the 
mitochondrial fraction, whilst the supernatant represents the cytosolic fraction 
of the cells. The supernatant was extracted and kept in separate eppendorfs 
whilst the mitochondrial pellets from all eppendorfs are combined and re-
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suspended in 10µl of MIB. Protein concentration was quantified for each fraction 
using Thermo Scientifics BCA protein Assay kit, Table 1.  
2.2.11 BCA protein assay 
BCA protein assay was utilized to determine protein concentration in cell lysates 
and mitochondrial extracts. The assay was performed as per manufacturer’s 
instructions, with standard curve generated for use with BSA standards. 
Absorbance at 562nm was measured for all samples and standards using the 
Molecular Devices SpectraMax Plus 384 spectrophotometer and SoftmaxPro 
software. 
2.2.12 Preparation of isolated mitochondria and cell lysates 
for SDS-PAGE/Western blot 
In preparation for SDS-PAGE/Western blot analysis both cell lysates and isolated 
mitochondrial preparations were prepared to a final volume of 50µl with final 
concentration of 20µg/50 µl of protein for isolated mitochondria and 40µg/50 µl 
of protein for cell lysates as follows: 
Cell lysates; for each sample 12.5 µl of NuPAGE LDS sample buffer (4x) and 5 µl 
β- mercaptoethanol were mixed and then the sample added, diluted to the 
correct concentration in deionized water (ddH2O), to a total volume of 50µl. 
Isolated mitochondria; for each sample 12.5 µl of NuPAGE LDS sample buffer (4x) 
and 5 µl β- mercaptoethanol were mixed and then the sample added, diluted to 
the correct concentration in MIB, to a total volume of 50µl. 
2.2.13 SDS-PAGE 
Cell lysates and isolated mitochondrial extracts were resolved using SDS-PAGE. 
Denaturing polyacrylamide gels were poured at either 10% or 15% acrylamide 
(dependent upon the protein to be detected), and allowed to set with a covering 
of butanol saturated water to prevent the desiccation of the gel. Once set the 
water was removed and stacking gel poured on top (13% of 30% acrylamide, 12% 
of 1M Tris pH6.8, 1% of 10% SDS, 72% H2O, 0.6% of 10% APS and 0.6% TEMED) and 
gel comb (10 well) was inserted. Once the stacking gel had set the entire gel was 
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transferred into the gel tank, Table 2, and the tank filled with 1xSDS-PAGE 
running buffer (Table 5). The comb was then removed and 10µl of protein 
molecular weight marker (Full range rainbow molecular weight marker GE 
healthcare Life sciences) was added to the first well of the gel. The protein 
samples were added to the other wells. Each gel was run at 100 Volts 
continuously until the required degree of separation was achieved.  
2.2.14 Western blot 
Following protein resolution by SDS-PAGE proteins were transferred from the gel 
to a PVDF membrane (Table 1) using the Invitrogen Xcell II blot module, as per 
manufacturer’s instructions. Once the gel, membrane and sponges have been 
composed inside the Xcell II Blot module as per manufacturer’s instructions, it is 
then placed inside the Xcell Surelock Mini-cell and locked in place. The chamber 
of the Xcell II blot module was then filled with 1x blotting buffer (Table 5) whilst 
the chamber of the Xcell Surelock Mini-cell was filled with water to keep the 
apparatus cool during blotting. Transfer was performed at 400mA for 1.5 hours. 
The membrane was incubated briefly in ponceau to determine if the transfer 
was a success, followed by incubation in 5% Milk (Table 5) for 1 hour to block the 
membrane. The membrane was then incubated in primary antibody (Table 3) 
overnight in 5% milk (and 0.1% NaN3) at 4°C. The following day the membrane 
was washed four times in PBST (Table 5), and then the appropriate HRP linked-
secondary antibody applied in 5% milk solution and incubated for 1 hour at room 
temperature. The membrane was then washed again four times in PBST and 
proteins visualised using either ECL western blotting detection reagent from GE 
healthcare Life Science or Supersignal West Femto Chemiluminescent substrate 
from Thermo Scientific (Table 1) if a more sensitive detection system was 
require (as for LC3 detection) and Fuji X-ray film. On rare occasions the 
membrane required to be stripped to allow for re-probing of the membrane with 
different antibodies. This was undertaken using the Western Strip Buffer from 
Thermo scientific (Table 1). The membrane was incubated in this buffer for 10 
minutes and then re-blocked in 5% Milk, after which the process described above 
for antibody application and visualisation is repeated. 
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2.2.15 Cardiolipin mass spectrometry 
Cardiolipin mass spectrometry was performed to determine the levels of puCL in 
the various fibroblast cell lines used. For each fibroblast cell line cells were 
grown to 100% confluence in T175 flasks. Cells were then detached using 6ml 1X 
trypsin solution and centrifuged at 500xg for 5 minutes to pellet the cells. The 
pellets were then washed twice with PBS and finally centrifuged again to allow 
removal of all PBS. The cell pellets were then frozen -80°C at least overnight. 
Then pellets were shipped to Frédéric M. Vaz and Riekelt Houtkooper at The 
Laboratory of Genetic and metabolic diseases at the University of Amsterdam 
where cardiolipin mass spectrometry analysis was performed using the following 
protocol for lipid extraction and analysis (158).  
2.2.15.1 Phospholipid extraction 
Fibroblasts were re-suspended in PBS and sonicated for 20 seconds using a tip 
sonicator. The protein concentration was determined according to the Bradford 
protocol (158). Phospholipids were extracted from fibroblast homogenates using 
a single-phase extraction. In the single-phase extraction 3ml of chloroform-
methanol 1:1 (v/v) was added to a maximum of 300µL of homogenized cells to 
prevent phase separation. After addition of the CL internal standard (0.4nmol of 
CL(14:0)4 (Avanti Polar Lipids) dissolved in 50µL chloroform), the mixture was 
shaken vigorously for 2 minutes and placed on ice for 15 minutes, followed by 
centrifugation at 1000×g. The supernatant was transferred to another tube, and 
the protein pellet was extracted once again with 3ml of chloroform-methanol 
2:1 (v/v). The organic layers were combined and evaporated under a stream of 
nitrogen at 45°C. The residue was dissolved in 150µL of 
chloroform/methanol/water (50:45:5 v/v/v) containing 0.01% NH4OH, and 10µL 
of this solution was injected into the HPLC-MS system. 
2.2.15.2 HPLC mass spectrometry 
The HPLC system consisted of a Surveyor quaternary gradient pump, a vacuum 
degasser, a column temperature controller and an autosampler (Thermo Electron 
Corporation, Waltham, MA). The column temperature was maintained at 25°C. 
The lipid extract was injected onto a LiChrospher 2×250mm silica-60 column, 
5µm particle diameter (Merck, Darmstadt, Germany). The phospholipids were 
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separated from interfering compounds by a linear gradient between solution B 
(chloroform-methanol, 97:3, v/v) and solution A (methanol-water, 85:15, v/v). 
Solution A and B contained 1ml and 0.1ml of 25% (v/v) aqueous ammonia per 
litre of eluent, respectively. The gradient (0.3ml/min) was as follows: 0–10 
minutes: 20% A to 100% A; 10-12 minutes, 100% A; 12-12.1 minutes: 100% A to 0% 
A; and 12.1–17 minutes, equilibration with 0% A. All gradient steps were linear, 
and the total analysis time, including the equilibration, was 17 minutes. A 
splitter between the HPLC column and the mass spectrometer was used, and 
75µl/minutes eluent was introduced into the mass spectrometer. A TSQ 
Quantum AM (Thermo Electron Corporation) was used in the negative 
electrospray ionization mode. Nitrogen was used as nebulizing gas. The source 
collision-induced dissociation collision energy was set at 10V. The spray voltage 
used was 3600V, and the capillary temperature was 300°C. Mass spectra of CL 
and MLCL molecular species were obtained by continuous scanning from m/z 380 
to m/z 1100 with a scan time of 2s. 
2.2.16 Mitochondrial function assays: Seahorse 
The Seahorse measures Extracellular acidification rate (ECAR) as a surrogate 
measure of lactate production and oxygen consumption rate (OCR) as a surrogate 
for OXPHOS activity. It uses two probes located in the cartridge plate, one 
measures oxygen concentration and one detects acidity using fluorescence 
(Figure 2:3). Using these probes the seahorse monitors fluctuations in oxygen 
levels and acidity over time and then calculates the consumption and production 
rates that are OCR and ECAR. There are also drug delivery ports which can be 
used to examine the activity of various complexes in the ETC by addition of 
specific inhibitors of one or more of the complexes, followed by monitoring of 
OCR and ECAR to determine if and how mitochondrial function is affected. There 
are four drug ports on the Seahorse plate and these can be filled with four 
different mitochondrial disruptors typically, oligomycin, CCCP, antimycin and 
rotenone. 
Oligomycin inhibits ATP synthase by blocking its ability to transport protons back 
into the mitochondrial matrix. Addition of this will typically reduce OCR and 
increase ECAR as cells resort to glycolysis for ATP generation. However there is a 
slight proton leak whereby other protein uncouplers allow movement of protons 
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back into the matrix without the need for ATP synthase. This does not generate 
ATP but for the other ETC complexes to pump protons back out does require 
oxygen; hence oligomycin treatment reduces oxygen consumption dramatically 
but not fully. Oligomycin is usually the first drug to be added in a Seahorse 
assay, followed by CCCP addition. 
As previously mentioned CCCP is a mitochondrial uncoupler, abolishing the 
proton gradient established by complexes I-IV allowing un-restricted flow of 
protons across the inner mitochondrial membrane, uncoupling the whole OXPHOS 
system. This causes a dramatic increase oxygen consumption to be detected by 
the Seahorse due to complexes I-IV running at maximal speed trying to re-
establish the proton gradient. The next drug to be added is either rotenone or 
antimycin. 
Rotenone inhibits the transfer of electrons from complex I thereby blocking 
OXPHOS. Antimycin inhibits complex III, again blocking OXPHOS. Both prevent 
the transfer of electrons through the electron transport chain, preventing the 
proton gradient forming, essentially halting OXPHOS completely. This results in 
complete loss of mitochondrial oxygen consumption, any residual oxygen 
consumption detected is non-mitochondrial. 
 
Figure 2:3- The Seahorse assay explained 
The above scheme is taken from Seahorse Bioscience promotional material. It shows the setup of 
plates required to run a Seahorse assay with the cells in a confluent monolayer at the bottom of the 
cell plate, which in specific Seahorse media. The green cartridge plate above contains the 
Fluorescent sensors and probes for detection of oxygen consumption and acidification rate. It also 
contains drug injection ports so that compounds can be added during the assay and their effect on 
respiration recorded. 
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These measurements require a confluent monolayer of cells to be present in the 
cell plate with no gaps to ensure an accurate reading from the probe plate. To 
take a reading the probe plate is pushed down into the cell plate to create a 
sealed chamber between the cells and the probes. On forming the chamber the 
Seahorse then monitors oxygen and acidity levels over time and calculates OCR 
and ECAR. The probes are then lifted to allow influx of oxygen and nutrients and 
the process repeated again. 
All six cell lines were assayed for mitochondrial function using the Seahorse Flux 
Analyser. The method below was applied for all cell lines. 
Cells were seeded at 40,000 cells/well in a XF24 cell culture micro plate 
(Seahorse bioscience) in 150µl of DMEM, supplemented with 10%FCS and 1% L-
glutamine and left to attach overnight at 37°C under 5% CO2. Four wells were 
left with no cells to serve as background wells for the assay. 
The following day 1ml of XF calibrant was applied to every well of the cartridge 
plate of an XF24 Assay Kit (Seahorse Bioscience). The plate was then placed at 
37°C in a non-gassed incubator for a minimum of 1 hour. This allows the probes 
to hydrate and equilibrate. During this time the Seahorse assay media (Seahorse 
DMEM, Table 1) was warmed to 37°C supplemented with; 25mM glucose, 2% FBS 
and 1% L-glutamine and pH adjusted to 7.4.  The stress test drugs, oligomycin, 
CCCP, antimycin and rotenone (Table 1) were then diluted in the seahorse media 
to concentrations of 1µM. Each drug was then applied to the appropriate ports in 
the probe plate of the XF Assay kit; oligomycin port A, CCCP port B, antimycin 
port C and rotenone port D. The plate was then returned to the incubator until 
required. 
The DMEM on the cells in the cell culture plate was removed and replaced with 
675µl of pre-prepared seahorse media. This was done row by row, as media has 
to be added slowly and carefully to prevent cells detaching, this prevents cells 
drying out between aspiration of DMEM and application of seahorse media. 
Following the media change the cell plate was transferred to the non-gassed 
37°C incubator to equilibrate. This step is crucial as it allows the cells and 
media to equilibrate to the change in CO2 concentration from 5% to atmospheric 
levels, which is important as the Seahorse Flux analyser operates at atmospheric 
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CO2 levels. This is the reason for the change in media as DMEM contains 
bicarbonate which is appropriate for buffering at 5% CO2 concentrations however 
at atmospheric CO2 concentrations this buffering will skew the pH and affect the 
assay. Seahorse media does not contain bicarbonate so this is not an issue when 
using this media. 
The cells have to equilibrate to this new CO2 level and as such need to be 
incubated for at least 30 minutes at 37°C in atmospheric CO2 levels. Whilst this 
is on-going the calibration of the XF Assay kit plate can begin. It is loaded into 
the Seahorse Flux analyser to begin calibration of the probes, which takes 
approximately 30 minutes thus on completion the cell plate will have finished 
equilibrating and can be loaded.  
The measurement protocol was the same for all assays; 3x mix/wait/measure 
steps to give three basal readings for oxygen consumption rate (OCR) and 
extracellular acidification rate (ECAR). The first port was then injected and the 
3x mix/wait/measure protocol repeated to get OCR and ECAR readings based on 
the effect of the drug. This was repeated for all ports and measurements for all 
drugs in succession. 
Following assay completion the cells were fixed within cell culture plate by 
adding 100µl 10% Trichloroacetic acid to the 675µl seahorse media already in the 
each well (TCA, Table 1). The plate was then incubated at 4°C for 1 hour, 
following which the TCA/media solution was removed and the plate washed with 
water. The plate was then air dried, until completely dry, usually overnight. The 
following day 100µl of 0.04% sulforhodamine B (SRB, Table 1) was added to each 
well and incubated for 30 minutes at room temperature. SRB staining is a well-
established colorimetric protein assay, and based on standard curve of cell 
number versus SRB absorbance at 510nm the data from the seahorse can be 
normalised on a well by well basis to cell number (159). 
Following incubation the excess SRB was aspirated off and the wells washed with 
1% acetic acid (Table 1). Again the plate was left to air dry overnight. Once dry 
the bound SRB is eluted by adding 100µl 10mM Tris pH10.5 to each well. Of this 
100µl, 50µl from each well was transferred to a well of a clear bottomed 96 well 
plate which already contained 200µl 10mM Tris pH10.5 in each well, including 
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the background wells devoid of cells in order to get background SRB readings. 
The plate was then assayed for absorbance at 510nm using Molecular Devices 
SpectraMax 384 spectrophotometer. These readings were converted to cell 
number based on standard curves and used to normalise the Seahorse OCR and 
ECAR readings  
2.2.17 Flow cytometry 
2.2.17.1 Mitochondrial mass 
Mitochondrial mass was measured using flow cytometry by measuring 
mitotracker green fluorescence as a surrogate for mitochondrial mass. 
Mitotracker green is a mitochondrial specific dye that can be used on live cells, 
where green fluorescence intensity can be directly correlated with 
mitochondrial mass. 
To perform this assay each cell type was measured three times in three different 
experiments. For each experiment each cell type was seeded in two wells of a 
six well tissue culture plate and grown to confluent. Mitotracker green was then 
applied to one of the two wells for each cell type at a final concentration of 
100nM and cells incubated for 1 hour in the dark at 37°C in 5% CO2. The cells 
were then washed twice in PBS to remove all media and excess mitotracker 
green and then detached from the well using 1ml of 1X trypsin (Table 1). They 
were then transferred to FACS tubes, one tube per well per cell line and these 
were then centrifuged at 600xg for 5 minutes to pellet the cells. The 
supernatant was then carefully removed and cells re-suspended in 500µl of PBS. 
The cell suspension was then analysed using the BD FACS Calibur, with 
fluorescence detected between 515-545nm allowing detection of the green 
fluorescence from mitotracker green. 10,000 cells were counted from each 
sample and data corrected for background using the unstained samples for each 
cell line. This was repeated till three replicates were obtained for each cell line.  
2.2.17.2 Mitochondrial membrane potential 
Two measures of mitochondrial membrane potential were performed in this 
thesis. One giving data of basal and CCCP treated membrane potential for all 
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cell lines and the second showing the effect of H2O2 on membrane potential over 
time. Although Flow cytometry was the same in both cases the treatment of 
cells prior to analysis by the FACS Calibur was different in each case.  
For basal and CCCP based measurements the cells were treated as follows. Each 
cell type was seeded in two wells of a six well plate were grown until confluent. 
Once confluent 100nM (final) Mitotracker Green and 20nM (final) 
tetramethyrhodamine ethyl ester (TMRE is a potentiometric mitochondrial 
specific dye that fluoresces when mitochondrial membrane polarity is intact and 
loses fluorescence upon loss of mitochondrial membrane potential, Table 1) was 
added to one well of the two for each cell line. The untreated well served as a 
background control for fluorescence. The cells were incubated for 1 hour in the 
dark at 37°C in 5% CO2.  and then washed twice in PBS to remove all media and 
excess dye before detaching cells from the well using 1ml of 1X trypsin (Table 1) 
and transferring  to FACS tubes, one tube per well per cell line. These were then 
centrifuged at 600xg for 5 minutes to pellet the cells. The supernatant was then 
carefully removed and cells re-suspended in 500µl of PBS. 
The cell suspension was then analysed using the BD FACS Calibur, with 
fluorescence detected at 515-545nm for mitotracker green and 564-601nm for 
TMRE. 10,000 cells were counted from each sample and data corrected for 
background using the unstained samples for each cell line and for mitochondrial 
mass using the mitotracker green data. Each sample was analysed for basal 
mitochondrial membrane potential and the same sample is treated with 10µM 
CCCP and re-analysed by the FACS Calibur to measure loss of mitochondrial 
membrane potential. This was repeated till three replicates were obtained for 
each cell line. 
For determination of the effect of H2O2 on mitochondrial membrane potential 
over time, eight wells across two six well plates were seeded with the same cell 
line and grown till confluence. Then each well was treated every 30 minutes 
with 500µM (final) H2O2. Each well represents a different exposure time for H2O2 
with three wells remaining untreated as controls whilst every other well was 
treated for either 1 hour (two 500µM treatments), 1.5 hours (three 500µM 
treatments), 2 hours (four 500µM treatments), 3 hours (six 500µM treatments) or 
4 hours (eight 500µM treatments). An hour before all H2O2 treatments are 
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completed 100nM (final) Mitotracker Green and 20nM (final) TMRE (Table 1) was 
added to all wells except one of the H2O2 untreated wells, as this served as a 
control for background fluoresce. The cells were incubated for 1 hour in the dark 
at 37°C in 5% CO2 and H2O2 treatments completed.  The cells were then washed 
twice in PBS to remove all media and excess dye and detached from the well 
using 1ml of 1X trypsin (Table 1) then transferred to FACS tubes, one tube per 
well per cell line. These were then centrifuged at 600xg for 5 minutes to pellet 
the cells. The supernatant was then carefully removed and cells re-suspended in 
500µl of PBS. 
The cell suspension was then analysed using the BD FACS Calibur, with 
fluorescence detected at 515-545nm for mitotracker green and 564-601nm for 
TMRE. 10,000 cells were counted from each sample and data corrected for 
background using the unstained samples for each cell line and for mitochondrial 
mass using the mitotracker green data. In addition the two remaining H2O2 
untreated samples that were stained with TMRE and mitotracker green are used 
as positive and negative controls for mitochondrial membrane potential. One of 
these two samples was treated with 10µM CCCP to depolarise the mitochondria 
and serve as the negative control whilst the other remained untreated and 
represented the positive control. This was repeated till three replicates for each 
exposure time were obtained for each cell line.    
2.2.18 Microscopy: Imaging 
With the exception of the electron microscopy all other imaging was undertaken 
using the NIKON A1R confocal microscope (Table 2). 
2.2.18.1 Mitochondrial length 
Fibroblast mitochondrial length was measured based on fluorescent images 
obtained of the fibroblast mitochondria. Three of the final six cell lines were 
measured and imaged in this way. All aspect of this technique were kept 
constant for every cell line imaged, image acquisition parameters were set 
based on CONTROL_2 cells and then applied to both TAZMUT_1 and TAZMUT_3. 
The acquisition parameters and method of analysis of are described below. 
102 
 
 Laura Catherine Avril Galbraith 
Two days prior to imaging fibroblasts were transfected with Mito-dsRed using 
nucleofection as described in section 2.2.8.3. After a day of recovery from 
nucleofection the mitochondria were imaged as follows:  
Excitation and Emission; The 561.3nm laser was used to excite the dsRED 
fluorophore, laser power was set at 7.84%, emission was detected at 595nm with 
PMT voltage set at 101V and offset at -34V.  
Optics; A 60x Oil lens with a 1.4 numerical aperture was used and pinhole 
diameter was set at 34.5µm.  
Scanning system and acquisition; The piezo stage was used in order to acquire 
detailed Z-sections through the cells. As cells were live and no heater could be 
used due to use of the piezo stage images had to be taken as quickly as possible. 
Therefore the less accurate but faster resonant scanner was used, with a scan 
size of 512x512 pixels at a speed of 1 frame/second and line averaging of 4. All 
images were three dimensional in nature, composed of a 77 Z-sections. The Z-
sections were taken at a 0.2µm step size using the Nikon A1 Piezo Z Drive stage.   
All images we analysed using metamorph software as detailed below.  
2.2.18.2 Electron Microscopy 
Electron microscopy was performed as described in the following papers, with an 
overview given here (160, 161). 
Samples for electron microscopy (EM) were prepared as follows: Cells were 
grown until confluent on glass-bottom culture dishes (MatTek Corporation, 
Ashland, MA). Where-upon they were fixed for 10 minutes using a mixture of 
paraformaldehyde 4% and glutaraldehyde 2% (v/v), both EM grade, in HEPES (pH 
7.2). After the fixation, cells were incubated in a mixture of 4% 
paraformaldehyde in HEPES (pH 7.2) for 30 min. Each dish was then filled with 
HEPES and sealed using parafilm to limit leakage. All samples were shipped to 
Australia for processing by Massimo Micaroni at The University of Queensland as 
follows: 
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Cells were washed in 20mM glycine in PBS for 10 minutes followed by 3 x 10 
minutes washes with distilled water. Samples were then incubated in 1% OsO4 in 
Cacodilate buffer 0.2M, for 1 hour, in the dark. Then removed and samples were 
washed with distilled water 3x for10 minutes each. Then six ethanol washes 10 
minutes each increasing in percentage ethanol for each of the first four washes, 
50%, 70% 90% to 100%, the final two washes were at 100% ethanol. Then samples 
were incubated in a 1:1 Et-OH:Epon 812 (Electron Microscopy Science) mix for 1-
2 hours at room temperature, followed by a further 1-2 hour incubation in Epon 
812 alone at room temperature. Then the Epon 812 was removed and replaced 
with fresh Epon 812 and samples incubated in an oven for 18 hours at 70ºC. 
The cells included in the resin were detached from the dish and mounted on a 
bullet of resin and left to polymerize for a further 24 hours in the oven at 
70ºC.Thin sections were cut at 70 nm thickness with a Leica UltraCut 7 
microtome and examined at an accelerating voltage of 80KeV with a Tecnai F20 
intermediata voltage electron microscope (FEI Co., Nehterlands) or with a Jeol 
1011 (JEol, Japan). Images were collected with a 4K FEI Eagle CCD camera. Once 
cut, the sections were loaded on copper/nickel slot grids and then stained with 
Reybold's solution for 1 minute before image acquisition using the electron 
microscopy. 
2.2.18.3 Mitochondrial dynamics 
Mitochondrial dynamics was monitored using confocal microscopy in conjunction 
with a photoactivable mitochondrial construct Mito-PAGFP which was generated 
in our lab by a pervious lab member. This construct along with the Mito-dsRED 
construct described previously were transiently transfected into the fibroblasts 
using nucleofection as described in section 2.2.8.3. Three of the final six cell 
lines were imaged in this way. All aspects of this technique were kept constant 
for every cell line imaged; image acquisition parameters were set based on 
CONTROL_2 cells and then applied to both TAZMUT_1 and TAZMUT_3. 
The day following nucleofection media was removed and 2- ml fresh media 
added to the dishes. The cells were then given one further day to recover from 
nucleofection. Following recovery mitochondria were imaged; activation of the 
PAGFP construct in selected mitochondria was directed by the drawing and 
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positioning of a stimulation region of interest (ROI) over the mitochondria to be 
activated. The ROI dimensions were saved and re-loaded for every image taken. 
Settings for imaging and activation are given below.  
Excitation and Emission; Activation of the PAGFP-mito construct was induced by 
the 405nm laser set at 53% power, scan speed for activation was 1 
frame/second. The activated fluorophore was then excited using the 488nm 
laser at 3.4% power; emission was detected at 525nm with PMT voltage set at 
81V and offset at -9V. Finally, the 561.3nm laser was used to excite the dsRED 
fluorophore; laser power was set at 0.5% to prevent bleaching. Emission was 
detected at 595nm with PMT voltage set at 92V and offset at -4V.  
Optics; A 60x Oil lens with a 1.4 numerical aperture was used and pinhole 
diameter was set at 73.9µm.  
Scanning system and acquisition; each image was taken using the galvano 
scanner, with a scan size of 512x512 pixels at a speed of 1 frame/second and no 
line averaging. Each time-lapse initially lasted 3 minutes with images taken 
continuously over this time. However, to observe any dynamic activity of the 
mitochondria in the TAZMUT cells the later time-lapses lasted 10 minutes. The 
resonant scanner was used during this imaging for its speed and as images were 
only being taken in one plane the piezo stage was not required and as such the 
temperature and CO2 levels could be controlled to ensure cells were kept in 
optimal conditions throughout acquisition. 
2.2.18.4 Mitophagy 
2.2.18.4.1 Lysotracker red Mitotracker green live cell imaging 
Initial mitophagy data was gathered using a live cell system staining 
mitochondria with mitotracker green and lysosomes with lysotracker red. 
Measurement of co-localisation of mitotracker green and lysotracker red was 
used as a surrogate for the measurement of mitophagy.  
Two days prior to imaging fibroblasts were seeded in four 35mm glass bottomed 
plates (Mattek). Six hours prior to imaging two of the four plates were treated 
with the Cathepsin inhibitors (CI), pepstatin A (Calbiochem) and E64d (Enzo life 
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sciences) at 5µg/ml and 10µM respectively. After three hours one of these CI 
treated plates and one of the otherwise untreated plates were treated with 
10µM CCCP (Table 1). Of the four original plates, one was now untreated, one 
treated only with CI, one only treated with CCCP and finally one with both CI 
and CCCP. One hour before imaging all four plates were treated with 100nM 
(final) Mitotracker green, and 60nM (final) Lysotracker Red (Table 1). All plates 
were then incubated for one hour at 37°C at 5% CO2. Just prior to imaging all 
cells were washed twice with PBS (pre-warmed to 37°C) and media replaced. 
Images were then acquired from each plate as described below. Plates not being 
imaged were incubated at 37°C at 5% CO2 until required. For each cell line 
imaging was performed on two separate occasions with at least seventy cells 
imaged for each cell line.     
Excitation and Emission; Mitotracker green was excited using the 488nm laser at 
3.3% power, emission was detected at 525nm with PMT voltage set at 104V and 
offset at -8V. The 561.3nm laser was used to excite the lysotracker red, laser 
power was set at 26.6% and emission was detected at 595nm with PMT voltage 
set at 115V and offset at -9V.  
Optics; A 60x Oil lens with a 1.4 numerical aperture was used and pinhole 
diameter was set at 34.5µm.  
Scanning system and acquisition; the piezo stage was used in order to acquire 
detailed Z-sections through the cells the heater cannot be used with the piezo 
stage. Therefore, images had to be taken as quickly as possible using the less 
accurate but faster resonant scanner, with a scan size of 512x512 pixels at a 
speed of 1 frame/second and line averaging of 4. All images were three 
dimensional in nature, composed of a 77 Z-sections through the cell. The Z-
sections were taken at a 0.2µm step size using the Nikon A1 Piezo Z Drive stage. 
2.2.18.4.2 LC3-Cherry, TOM20/Alexa488 and LAMP2/Alexa 405 Fixed cell 
imaging 
The LC3-cherry expressing stable cell lines (generated as described in section 
2.2.8.4) were fixed and stained with antibodies for the mitochondria (TOM20) 
and the lysosome (LAMP2) and using confocal microscopy, as described below, 
cells were imaged in order to identify mitophagy events by co-localisation of the 
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three components of mitophagy, the autophagosome (LC3-Cherry), the 
mitochondria (TOM20/Alexa488) and the lysosome (LAMP2/Alexa 405). Five cell 
lines were imaged in this way CONTROL_2, TAZMUT_1, TAZMUT_3, TAZREV_1 
and TAZREV_3. The method was designed using the CONTROL_2 cells and was 
then applied to all other cells. 
Cells were prepared for fixation as follows: 19mm coverslips (Table 2) were 
sterilized by immersion in ethanol and then left to air dry in a tissue culture 
laminar flow cabinet. Once dry the cover slips were transferred in the wells of a 
six well plate, one coverslip per well (four wells per cell line). Cells were then 
seeded in each well at a density of 0.3x106 cells per well with 2ml of 
supplemented DMEM as described in section 2.2.1 and grown till 90% confluent.  
Upon reaching 90% confluence, one well was treated with Cathepsin inhibitors 
(CI), pepstatin A (Calbiochem) and E64d (Enzo life sciences) at 5µg/ml and 10µM 
respectively six hours prior to fixation (only for CONTROL_2 cells). Three hours 
prior to fixation a second well was treated CCCP at 10µM (only for CONTROL_2 
cells). Finally 1.5 hours prior to fixation one of the remaining untreated wells 
and the previously CI treated well (CONTROL_2 only) are treated with H2O2 at 
500µM (final) every 30 minutes for the entire 1.5 hour period. Following 
completion of this treatment all cells will be ready for fixation. 
Cells are fixed as follows: media was aspirated from all wells and each washed 
twice in 1ml PBS which was then aspirated and 2ml of ice cold acetone (Table 1) 
added to each well and the entire plate incubated at -20°C for 7 minutes. The 
acetone was removed and cells washed again twice with PBS to remove any 
remaining acetone. It is important that prior to and following fixation the cells 
are not allowed to dry out. Next the coverslips were blocked by adding 2ml 5% 
BSA (Table 5) and incubated in the dark on a rocker at room temperature for 1 
hour. 
Once blocked the coverslips were stained with the primary antibodies TOM20 
(for the mitochondria) and LAMP2 (for the lysosome). The two antibodies were 
diluted 1:50 in 5% BSA. Both antibodies were applied to the coverslips 
simultaneously; 200µl of the 5% BSA/dual antibody mix applied to each coverslip 
as detailed in Figure 2:4.  
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Figure 2:4- Antibody application for coverslips 
This schematic shows the set up for antibody staining of coverslips. In black is a shallow plastic 
tray inside which other components are composed. At the bottom, in blue, are three sheets of 
Whatman Filter paper cut to fit the tray. These sheets are soaked in water, such that each sheet is 
fully saturated but not so a layer of water is lying on top of the sheet, this prevents the coverslips 
drying out during antibody incubation. Over the top of the Whatman paper is a sheet of parafilm, in 
purple, covering completely all the water saturated whatman paper. To this parafilm 200µl droplets 
of 5%BSA/antibody mix (in yellow) are added, one droplet per coverslip to be stained. Finally the 
coverslips (blue disks) are placed cell side down on top of the BSA/antibody mix. The whole tray is 
covered/sealed with aluminium foil (in grey) as a lid which limits evaporation and protects the 
contents from the light. Care must be taken not to allow the foil to touch or dislodge the coverslips. 
The entire tray and contents are then placed at 4°C to incubate.  
Following overnight incubation at 4°C each coverslip was carefully retrieved and 
placed cell side up in a well of a new 6 well plate (one well per coverslip), with 
2ml PBST in each well. The coverslips were washed for 5 minutes four times in 
PBST, at room temperature protected from light whenever possible. After 
washing the secondary antibodies were applied; Anti-Rabbit Alexa 488 (Table 4) 
for TOM20 and Anti-Mouse Alexa 405 (Table 4) for LAMP2. The secondary 
antibodies were again diluted 1:250 in 5% BSA and as before both secondary 
antibodies were applied simultaneously using the method described in Figure 2:4 
although on this occasion incubation lasts only 1 hour. 
Again coverslips were washed for 5 minutes four times in PBST at room 
temperature in the dark. Whilst this was on-going the microscope slides are 
prepared for coverslip mounting by labelling, and an aliquot the mountant, 
Prolong Gold (Table 1) was defrosted. After washing was complete two drops of 
Prolong Gold are applied to each slide using a p200 Gilson pipette. The 
coverslips were then applied as follows: using forceps the coverslip is removed 
from the PBST and immersed briefly in deionized water to wash off traces of 
PBST. It is then dabbed gently on absorbent tissue paper to remove excess water 
before placing cell side down in the Prolong Gold on each slide. The slide is then 
carefully transferred to a dark place at room temperature to allow the Prolong 
Gold to harden; this can take 24-48 hours. Once hardened coverslips were finally 
sealed by applying a thin layer of nail varnish around the join between the 
coverslip and slide, this can be undertaken before the Prolong gold hardens if 
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the slides are required sooner. Once the nail varnish sets the slides are then 
ready for imaging as described below using the NIKON A1R confocal microscope.  
Excitation and Emission; Alexa 405 (LAMP2) was excited using the 405nm laser at 
13.3% power; emission was detected at 450nm with PMT voltage set at 106V and 
offset at -5V. Alexa 488 (TOM20) was excited using the 488nm laser at 3.5% 
power; emission was detected at 525nm with PMT voltage set at 86V and offset 
at -8V. The 561.5nm laser was used to excite the mCherry fluorophore, laser 
power was set at 3.4%, and emission was detected at 595nm with PMT voltage 
set at 144V and offset at -9V.  
Optics; A 60x Oil lens with a 1.4 numerical aperture was used and pinhole 
diameter was set at 39.72µm.  
Scanning system and acquisition: As cells were fixed speed of acquisition was not 
critical and as such the more accurate but slower galvano scanner was used, 
with a scan size of 1024x1024 pixels at a speed of 1 frame/second and no line 
averaging. All images were three dimensional in nature, composed of a 33 Z-
sections. The Z-sections were taken at a 0.2µm step size using the Nikon A1 
Piezo Z Drive stage. 
2.2.19 Image analysis 
2.2.19.1 IMAGEJ 
The initial mitophagy image analysis was performed using an IMAGEJ macro that 
was written by David Strachan of the BAIR and myself by modifying the 
established “colocalisation colour map macro” which is freely available online 
and details documented in the paper by Jaskolski et al (162), details of the way 
the macro was modified and used are given in Chapter 4 section 4.3.2. Below is 
the Java script for the macro which could be used in any version of IMAGEJ. It 
can only be used on two channel images i.e. images in which two fluorophores 
are to be analysed for co-localisation. It can be used to interrogate images saved 
in ND2, OIF or OBI format, i.e. acquired using the NIKON A1R or OLYMPUS 
FV1000.  
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// 20/10/2010 Macro written by David Strachan to load oib files from 
a given directory 
// Run the Colocalisation Colour map macro, as well as the modified 
grey scale colour map macro 
//  
//  
requires("1.43n"); 
// setBatchMode(true); 
print("\\Clear"); 
run("Clear Results"); 
run("Close All Without Saving"); 
 
dir = newArray(3); 
image=newArray(5); 
dir[1] = getDirectory("Select the directory that contains the image 
files"); 
//dir[2]=dir[1]+"Results/"; 
dir[2] = getDirectory("Select the output directory"); 
f=File.open(dir[2]+"Results.xls"); 
var f=f; 
 
print("The following files have been processed"); 
//print titles for data format into results.txt 
print(f,"Image Name \t Slice \t Value \t Count"); 
print("Image Name \t Slice \t Value \t Count"); 
filename = getFileList(dir[1]); 
// Open each file that exists in the selected directory and if it is 
the correct type perform the analysis on it. 
for (a=0;a<filename.length;a++){ 
 // if filename is a valid file then analyse 
 run("Close All Without Saving"); 
 validExtention=endsWith(filename[a],".oib") || 
endsWith(filename[a],".nd2") || endsWith(filename[a],".oif"); 
 // validExtention=endsWith(filename[a],".oib") || 
endsWith(filename[a],".tif"); 
 if(validExtention == 1){ 
  open(dir[1]+filename[a]); 
  print("Analysing ....."+filename[a]); 
 
 
  for (i=1;i<=2;i++){ 
   selectImage(i); 
   //********** Change the Values here to chop a 
different amount from each stack ********** 
   //  chop end slices from 65 inclusive 
   setSlice(nSlices); 
   for (k=nSlices;k>=65;k--){ 
    run("Delete Slice"); 
   } 
   // Chop the begining to slice 27 inclusive 
   setSlice(1); 
   for (k=1;k<=27;k++){ 
    run("Delete Slice"); 
   } 
  } 
 
 
  // Jump to function to do the actual analyses, supply 
output directory for results to be saved to. 
  run("Tile"); 
  for (j=1;j<=2;j++){ 
   selectImage(j); 
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   image[j]=getTitle(); 
   run("8-bit"); 
  } 
  run("ColocalisationColormap ", "  channel1=["+image[1]+"] 
channel2=["+image[2]+"]"); 
  image[3]=getTitle(); 
  saveAs("Tiff",dir[2]+replace(filename[a],".oib",".TIF")); 
  run("ColocalizationColormap2 ", "  channel1=["+image[1]+"] 
channel2=["+image[2]+"]"); 
  run("8-bit"); 
  image[4]=getTitle(); 
 
 saveAs("Tiff",dir[2]+replace(filename[a],".oib",".grey.TIF")); 
  run("Tile"); 
  // loop to select each slice in turn 
  for (j=1; j<= nSlices;j++){ 
   //Select Image 3 and slice just to visually watch 
what is happening. 
   selectImage(3); 
   setSlice(j); 
   //Select image 4 and slice to pull the numbers. 
   selectImage(4); 
   setSlice(j); 
   // use 
getStatistics(area,mean,min,max,std,histogram) to get the data from 
each slice 
   getStatistics(area, mean, min, max, std, histogram); 
         if (bitDepth==8 || bitDepth==24) { 
    for (i=0; i<histogram.length; i++) { 
     setResult("Slice", i, j); 
     setResult("Value", i, i); 
     setResult("Count", i, histogram[i]); 
     updateResults(); 
     // append data to results.xls file 
     print(f,filename[a]+"  \t"+j+" \t"+i+" 
\t"+histogram[i]); 
     print(filename[a]+"  \t"+j+" \t"+i+" 
\t"+histogram[i]); 
    } 
   } else { 
    value = min; 
    binWidth = (max-min)/256; 
    for (i=0; i<histogram.length; i++) { 
     setResult("Slice", i, j); 
     setResult("Value", i, value); 
     setResult("Count", i, histogram[i]); 
     value += binWidth; 
     updateResults(); 
     // append data to results.xls file 
     print(f,filename[a]+"  \t"+j+" \t"+i+" 
\t"+histogram[i]); 
     print(filename[a]+"  \t"+j+" \t"+i+" 
\t"+histogram[i]); 
    } 
   } 
   updateResults(); 
   
  } 
   
 } 
} 
File.close(f); 
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print("Finished"); 
   
2.2.19.2 Metamorph 
Metamorph software was utilized to measure mitochondrial length. Essentially 
this was performed as described by Song et al in their Methods paper in 2008 
(163). However certain parameters are variable dependent upon the cells being 
imaged; as such brief details of the parameters, thresholds and processes 
performed at each stage are given in the below. 
1. Import Z-stack image into Metamorph software 
2. Using Basic filters tab apply a median filter to every section of Z-stack: 
Filter width 3 pixels, filter height 3 pixels and subsample 1. 
3. Using Arithmetic tab subtract the median filtered image from every slice 
of the original Z-stack – resultant image is called subtract. 
4. Using Stack Arithmetic tab take “subtract” image and generate a 
maximum projection by selecting ‘Maximum’ – resultant image is called 
Maximum. 
5. Using the Scale Image tab take “Maximum” image and scale with low set 
at 202 and high at 888 and copy to 8bit. 
6. With the scaled “Maximum” image select adjust digital contrast tab set 
the brightness to 50, contrast to 50 and gamma to 1.4. 
7. With the adjusted image select the binary operations Tab, select binarize 
with the range set to low 246 and high 2511. The resultant image is called 
“Binary” 
8. Again using the binary operations tab select the “Binary” image and select 
erode, with neighbourhood set at 6 pixels and repeat count at 1 – the 
resultant image is called “Erode”. 
9. Again with the binary operations tab selecting the “Erode” image select 
skeletonize – the resultant image is called “Skeleton”. 
10. The final binary operations function is to select the “Skeleton” image and 
select the remove single pixel option – resultant image is called “Remove 
Pixels”. 
11. Using the “remove pixel” image regions are manually drawn round each 
cell in the image taking care to exclude the perinuclear region. The 
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mitochondrial network is highly complex in all cells in that region which 
makes it difficult to get accurate measurements. Then using the ‘Regions’ 
tab select create regions round objects. This traces round the perimeter 
of every mitochondria contained within the manually drawn cell regions.  
This perimeter is then measured as described in the paper (163), and the 
length of each mitochondria calculated by dividing the perimeter 
measurement for each mitochondria by two. 
 
2.2.19.3 IMARIS 
The BitPlane IMARIS software represents an effective 3D rendering of three 
dimensional Z-stack images as described in chapter 5 section 5.3.1. However it is 
also possible to use this software to obtain quantitative data from images, 
unfortunately currently there is no option to ‘batch process’ images under the 
same protocol to obtain this quantitative data (as is possible using Volocity) as 
such IMARIS was not used in this thesis in this manner. 
It was used however to generate several 3D renderings of images, taken as 
described in section 2.2.18.4, for presentation. A few of these have been 
presented in chapter 5 section 5.3.1. The method for this is also described in 
chapter 5 section 5.3.1 and so will not be revisited here. 
2.2.19.4 Volocity 
The Perkin Elmer Volocity software was used to analyse the images taken of the 
fixed cells as described in section 2.2.18.4.2. The design of this analysis protocol 
was a significant element of this thesis and as such it is described in chapter 5 
section 5.3.2 however details of specific parameters set will be given here. 
Although all the images were taken under the best possible imaging settings 
there was still an element of background noise, as such removal of noise and 
contrast enhancement was applied to all images in Alexa Fluor 405 and mCherry 
channels. A fine filter was used in each case for noise reduction and for contrast 
enhancement the black threshold was set to 500 and the white threshold left at 
4095 with a gamma of 1.  
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Having altered our images to give, in our opinion, the clearest images for 
analysis we set about developing the protocol that would measure mitophagy. 
Once all components have been identified Volocity can then quantify the 
occurrence of each component interacting with others. This simply requires the 
addition of an “INTERSECT” function to the Volocity protocol. To quantify 
mitophagy we simply direct Volocity to measure the number of intersections of 
mitochondria and autophagosomes; for late stage mitophagy we ask Volocity to 
measure the number of mitophagy events, as defined previously, that intersect 
with lysosomes. There are no thresholds to be set during this part of the 
protocol, Volocity makes these measurements based on the parameters set 
previously to define mitochondria, autophagosomes and lysosomes and simply 
looks for interaction between these defined components. 
Mitochondria are identified by setting parameters for the Alexa 488 channel (300 
as a minimum fluorescence intensity threshold, no upper limit and to separate 
touching components from one another the object size guide was set at 40µm3 
with minimum size limited at 1µm3), the autophagosomes are identified by 
setting parameters for the mCherry channel(1764 as a minimum fluorescence 
intensity threshold, no upper limit and to separate touching components from 
one another the object size guide was set at 0.22µm3 with minimum size limited 
at 0.22µm3) and the lysosomes through parameters within the Alexa 405 channel 
(1370 as a minimum fluorescence intensity threshold, no upper limit and to 
separate touching components from one another the object size guide was set at 
0.22µm3 minimum size limited at 0.22µm3). This approach allowed us not only to 
identify the different components in each image and consequently measure 
mitophagy events as described above, but also count the numbers of 
mitochondria, lysosomes and autophagosomes in each image.  
The data returned by Volocity was normalised to cell number and statistical 
tests applied as described below to determine the significance of the differences 
detected between cell lines analysed in this way. 
2.3 Statistical analysis 
The statistical tests performed throughout this thesis are indicated in the 
legends of each figure. However the statistical testing performed on the data 
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generated from Volocity analysis of the imaging data requires further 
explanation. Gabriela Kalna undertook the statistical analysis of the Volocity 
data using a generalized linear model as described below. 
To investigate the significance of the differences between the means of groups 
of continuous response variables t-test or analysis of variance are usually 
applied. The groups of data should be independent, normally distributed and 
have the same variance. However, our data violates assumptions of normality 
and/or same variance. Therefore, a generalized linear model with gamma 
probability distribution was fitted to the data. This is a sensible model for 
biological data that are restricted to positive continuous values and their 
variance is a function of their mean that is the variance of the response 
variables tends to zero as their mean tends to zero. 
Statistical analysis was performed in R package. Normality of data subsets were 
tested by shapiro.test. Generalized linear models were implemented using 
function glm and corresponding summary output tables contained the two-tailed 
p-values of interests.  
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Chapter 3 Characterisation of experimental system 
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3.1 Introduction 
Cardiolipin (CL) is a unique phospholipid in that it is composed of four acyl 
chains and found exclusively in the mitochondrial membranes. As mentioned in 
Chapter 1 it plays important roles in mitochondrial respiration, apoptosis and 
mitochondrial dynamics (39-42, 64, 143, 154, 161, 164, 165). Its role in each of 
these processes relies heavily on its structure. The four acyl chains of CL vary in 
length and degree of saturation. Specifically the polyunsaturated forms of CL, 
puCL, play major roles in these processes due firstly to the fluidity that they 
confer on the mitochondrial membrane and secondly due to the ease by which 
these unsaturated bonds can be oxidized. 
It is my hypothesis that these two properties of CL also have roles to play in 
mitophagy. First oxidation of the unsaturated double bonds in puCL species act 
as a signal of damaged mitochondria which is recognised and acted upon by the 
mitophagic machinery. In addition the role of CL in mitochondrial dynamics is 
also important to mitophagy: fission and or fusion of damaged mitochondria are 
a key determinants in mitochondrial fate. Loss of puCL affects these dynamic 
processes by reducing the fluidity of the mitochondrial membranes, causing 
them to be less flexible. As a result it is more difficult to induce the membrane 
bending, pinching and flexion require for fission and fusion. 
The synthesis of CL is described previously (Chapter 1, section 1.3.1), two 
dedicated enzymes stand out as key targets to affect CL synthesis; Cardiolipin 
synthase and Tafazzin (TAZ). CL synthase allows the conversion of PG and 
CDP_DAG to CL (Figure 1:4). This form of CL, although present to some level in 
mitochondria, appears not to be as functionally significant as puCL. However the 
next stage in the synthesis pathway allows for the conversion of immature CL 
generated by CL synthase to MLCL by phospholipase A. TAZ then takes this MLCL 
and adds a polyunsaturated acyl chain, phospholipase A then acts on this form of 
CL again to remove another saturated acyl chain which again replaced by an 
unsaturated one by TAZ. This cycle is repeated four times until all the original 
acyl chains are replaced by polyunsaturated ones, creating puCL. puCL is not 
only functionally important to the cells but our hypothesis relies on the 
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oxidation of puCL to form oxidised cardiolipin (oxi-CL). Oxi-CL cannot be formed 
from saturated CL due to the lack of doubled bonds present in the saturated acyl 
chains. 
This makes TAZ a very important enzyme, so important that loss of function of 
this enzyme in humans results in a severe genetic disease known as Barth’s 
syndrome, described in more detail in chapter 1(129, 146, 152).This condition 
results from the ablation of TAZ activity. It is already known that loss of TAZ 
effects cell death, mitochondrial dynamics and respiration (39-42, 64, 143, 154, 
161, 164, 165). However we believe that it also affects mitophagy. Based on this 
hypothesis patients with Barth syndrome would show reduced levels of 
mitophagy, due to low or non-existent puCL levels consequently resulting in low 
or non-existent oxi-CL levels and thus failure of damaged mitochondria to signal 
to the mitophagic machinery . In this chapter, using cell lines derived from Barth 
syndrome patients, we begin to investigate this hypothesis.  
3.2 The Model system 
Human skin Fibroblasts donated by two healthy individuals and two Barth 
syndrome suffers: C106, C109, Taz001, Taz003 respectively, were isolated by 
Riekelt Houtkooper(148). Details of the mutations affecting Taz001 and Taz003 
can be found in Houtkooper et al 2009 (148), and have been reproduced here in 
Table 7.  
 
Table 7- Mutations in Tafazzin gene for Barth syndrome cells. 
 
Here after these cell lines shall be referred to as Control_1, Control_2, 
TAZMUT_1 and TAZMUT_3 respectively. The cell lines were immortalised by 
over-expression of the catalytic subunit of human telomerase htert, this was 
introduced to the cells by retroviral infection performed by Zach Schug from our 
lab. 
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3.2.1 Mass Spectrometry analysis for Cardiolipin 
 As described in Chapter 1, Barth syndrome results from mutations in the gene 
encoding TAZ which in turn results in failure to produce mature puCL. The 
classic diagnostic test for individuals suspected of having Barth syndrome is mass 
spectrometry analysis of the CL profile of the patient. Those with Barth 
syndrome have decreased levels of puCL and increased levels of MLCL. To 
confirm the Barth’s nature of TAZMUT_1 and TAZMUT_3 mass spectrometry was 
performed. Cell pellets of all four cell lines were sent to The Laboratory of 
Genetic and metabolic diseases at the University of Amsterdam, where the lipids 
were extracted and analysed by Riekelt Houtkooper and Fred Vaz, separating 
lipids by High performance chromatography (HPLC) and analysing by mass 
spectrometry. Figure 3:1 gives the spectra for MLCL and CL for all four cell lines. 
All data are normalised to an internal standard of CL (m/z 619.5) which is added 
to each sample and set to 100%. 
 
Figure 3:1- Cardiolipin profiles for Control_1, Control_2, TAZMUT_1 and TAZMUT_3. 
(A) Mass Spectra for Control_1 and Control_2 cell lines. (B) Mass spectra for TAZMUT_1 and 
TAZMUT_3.  Spectra show MLCL and CL molecular species. Red boxed area highlights the MLCL 
species. IS corresponds to the CL internal standard added to each sample. Red arrows indicated 
increased MLCL levels; blue arrows show reduced MLCL levels and increased levels of puCL. 
Green arrows indicate loss of puCL species and increased saturated CL. 
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On the right of the spectra several clusters of peaks are observed, each cluster 
relates to different lengths of acyl-chains. CL can be synthesised from a variety 
acyl chains of different lengths. Each cluster is composed of several peaks; each 
cluster represents the same length of acyl chain but at different degree of 
saturation, with high m/z peaks representing highest degree of saturation. To 
the left of the spectra, highlighted with red boxes, are the MLCL species, the 
precursor molecule to puCL. CONTROL cells show low levels of MLCL and wide 
clusters of CL indicating the presence of both saturated CL and puCL. Comparing 
TAZMUT cells with CONTROL, the MLCL levels are highly increased (red arrows) 
in the TAZMUT cells and almost negligible in the Control cells (blue arrows). To 
the right of the spectra in TAZMUT cells we see a shift of the clusters toward the 
right, indicating longer acyl chains are being used to synthesize CL. In addition 
to this the clusters are much narrower, as highlighted by the green arrows, 
which indicates increased saturation of the CL species as compared to control 
cells. These three differences are key indicators of Barth syndrome, and confirm 
reduced levels of puCL as a result of the reduction in TAZ activity.  
3.2.2 Mitochondrial Length 
Upon initial imaging striking morphological differences between the 
mitochondria of TAZMUT and CONTROL cells was observed. It appeared that 
mitochondria of the TAZMUT cells were longer than that of CONTROL cells, 
Figure 3:2.  
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Figure 3:2- Initial imaging of Mitochondria 
Confocal images of live cells dyed with Mitotracker green. White boxes indicate region magnified in 
the images on the left. 
Electron microscopy of these cells also gave supporting results, showing once 
again the increased length of mitochondria in TAZMUT cells versus CONTROL, 
Figure 3:3. 
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Figure 3:3- Electron Microscopy to visualise mitochondria 
Representative images taken by Massimo Micaroni, shows the relatively short mitochondria of 
CONTROL_2 cells versus the elongated Mitochondria in TAZMUT_1 and exceptionally long 
mitochondria in TAZMUT_3.  Red arrows indicate mitochondria, whilst blue boxes give 
representation of length; only two mitochondria in each image have been identified in this way. 
Three dimensional imaging is of great importance when measuring mitochondrial 
length for two reasons. Firstly mitochondria exist on all planes of the cell and in 
all areas (other than the nucleus), their localisation is not fixed. Secondly 
mitochondria are not static and are free to move within the 3D volume of the 
cell, and are present in any orientation in that volume from horizontal to 
vertical. Therefore by imaging only in a single plane it is not possible to capture 
all the mitochondria present in the cell and also those that are captured may be 
mis-represented; a mitochondria may appear as a sphere if imaged in a single 
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plane but in fact be represents only a small portions of a mitochondrial filament 
that extends vertically through the cell. This kind of mistake would have a 
dramatic effect on any data regarding mitochondrial length. Therefore any 
method used to measure mitochondrial length must take into account the three 
dimensional movement and positioning of mitochondria, as is the case with the 
method described below. 
Song et al, developed a method by which mitochondrial length could be 
measured using three dimensional imaging and the software analysis package 
Metamorph (163). To apply this method required further imaging to obtain Z-
stack images for each cell line, numerous images taken through the 3D volume of 
the cell. Therefore we transiently expressed Mito-dsRED (red fluorescent protein 
targeted to the mitochondria by fusion with the mitochondrial targeting 
sequence of cytochrome C) as our mitochondrial marker, in three of the four cell 
lines; CONTROL_2, TAZMUT_3 and TAZMUT_1, and imaged each. Figure 3:4 
shows representative images for each cell line, the images are 3D projections of 
the original Z-Stacks from which increased length of the TAZMUT cells is 
apparent. 
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Figure 3:4- Mitochondrial length Z-stack images  
Three representative images from the three cell lines CONTROL_2, TAZMUT_3 and TAZMUT_1. 
Images are derived from 3D projections of the original Z-stack image; all cells were transiently 
transfected with Mito-dsRED. 
All images for each cell line were then analysed using the aforementioned 
method (163). All of the Z-stack images were interrogated using this method, 
which results in a measurement labelled “Distance” (N.B. in some versions of 
Metamorph this measurement is labelled “Perimeter”) this refers to 
measurement made around each object, which in the case of these images are 
mitochondria as seen in Figure 3:5. 
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Figure 3:5- How mitochondrial length is measured 
This schematic shows how mitochondrial perimeter is measured by Metamorph and how this 
relates to mitochondrial length. Step one show how the perimeter (pink) of mitochondria (green) is 
determined. This is then measured by Metamorph giving the distances shown below at stage 2. 
The following stages 3 and 4 are performed by the user and the above is just a pictorial 
representation. When the perimeter measurement is halved we are measuring the length along one 
side of the mitochondria as seen at stage 4, which is essentially the length of the mitochondria in 
question. 
The “Distance” values are actually measures of the perimeter of each 
mitochondrion, to obtain the actual length these need to be halved to give the 
length as described in Figure 3:5. It should be noted that one inherent flaw of 
this method is the possibility of underestimating mitochondrial length. The 
method measures mitochondrial length from a maximum intensity projection 
(compressed image) of each Z-stack image. Whilst this will give a good 
representation of mitochondrial length in most cases, were mitochondria pass 
diagonally through several planes the length may be underestimated. In this case 
the length is represented in the compressed image as the distance the 
mitochondria covers in the X or Y plane, it does not take into account the 
distance the mitochondria also covers in the Z plane which in fact may be 
greater than the distance covered in either X or Y planes. It is important 
therefore to consider this when interpreting the data generated form this 
method, however such an inherent error would be applicable to all data sets.   
The final data can be seen in Figure 3:6, Which shows that both TAZMUT cells 
have increased mitochondrial length as compared to CONTROL_2, with 
TAZMUT_3 having the longest mitochondria of all three cell lines tested. 
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Figure 3:6- Mitochondrial length 
Graph shows mean mitochondrial length for each cell line, with error bars of +/- SEM. * indicate 
data is statistical significant (* indicate p<0.5) from CONTROL_2. Thirteen images were taken and 
analysed for each cell line and statistical significance determined by ANOVA. 
Mitochondrial Length is of great importance in terms of mitophagy. Upon 
starvation mitochondria have been observed to elongate and as such avoid 
degradation by the autophagosome (6, 82). This is essential in this case as it 
ensures mitochondria are available to utilize the fuel sources derived by 
autophagy of other cellular components. However following mitochondrial 
damage it is observed that fission and thus reduced mitochondrial length is 
essential for mitophagy to proceed (106, 159, 163). 
Both scenarios highlight a common theme; if mitochondria remain or become 
elongated they simply cannot fit into an autophagosome and therefore cannot be 
degraded by mitophagy. As cell with mutant TAZ and therefore low puCL levels 
have increased mitochondrial length, it would suggest difficulty of mitochondrial 
engulfment by the autophagosome in these cells as well as a role for puCL in 
mitochondrial length determination. It would be expected that the loss of TAZ 
activity and the consequential decrease in puCL and increase in saturated CL 
affects the mitochondrial membrane fluidity.  
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The fluidity of any biological membrane is governed by the ratio of saturated to 
unsaturated lipids found in the membrane. Increases in the levels saturated 
lipids in a biological membrane result in increased membrane rigidity. This 
increase in rigidity means the capacity of the membrane to curve bend and flex 
is diminished. In the case of mitochondria, the ability of the mitochondria to 
bend and flex allows it to maintain a dynamic fluid network with the ability to 
undertake fission and fusion processes. Reduced fluidity makes the membrane 
recalcitrant to bend and flex movements resulting in fewer fission events. In 
mitophagy, mitochondrial fission is a key step in the isolation of damaged 
mitochondria from the rest of the mitochondrial network. If this cannot occur 
due to reduced membrane fluidity, it may be possible that mitophagy is reduced 
and damaged/dysfunctional mitochondria are maintained within the cell. As 
such perhaps the increased length of mitochondria we observe in our TAZMUT 
cells results from failed fission. This could lead to maintenance of damaged 
mitochondria due to their inability to detach from the rest of the healthy 
network. Further to this if biogenesis of mitochondria continues new healthy 
mitochondria may fuse with the damaged mitochondria in attempts to “rescue” 
them creating long filaments of mitochondria, perhaps explaining the increase in 
mitochondrial length observed in TAZMUT cells as compared to CONTROL.  
3.2.3  Mitochondrial Dynamics 
As mentioned above increased mitochondrial length may result from altered 
fission/fusion dynamics brought about by reduced membrane fluidity. It is also 
known that CL plays a more direct role in mitochondrial dynamics as discussed in 
Chapter 1, (39, 107, 161). Therefore we investigated the dynamics of the 
mitochondrial networks in our cells comparing CONTROL cells to TAZMUT. 
By transiently transfecting cells with Mito-dsRed and also with photo-
activateable GFP targeted to the mitochondria (both fluorophores targeted to 
the mitochondrial matrix by the mitochondrial targeting sequence of cytochrome 
C) we were able to monitor steady state mitochondrial dynamics of our cells. As 
the cells were doubly labelled (firstly with the stable mito-dsred and secondly 
with the activatable Mito-PAGFP) we were able to be quite precise with our 
laser activation of the PAGFP fluorophore. This allowed for specific activation of 
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only a small portion of the mitochondrial network and the dynamic nature of the 
network over time using time-lapse confocal microscopy. 
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Figure 3:7- Mitochondrial dynamics, CONTROL_2 
(A + B) Show selected frames from a time lapse taken following activation of Mito-PAGFP. The 
time following activation is given in seconds above each frame. The white circle in the first frame, 
0s, of each panel shows the point of initial activation. White arrows indicate fission and fusion 
events and emphasise the interconnected nature of the mitochondrial network as evidenced by 
diffusion of the activated fluorophore into adjacent areas of the mitochondrial network. The second 
frame in each panel is the one captured directly after activation.  
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Looking first at CONTROL_2 (Figure 3:7) we observed a highly dynamic and 
interconnected mitochondrial network. In the 1.9s  image of panel A of Figure 
3:7 shows the field of view directly after activation of the PAGFP fluorophore, 
showing already some degree diffusion of the activated fluorophore away from 
the small area of activation identified in the 0s image. Furthermore over a short 
period of time (18s) this area of GFP fluorescence spreads quickly as indicated 
by the white arrows in the third frame. This continues throughout all the frames 
in panel A, indicating a highly connected dynamic mitochondrial web in these 
cells. Indeed the diffusion of the fluorophore observed could result not only from 
high interconnectedness of the mitochondrial network but also as the result of 
fusion events and possibly mitochondrial biogenesis, examples of these potential 
events can be observed in the images at 57.19s,125.4s and 133s (again indicated 
by white arrows).  
Panel B shows a similarly dynamic interconnected mitochondrial web as observed 
in panel A. In addition we also see a number of both fission and fusion events 
taking place. Frame three, (27.6s) shows two possible fusion events that have 
occurred since initial activation, followed by another possible fusion event at 
57.19s. This last event appears to quickly lead to a fission event as observed at 
125.4s and again highlighted at 133s along with another fission event indicated 
by the second arrow. Taking the two panels together we observe a highly 
interconnected dynamic mitochondrial network, which is capable of both fission 
and fusion. 
Imaging of TAZMUT cells revealed a different situation, Figure 3:8 and Figure 
3:9. 
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Figure 3:8- Mitochondrial Dynamics, TAZMUT_1 
(A + B) Show selected frames from a time lapse taken following activation of Mito-PAGFP. The 
time following activation is given in seconds above each frame. The white circle in the first frame, 
0s, of each panel shows the point of initial activation. White arrows indicate fission and fusion 
events and emphasise the interconnected nature of the mitochondrial network as evidenced by 
diffusion of the activated fluorophore into adjacent areas of the mitochondrial network. The second 
frame in each panel is the one captured directly after activation. 
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Figure 3:9- Mitochondrial dynamics, TAZMUT_3 
(A + B) Show selected frames from a time lapse taken following activation of Mito-PAGFP. The 
time following activation is given in seconds above each frame. The white circle in the first frame, 
0s, of each panel shows the point of initial activation. White arrows indicate fission and fusion 
events and emphasise the interconnected nature of the mitochondrial network as evidenced by 
diffusion of the activated fluorophore into adjacent areas of the mitochondrial network. The second 
frame in each panel is the one captured directly after activation.  
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TazMUT_1 cells are shown in Figure 3:8 and the mitochondrial dynamics 
observed seemed very different compared to CONTROL. Despite the same size of 
region of activation for both TAZMUT_1 and CONTROL cells the degree of 
diffusion of the activated PAGFP directly following activation (Figure 3:8 panels 
A and B 1.9s) appears less in the TAZMUT_1 cells as compared to CONTROL_2. 
This may indicate that the mitochondrial network in TAZMUT_1 is less 
interconnected and thus preventing a similar level of fusion as was observed in 
CONTROL_2 cells. The time-lapse for this cell line was continued much longer 
than CONTROL_2, up to ten minutes, and yet in comparison very few potential 
fission or fusion events were observed. In panel A it takes the whole ten minutes 
before any potentially dynamic activity is observed within the activated region 
of the mitochondrial network.  
The activation and dynamics of mito-PAGFP in TAZMUT_3 cells was qualitatively 
similar to TAZMUT_1 (Figure 3:9). Panel A shows a slightly larger activated area 
as compared to TAZMUT_1, which may suggest this network is slightly more 
connected as compared to TAZMUT_1. However, in comparison to CONTROL_2 
TAZMUT_3 shows a lower degree of activated PAGFP diffusion, suggesting that 
TAZMUT_3 cells have reduced mitochondrial network interconnectivity. Over a 
similar timeframe and to CONTROL_2, panel A shows no further fluorophore 
diffusion over time following activation again in contrast to CONTROL_2 which 
does show further diffusion along with possible fusion and fission events over 
time. In panel B again a similar a lack of diffusion of GFP fluorescence following 
the initial activation as observed in panel A and data from TAZMUT_1. Panel B 
also highlights another between the cells lines which is observed at 11.5s. The 
activated mitochondrion appears ‘pinched’ along its length. Recent work by Gia 
Volts highlights a role for the endoplasmic reticulum in mitochondrial fission, 
and by using three dimensional imaging she has shown how the ER encircles and 
pinches mitochondrial filaments to induce fission (44, 47, 166). It may be that 
the pinching effect observed in our TAZMUT_3 cells results from attempted ER-
driven fission, but failure on the part of DRP1 and MFF to complete the process. 
Perhaps these two fission proteins require a puCL platform in the mitochondria 
from which to work. The oxidative effect of the 405nm laser used to excite the 
PAGFP could be damaging the targeted mitochondria and what is observed is the 
effect of the ER on this damaged mitochondrion, in an attempt to excise, by 
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fission, the laser damaged mitochondria prior to mitophagic degradation. 
However as we see from the following frame no complete fission results. 
Instead at the centre of the activated mitochondrion a ring structure appears. It 
has been shown that upon CCCP induced mitochondrial depolarisation 
mitochondria fragment and form donut like structures (104). Therefore in this 
frame we may be witnessing the formation of one a donut like structures 
without the preceding fission event. However the following frame again displays 
the pinched morphology of the mitochondrion- suggesting the cell is once again 
attempting to induce fission of this mitochondrial filament. In this attempt it 
appears it may have been successful as the final frame shows a possible fission 
event at the top left of the activated mitochondrion – perhaps suggesting that 
low puCL levels of the TAZMUT_3 cells does not completely block fission but 
does cause the process to become less efficient.  
In similar events have been observed in images (not presented herein) where the 
mitochondria become pinched and then as observed here undergo what appears 
to be extensive fission of one filament into many mitochondrial spheres. 
Remarkably these spheres remain in line with one another, like beads on a 
string, and then later appear to re-fuse to form the original filament. Perhaps 
these mitochondria are not undergoing full fission but only fission of one 
membrane. Others have shown how during fusion the inner and outer 
membranes fuse separately, (167). Perhaps the same is also true of fission, were 
each membrane inner and outer undergo fission separately. Thus what we 
observe here could be successful fission of the inner membrane only whilst the 
outer remains as one continuous membrane. As previously mentioned the two 
mitochondrial fluorescent markers used for this imaging approach are targeted 
to the mitochondrial matrix- therefore  the ‘mitochondria’ observed here is in 
fact only the mitochondrial matrix and inner membrane, the outer membrane is 
not identified. Consequently the ‘fission’ we observe is inner membrane fission 
and perhaps the outer membrane remains intact holding the now separated 
inner membrane compartments together appearing in our images like beads on a 
string and as though full fission has occurred. Yet later due to the failure of the 
outer membrane to 'fis' we see the inner membrane re-fuse once again forming 
the complete mitochondria. 
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It is unclear based on the images taken thus far how fission and fusion are 
affected in the TAZMUT cells. However there may be a problem with fission (and 
possibly fusion) in the TAZMUT cells and this may account for the difference 
observed in mitochondrial length, but further investigation is required to 
understand this fully. In addition we have observed that the CONTROL_2 cells 
have a far more interconnected mitochondrial network as compared to either of 
the TAZMUT cells and this too may be contributing to the differences observed in 
mitochondrial length of these cells as well as the health of the mitochondria and 
consequently the cells. These kinds of differences in morphology and 
mitochondrial dynamics almost certainly affect the health of the cell and 
mitochondrial network and potentially account for some of the symptoms 
attributed to Barth syndrome. Furthermore these differences could affect 
mitophagy and as such our next investigation was into the effect of reduced 
puCL levels on mitophagy. 
3.3 Initial Mitophagy Measurements 
We decided on an imaging approach to investigate mitophagy, using confocal 
microscopy to observe and hopefully quantify mitophagic events.  
3.3.1 Image acquisition 
As previously mentioned (section 3.2.2) live imaging of mitochondria should be 
three dimensional and fast. Therefore it is essential to pick the correct system 
with which to image. We chose the NIKON A1R confocal microscope. This 
microscope is equipped for both live and fixed cell imaging; it has three Lasers 
405nm, 488nm and 564nm. However the two most important features for our 
work were the piezo stage and the ability to switch between two types of 
scanners: the galvano (for slow high resolution image acquisition) and the 
resonant (for faster lower resolution image acquisition).  
The NIKON-A1R is equipped with a standard motorized staged giving X, Y and Z 
movement. However the Piezo stage allows for much finer and quicker Z 
movement, resulting in a more detailed image. This increased detail is of great 
importance when looking at small rare events like mitophagy. Less detail can 
135 
 
 Laura Catherine Avril Galbraith 
result in false positives, were for example an autophagosome may look like it is 
engulfing a mitochondria but in fact it is just sitting above it. Less fine Z-
sectioning can result in events being missed due to an event occurring in the 
plane of transition- i.e. the distance not imaged when using a standard 
motorised stage when moving from one section to another. The piezo stage 
reduces these kinds of occurrences dramatically by decreasing the distance of 
transition between z-sections. 
The Resonant scanner has a very fast speed (thirty frames per second at 
512x512) compared to the standard galvano scanning confocal (with scan speed 
of ten frames per second). The resonant scanner has a pitfall however in that 
this increased speed results in very poor quality images, but a “work around” is 
possible with very little effect on the image acquisition speed but dramatic 
improvement on image quality, and that is to add in line averaging, in our case 
we averaged over four lines, i.e. line of an image is scanned four times and an 
image produced based on the average of those scans images. This reduces the 
noise significantly for every image, increasing the image quality, as the signal to 
noise ratio is improved by the square root of the number of frames averaged. 
Yet this hardly affects the scan speed advantage given by using the resonant 
scanner in the first place.  
3.3.2 Mitophagy after depolarisation 
Loss of mitochondrial membrane potential has been identified as one of the 
preliminary stages and potentially a signalling mechanism in mitophagy 
induction. Depolarization of mitochondria occurs when the proton gradient 
maintained by the activity of the ETC is abolished. This gradient occurs over the 
inner mitochondrial membrane with the protein complexes of the ETC pumping 
hydrogen ions (H+) out of the mitochondrial matrix into the intermembrane 
space. The inner mitochondrial membrane acts as an impermeable barrier to H+ 
preventing free movement into the matrix. This barrier can be circumvented by 
proteins that transport H+ back across this membrane; mainly this occurs through 
ATP synthase to facilitate the generation of ATP. However other pore forming 
proteins can also carry protons back across and this is known as the ‘proton 
leak’. In addition some chemicals added to cells can also have similar effect by 
136 
 
 Laura Catherine Avril Galbraith 
carrying H+ across the membrane and these chemicals are known as 
protonophores. One well known protonophore is carbonyl cyanide m-
chlorophenyl hydrazone (CCCP). The actions of protonophores like CCCP abolish 
the proton gradient established by the ETC complexes, resulting in mitochondrial 
depolarization. This is known as uncoupling of the mitochondria as the actions of 
the ETC complexes are ‘uncoupled’ from ATP synthase by destruction of the 
proton gradient. The effect of CCCP is damaging to the mitochondria, disrupting 
their function and has been shown by many to induce mitophagy. It is now used 
regularly to trigger mitophagy to study the downstream events such as PARKIN 
recruitment. For this reason we have used CCCP as a mitophagy inducer in our 
cells.  
A variety of mitophagy inducing exposure times and concentrations are used by 
others. As such we decided to test our own cells to find the best inducing 
conditions. We found 10µM CCCP instantly depolarised mitochondria (Figure 4:6) 
however how long after depolarisation mitophagy occurs was unclear.  
To monitor mitophagy we stained the mitochondria with mitotracker green and 
lysosomes with lysotracker red. As Lysosomes fuse with autophagosomes in the 
final stage of mitophagy/autophagy, forming the autolysosome which breaks 
down the contents of the autophagosome using the lysosomal localised 
cathepsins, then used co-localisation of mitotracker green (mitochondria) and 
lysotracker red (lysosomes) as a surrogate for the measure of mitophagy. Using 
these two dyes we found a timeframe of 3 hours from the addition of CCCP to 
mitophagy (Figure 3:10). There has been some controversy over the specificity of 
the mitotracker probes following addition of CCCP, however no such issues were 
observed here (100).    
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Figure 3:10- Establishing the conditions for Mitophagy induction with CCCP 
CONTROL_2 cells were stained with Mitotracker green and Lysotracker red and then either treated 
for one or three hours with CCCP or left untreated before imaging using the NIKON A1R confocal 
microscope. 
The images show that there is little difference in co-localisation of mitochondria 
and lysosomes between the untreated and one hour treatment with CCCP cells, 
although it appears that the mitochondria are becoming fragmented. After three 
hours the mitochondria are completely fragmented. Fragmentation of 
mitochondria is a known effect of CCCP. The damaged caused by CCCP instigates 
the mitophagic response to remove the damaged organelles and as previously 
mentioned fission is required prior to engulfment of the damaged organelle by 
the autophagosome. Co-localisation between the mitochondrial spheres and the 
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lysosomes can be identified by the appearance of yellow dots at the three hour 
time-point which are not present before. These co-localisation events are what 
we used as our surrogate measure of mitophagy. After ascertaining the correct 
mitophagy inducing conditions with CCCP in our cells, we then began treating 
and imaging three of the four cell lines, CONTROL_1, TAZMUT_3 and TAZMUT_1, 
for comparison of levels of mitophagy.  
As mitophagic events are transient they are difficult to capture, to maximise our 
chances of observing these events we blocked the final stage in the pathway 
using the inhibitors (pepstatin A and E64d) of the lysosomal enzymes 
(cathepsins). These cathepsin inhibitors (CI’s) prevent the digestion of the 
mitochondria once they have been enclosed inside the autolysosome 
compartment. Essentially this inhibition results in an accumulation in 
autolysosomes and their contents, (in this case mitochondria) making a transient 
event more long lived and therefore easier to capture by microscopy. As such 
cells were imaged untreated, CI treated, CCCP treated and CCCP with CI’s 
treated. Firstly we imaged CONTROL_1 cells under these conditions, Figure 3:11. 
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Figure 3:11- Control_1 CCCP induced Mitophagy 
Representative images of CONTROL_1 cells under various treatments. All CCCP treatments are 
three hours at 10µM, whilst all CI treatments are for six hours prior to imaging, with Pepstatin A at a 
concentration of 5µg/ml and E64d at a concentration of 10µM. 
Untreated cells show a basal level of mitophagy which corresponds to the 
shortest, spherical, mitochondria in the field. For the most part the 
mitochondria remain in long filaments indicative of healthy undamaged 
mitochondria. 
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With addition of CI’s there is an accumulation of lysosomes, as to be expected. 
The lysosomes not only have roles in mitophagy but also general macro-
autophagy as well as direct lysosomal degradation of cellular components. Hence 
in adding the CI’s to the cells we block all of these degradative pathways the 
lysosomes are involved in resulting in the increase in their numbers as observed 
here. There may also be a slight increase in mitophagy levels as the background 
levels of mitophagy are blocked and mitochondria get stuck in the lysosomes and 
not degraded resulting in the increase seen. It appears that CI’s do not have an 
effect on mitochondrial morphology. 
With the addition of CCCP we see three distinct changes in the cells. Firstly the 
mitochondrial morphology is dramatically affected. Compared to untreated and 
CI treated we can see almost all mitochondria have become fragmented. 
Lysosome number and localisation appears similar to untreated as flux through 
the pathway is not blocked. Although it does appear that more mitophagic 
(yellow) punctae are present indicating CCCP treatment is inducing mitophagy. 
Finally the combined treatment of CCCP and CI’s gives yet further changes in the 
cells. As with CCCP alone the mitochondria are highly fragmented, but they also 
show perinuclear localisation. Perinuclear clustering of mitochondria has been 
identified as an indicator of imminent mitophagy (75). Furthermore the number 
of lysosomes has increased as seen in CI alone treatment and they to appear to 
become perinuclear in localisation. In terms of mitophagy the occurrence of 
mitophagic (yellow) punctae is dramatically increased in comparison to 
untreated and CI treated and CCCP treated cells. Together this data shows 
effective mitophagy induction by CCCP in these cells and how CI’s can be used to 
amplify the likelihood of capturing these events. This provides us with a control 
for mitophagy induction in cells with normal levels of puCL which can now be 
compared with our TAZMUT cells with their reduced levels of puCL (Figure 3:12 
and Figure 3:13). 
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Figure 3:12- TAZMUT_1 CCCP induced Mitophagy 
Representative images of TAZMUT_1 cells under various treatments. All CCCP treatments are 
three hours at 10µM, whilst all CI treatments are for six hours prior to imaging, with pepstatin A at a 
concentration of 5µg/ml and E64d at a concentration of 10µM. 
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Figure 3:13- TAZMUT_3 CCCP induced Mitophagy 
Representative images of TAZMUT_3 cells under various treatments. All CCCP treatments are 
three hours at 10µM, whilst all CI treatments are for six hours prior to imaging, with pepstatin A at a 
concentration of 5µg/ml and E64d at a concentration of 10µM. 
Both TAZMUT_1 and TAZMUT_3 appear to have low back ground levels of 
mitophagy, and low levels of mitophagy in CI only treated cells in each case.  
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Upon CCCP treatment fragmentation does occur but to a lesser degree than 
observed in CONTROL_1. This may be due to the fact that TAZMUT_1 and 
TAZMUT_3 have longer mitochondrial filaments to start with or represent the 
effects of reduced levels of fission resulting from low oxi-CL levels failing to 
signal adequately that a mitochondria is damaged and requires segregation by 
fission to allow mitophagy. The fragmentation effect is still present however to 
some degree. In TAZMUT_3 cells it does appear there is a slight mitophagy 
induction as compared to untreated, but this is not seen in the TAZMUT_1 and in 
either case is not to the same levels as in CONTROL_1 cells under this 
treatment. 
Looking at the dual treatment of CCCP and CI’s there may be a slight increase in 
the number of fragmented mitochondria, more evident in TAZMUT_3 cells, but in 
either TAZMUT line this is not as severe as observed for CONTROL_1. What is 
very evident however is a distinct lack of perinuclear localisation of the 
mitochondria. This localisation relies upon the function of PARKIN (75). The lack 
of this localisation here suggests a possible problem in PARKIN directed 
movement of mitochondria to the perinuclear region in the TAZMUT cells. Finally 
looking at mitophagy under this treatment, a slight induction may occur in the 
TAZMUT_3 cells but this does not appear in the TAZMUT_1 cells. This may result 
from potential residual activity of TAZ in the TAZMUT_3 cells which is absent in 
the TAZMUT_1 cells. As the TAZMUT_1 cells have a mutation resulting in the 
insertion of a premature stop codon it is most probable that these cells do not 
express any TAZ protein as it is likely that any transcript generated from this 
mutant gene would be degraded before translation. However the TAZMUT_3 
cells have appoint mutation in the TAZ gene resulting in an amino acid change, 
and whilst this appears to effect the activity of TAZ as observed by mass 
spectrometry (Figure 3:1) it does not preclude that protein may be expressed 
from this gene and that this protein may have some residual activity. Indeed the 
mass spectrometry data does indicate that the effect of this mutation in 
TAZMUT_3 although affecting the puCL levels dramatically as compared to 
CONTROL cells it is slightly less severe than that observed for TAZMUT_1 cells. 
This disparity between puCL levels in TAZMUT_3 and TAZMUT_1 cells, resulting 
perhaps form differing severity of the mutation effecting the TAZ gene, may 
account for the apparent difference in mitophagy as observed by mitochondrial 
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and lysosome co-localisation in Figure 3:12 and Figure 3:13. In either case the 
levels of both TAZMUT_1 and TAZMUT_3 appear much reduced as compared to 
CONTROL_1 cells. This suggests that the TAZMUT cells have a defect in 
mitophagy, and this may result from the reduced puCL levels in these TAZMUT 
cells.  
3.4 Discussion 
Here we present and characterize a model system for establishing if puCL levels 
effect mitophagy. Human skin fibroblasts have been donated by healthy 
individuals and patients suffering from Barth’s syndrome. These cells have been 
immortalized in all cases by the transfection of stable expression of htert, 
following which the cardiolipin profiles of each have been determined by mass 
spectrometry. This confirmed the Barth’s phenotype in the two TAZMUT lines as 
evidenced by the low levels of puCL, increased MLCL levels and a shift to longer 
chain saturated forms of CL. Whilst the healthy CL profile was represented in 
the two control cell lines. This gave us the confidence to move forward using 
these cell lines to investigate the two opposing scenarios. 
When we began imaging and characterizing our cells further it became evident 
that striking differences in mitochondrial length and dynamics were present 
when comparing CONTROL and TAZMUT cells. TAZMUT cells have longer 
mitochondria and the mitochondrial network was less dynamic than CONTROL 
cells, and that there is possibly an issue in mitochondrial membrane continuity in 
TAZMUT cells as compared to CONTROL. TAZMUT cells appear to have reduced 
matrix connectivity as compared to CONTROL, whilst it may be possible that the 
outer mitochondrial membrane is unaffected, however we were unable at this 
time for conclusively confirm this.  In addition in the TAZMUT cells we also 
observed what may be failed attempts at fission. In Figure 3:9 panel B 11.5s- 
243.5s we observed a swelling and pinching effect upon the activated section of 
the mitochondrial network. This could be resulting from failure of these 
mitochondria to undergo complete fission, whilst it is possible that the outer 
membrane is undergoing fission effectively, this pinching/swelling effect 
suggests that the inner mitochondrial membrane is refractory to this process. 
However this is only suggestive of such an issue, and further investigation of this 
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phenomenon would be required to make any conclusions. Since the fission/fusion 
dynamic and mitochondrial interconnectivity are crucial to cellular and 
mitochondrial health as well as progression of mitophagy, it seemed we had 
discovered the first indication that mitophagy in the TAZMUT cells could be 
affected. 
With this in mind a preliminary study of mitophagy in our cells was undertaken 
using the established inducer of mitophagy CCCP. Again striking differences in 
the effect of CCCP were noted. Firstly in mitochondrial morphology and 
dynamics, TAZMUT cells showed lower levels of mitochondrial fragmentation, 
which is usually caused by CCCP (and observed in CONTROL_1 cells). However 
this is consistent with the reduced level of fission observed in these cells during 
the study of mitochondrial dynamics. Also a lower degree of perinuclear 
mitochondrial localisation was noted following CCCP treatment. Perinuclear 
localisation of mitochondria has been identified as PARKIN driven process, which 
although not essential to mitophagy progression may indicate disruption to the 
function of PARKIN in the TAZMUT cells, which could affect mitophagy in other 
ways. In terms of mitophagy itself TAZMUT cells showed lower mitotracker green 
and lysotracker red co-localisation, indicating reduced mitophagy as compared 
to CONTROL_1 cells, although it appeared that TAZMUT_3 has slightly 
occurrence of mitophagy as compared to TAZMUT_1 which may result for the 
differing severity of mutation in the TAZ gene in each. 
Taken together this data supports our hypothesis that oxi-CL acts as a signal to 
initiate mitophagy. TAZMUT cells have lower levels of puCL and oxi-CL is derived 
by the oxidation of puCL. Therefore lower levels of puCL will result in lower 
levels of oxi-CL, potentially resulting in reduced signalling to the mitophagic 
machinery. 
However further analysis was required and our model system needed 
development in order that we could make these statements confidently. Our 
system relies on four cell lines derived from four genetically different 
individuals. In the work above we assume that only the known difference that 
exists between the cell lines is in TAZ activity and therefore puCL levels. 
However it is certain that other genetic differences exist between our cell lines 
since they are derived from four different individuals, and so it is possible that 
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the differences observed above are the result of these other genetic differences. 
To understand if the differences observed are TAZ activity related or not we 
needed to generate isogenic controls for the TAZMUT cells, where the only 
difference between the cells is in TAZ activity and puCL levels.  
In addition we have only begun to characterize our cell lines; further 
investigations into mitochondrial mass, mitochondrial membrane potential and 
mitochondrial function are also important for our investigation into mitophagy. 
Any one of these characteristics could affect mitophagy and so need to be 
considered. 
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Chapter 4 Generation of Revertants and first 
identification of Mitophagy. 
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4.1 Introduction 
The previous chapter began by characterizing our model system in terms of CL 
species present in each cell type, mitochondrial morphology and mitochondrial 
dynamics differences which could be related to differences in mitophagy as 
suggested from the initial imaging of lysosome and mitochondrial co-localisation. 
However it was noted that whilst our four cell lines represented a unique model 
to study the effects of loss of TAZ activity and reduced puCL levels, they harbour 
an inherent flaw. Each cell line was derived from genetically different 
individuals, meaning other genetic differences between the cell lines not 
involving TAZ could be causing the differences in mitophagy previously observed. 
Therefore it was essential to develop isogenic controls for our TAZMUT cells such 
that we could confirm that the observations made in the previous chapter were 
resulting only from differences in TAZ activity and puCL levels. Therefore this 
chapter firstly details the development of isogenic control cells and their 
characterization along with further characterization of the original four cell lines 
used. 
In addition we also felt that the differences in mitophagy observed in Chapter 3 
required quantifying. Mitophagic events are small and difficult to identify and 
quantitate accurately by eye without bias. Therefore in this chapter we also 
describe a method we developed to quantify our imaging data.  We also 
identified here a need for a direct oxidative stress as an inducer of mitophagy to 
help support our hypothesis that the oxidation of puCL acts as the initiator signal 
for mitophagy, and began to develop a system through which we could apply 
sufficient levels of oxidative stress using hydrogen peroxide to induce mitophagy 
and monitor its effects on mitophagy. 
4.2 Isogenic controls for TAZMUT_1 and TAZMUT_3 
4.2.1 Generation of the stable revertant cell lines 
To generate the isogenic controls required a functional copy of TAZ to be 
introduced into both the TAZMUT_1 and TAZMUT_3 cell lines. Along with the 
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original four cell lines Riekelt Houtkooper also provided four plasmids; three 
containing the most common spliceforms of TAZ: Full length-TAZ, TAZΔexon7 
and TAZΔexon5, as well as an empty vector control Figure 4:1B. Details of 
functional significance of each isoform was discussed in detail in Chapter 1 
section 1.3.2, to re-cap only the full length and Δexon5 isoforms have been 
observed to have the acyltransferase activity required for CL remodelling. These 
three variants were in a pLHCX vector backbone (clontech), which when used 
along with the amphotropic packaging cells PT67’s will generate retrovirus 
capable of infecting human cells as described Figure 4:1A. 
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Figure 4:1- Retroviral infection scheme and Plasmids 
(A) Schematic of viral generation taken and adapted from Clontech user manual (B) plasmid maps 
(i)pLHCX vector backbone, (ii) pLHCX_TAZ-Flag. 
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Each of the TAZMUT lines were infected with the three different TAZ variants, 
and following three days of infection and a day of recovery from viral pressure, 
cells were placed under selection to generate clones stably expressing TAZ-flag.  
Retroviral infection relies on a high rate of cell division; retrovirus can only 
infect cells that are undergoing cell division. Whilst standard cell lines like 
HEK293’s divide regularly and would be amenable to retroviral infection, our 
human fibroblasts cells grow and divide very slowly, consequently the chances of 
infection are much reduced. Combining this slow division rate with the labile 
nature of the virus generated by the packaging cells makes retroviral infection of 
these human fibroblasts challenging.  
Despite this three TAZ isogenic control clones were generated; a TazΔexon7 
variant clone and two clones of the Taz-full length variant. The TazΔexon7 
developed in a TAZMUT_3 background and one TAZ-full length clone in each 
TAZMUT background, TAZMUT_1 and TAZMUT_3.  
Disappointingly, the TazΔexon5 construct failed to produce any clones. The full 
length and Δexon5 variants have been shown to have the ability to restore the 
CL mass spectrometry profile of yeast, however only the Δexon5 variant was also 
able to rescue the growth defect observed in yeast in which the endogenous 
yeast homologue for human TAZ was disrupted(150). The Δexon7 variant failed 
to rescue either effect of loss of TAZ, giving no change in the CL species 
detected by mass spectrometry, no the growth defect observed in yeast (149, 
150). Similar results have also been shown in Drosophila, with full length and 
Δexon5 variants able to rescue the CL profile, in this case they show that the full 
length variant was able to rescue to the same degree as the Δexon5 variant. This 
differs from the findings in yeast, however they suggest that this may be due to 
the full length variant being only fully functional in higher organisms (149). So 
whilst it was disappointing not to obtain a Δexon5 variant clone in order to 
compare the two variants in our model, we felt confident that the full length 
clones would serve our purpose as isogenic controls for TAZMUT_1 and 
TAZMUT_3. 
Initial western blot of these newly derived clones, hereafter named TAZREV_1 
and TAZREV_3, corresponding to their parental lines TAZMUT_1 and TAZMUT_3, 
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for the full length variants and TAZ_EX7 for the Δexon7 variant (derived from 
TAZMUT_3),were positive for TAZ-FLAG (Figure 4:2).TAZ is typically difficult to 
detect, thus to increase the chance of detection fractionating cell extracts into 
a mitochondrial and cytoplasmic fractions effectively concentrates the 
mitochondrial fraction resulting in increased concentration of TAZ thus 
enhancing the likelihood of detection. The first Blot (Figure 4:2A) shows both 
cytoplasmic and mitochondrial fractions with VDAC 1 as a loading control. Its 
absence in the cytoplasmic fractions indicates a high efficiency of the 
fractionation process. The levels of VDAC1 are comparable across mitochondrial 
fractions indicating the equal loading. Only TAZEX7 (2) (hereafter called 
TAZ_EX7) clone was positive for TAZ-FLAG whilst the other clone was negative. 
The second panel of blots (Figure 4:2B) show only mitochondrial fractions for 
each clone. TAZEX7 is used as a positive control in each case and the vector 
control (TAZMUT_3 Vect CONT) as a negative control. GRP75, a mitochondrial 
heatshock protein was used as a loading control. Both the TAZREV_3 and 
TAZREV_1 tested positive for TAZ-FLAG, with the levels of TAZ expressed in 
TAZREV_1 being significantly higher than in either TAZREV_3 or TAZEX7. 
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Figure 4:2- Western Blot for TAZ-FLAG 
(A) Western blots to confirm expression of Δexon7 TAZ-FLAG. Two clones tested, TAZMUT_3 
TAZEX7 (1) and TAZMUT_3 TAZEX7 (2), with TAZMUT_3 Vect CONT as a negative control 
derived from infection with empty vector. Cells were fractionated into mitochondrial (M) and 
cytoplasmic(C) fractions. VDAC1 is used as a measure of the quality of fractionation as well as a 
loading control for the mitochondrial fractions. (B) Western blot to confirm full length TAZ-FLAG 
expression. Two clones tested TAZREV_3 and TAZREV_1, with TAZMUT_3 TAZEX7 as a positive 
control and TAZMUT_3 Vect CONT as a negative control. Only mitochondrial fractions were used 
and GRP75 was used as a loading control. 
Interestingly in both the blots TAZ-FLAG appeared as two bands. To try and 
tease out what the second band was we ran a second western and this time 
blotted for TAZ using a newly derived TAZ antibody, (kindly donated by Stephen 
Claypool) detecting endogenous TAZ rather than the FLAG tag. One suspicion 
was that the extra band was a non-specific band detected due to the nature of 
the FLAG antibody (Figure 4:3). Only the TAZREV_1 and TAZREV_3 were tested 
again and in both cases a second band was still detected. In this case whole cell 
lysate was used and all six cell lines were tested. In all cases two bands were 
detected at the correct size for TAZ, except in TAZMUT_1. It may initially be 
surprising to realise that TAZMUT_3 expresses TAZ, however unlike TAZMUT_1 
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TAZMUT_3 only has a point mutation within the TAZ gene, switching one amino 
acid for another rendering it inactive yet not precluding that protein may still be 
translated, transcripts from the TAZ gene are still generated in Barth syndrome 
patients in fact to elevated levels(148). However, TAZMUT_1 has a mutation that 
introduces a premature stop codon so it would be more likely that no protein 
would be generated in the case of this mutant, perhaps due to nonsense 
mediated decay of the transcript from the gene or some other post-
transcriptional process as this cell line like TAZMUT_3 still generates TAZ mRNA 
if not protein (Table 7(148)). In any case, where a positive result for TAZ 
expression is observed two bands are seen, this suggests that those seen in the 
FLAG blot are not due to non-specific nature of the antibody, perhaps they 
represent post-translational modifications of the TAZ protein, perhaps 
phosphorylation, acetylation or protein cleavage. Commercially available 
antibodies for TAZ are for the most part unreliable and non-specific. Therefore 
literature pertaining to these double bands is unclear, and as such we cannot 
draw on any information there to try and formulate and explanation. 
 
 
Figure 4:3- TAZ antibody Western blots all cell lines 
Western blots of all whole cell lysate from all six cell lines. Actin used as the loading control. 
Treatment with H2O2 is indicated by the +/- above each lane of the blot, + for treatment and – for no 
treatment. 
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4.2.2 Cardiolipin profile for revertant cell lines 
Expression of protein is not proof of rescue of the Barth’s phenotype. As seen by 
the blots above (Figure 4:3), TAZ is expressed even in TAZMUT_3 cells, where it 
does not function. So for the revertant cells it was important to establish that 
the re-introduced TAZ was indeed active and restoring the CL profile in the 
TAZREV_1 and TAZREV_3 to something akin to that observed in the original 
control cells (CONTROL_1 and CONTROL_2). Once again cell pellets, of the newly 
generated revertant cell lines were sent to The Laboratory of Genetic and 
metabolic diseases at the University of Amsterdam, where the lipids were 
extracted and analysed by Riekelt Houtkooper and Fred Vaz, separating lipids by 
High performance chromatography (HPLC) and analysing by mass spectrometry 
(Figure 4:4). 
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Figure 4:4- Cardiolipin profiles for TAZ Revertant cell lines 
(A) CL mass spectra for TAZMUT_1 and TAZMUT_3, same data as presented in figure 3.1. (B) CL 
spectra for isogenic revertant clones derived from TAZMUT_1 and TAZMUT_3 respectively by re-
introduction of the full length isoform of TAZ. (C) CL spectra for isogenic revertant clone derived 
from TAZMUT_3 by re-introduction of the Δexon 7 isoform of TAZ. The red box highlights the area 
corresponding to MLCL species. Red arrows indicate increased levels of MLCL, green arrows 
indicate decreased levels of puCL and increased levels of saturated CL. Blue arrows indicate 
decreased levels of MLCL and increased levels of puCL. IS indicates the exogenous CL standard. 
Comparing initially TAZMUT_1 with TAZREV_1, a dramatic decrease in the MLCL 
species is most obvious in the TAZREV_1 compared to the TAZMUT_1, whilst on 
the right hand side of the spectra the clusters have shifted to the left and have 
widened with a greater number of peaks at each cluster indicating increased 
levels of puCL. This is indicative of a functional TAZ protein and as such suggests 
that the re-introduction of full length TAZ into TAZMUT_1 has resulted in the 
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rescue of the CL profile. The same can also be said when comparing TAZMUT_3 
with TAZREV_3, although the loss of MLCL is perhaps not as dramatic, being as 
there was less MLCL in the TAZMUT_3 cells to begin with, there is still a 
significant loss of MLCL upon re-introduction of full length TAZ. In addition it is 
also observed that as with TAZREV_1, TAZREV_3 shows a shift in the position of 
the peak clusters on the right toward the left and a widening of the peaks 
indicating once more the increase in puCL species present. Suggesting, that in 
the case TAZREV_3, the introduction of full length TAZ has also resulted in the 
rescue of the CL profile. 
Of secondary interest is the result for the TAZ_EX7 revertant. This clone showed 
expression of the Δexon 7 isoform of TAZ through western blot. As mentioned 
previously this isoform has been shown in Yeast and Drosophila to be ineffective 
in mitigating the defects observed in TAZ mutant Yeast and Drosophila (149, 
150). It would seem that the same is also true of human fibroblasts. Indeed when 
examining the spectra (Figure 4:4C), there is in fact increase in the number 
MLCL species present when comparing to the parental line TAZMUT_3 (red 
arrows). Green arrows on the right of the spectra indicate further loss of the 
puCL by the narrowing of the peaks as well as a shift to the right of the spectra 
indicating the increase in molecular weight which is attributed to increased 
saturation of the CL species present. It is notable that this TAZ_EX7 spectra 
appears to show a worsening of the Barth’s phenotype as compared to the 
original TAZMUT_3 cells. This suggests that this isoform not only fails to rescue 
the mutant TAZ phenotype but may in fact cause further deterioration.   
Why this may be the case is unknown, perhaps one possible explanation is that 
the Δexon 7 isoform has a regulatory effect under normal conditions. Perhaps in 
healthy individuals expression of the Δexon 7 isoform may only occurs at times 
when TAZ activity is not required. At which time it could interfere with the 
functional isoforms Δexon 5 and full length by forming a heterodimer with the 
active isoforms there by preventing their function. Instead of directly acting on 
the functional isoforms the Δexon 7 isoform may act in reverse converting puCL 
to MLCL and saturated CL, such a reverse reaction of TAZ has been observed 
previously although not designated to any specific isoform (129, 147). In cells 
expressing a healthy complement of TAZ isoforms these potential functions of 
the Δexon 7 isoform could be balanced by the Δexon 5 and full-length isoforms 
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of TAZ, where TAZ is already mutated, as in TAZMUT_3 overexpression of 
negative regulator, Δexon 7, only serves to worsen and already altered situation. 
In any case the spectra here confirmed that the expression of the full length TAZ 
variant in two clones derived from the two original TAZMUT cell lines had 
successfully rescued the Barth syndrome phenotype, as defined by the CL 
spectra. Thus two isogenic controls had been created, one for each of the two 
TAZMUT cell lines. Which in combination with the original two controls, 
CONTROL_1 and CONTROL_2, can be used going forward as the controls for all 
experiments. 
4.2.3 Further Characterisation of the cell lines 
Having improved the model system by the generation of isogenic control cells 
investigation began into the various aspects of the cells relating to mitochondrial 
health, function and ultimately mitophagy. 
4.2.3.1 Mitochondrial Mass 
Whilst quantity is not a measure of quality it can give us some insight into the 
health of the cell. For instance increased mitochondrial mass may indicate 
reduced mitophagy with damaged mitochondria accumulating in the cell, or it 
could indicate increased biogenesis to compensate for poorly functioning 
mitochondria. Fewer mitochondria by contrast could indicate increased 
mitophagy rate, or more efficient mitochondria meaning less are required to 
carry out the necessary functions. If differences do exist in mitochondrial mass 
between the cell lines this may affect the frequency at which mitophagy is 
observed. Measuring mitochondrial mass at this stage will allow us to adjust all 
future measurements of mitophagy to account for this. Mitochondrial mass was 
measured in all cell lines using mitotracker green to stain the mitochondria of 
the cells and then flow cytometry to measure fluorescent intensity of 
mitotracker green; with high intensity equating to high mitochondrial mass 
(Figure 4:5A).  
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Figure 4:5- Mitochondrial Mass 
Mitochondrial mass was measured in all cells by dying cells with mitotracker green and measuring 
fluorescence intensity of mitotracker green on the flow cytometer. Each cell line was analysed three 
times with ten thousand cells counted each time, error bars represent standard error of the mean 
fluorescence intensity. There was no statistical difference in mass between matched pairs, i.e. 
TAZMUT_1 and TAZREV_1 etc.  
Analysis of the flow cytometry data indicated that whilst slight variation existed 
between cell lines this variation was not significant; in short all cell lines had 
relatively similar mitochondrial mass.  
4.2.3.2 Mitochondrial membrane potential 
Following on from mitochondrial mass we also utilized the flow cytometer to 
investigate the mitochondrial membrane potential in each of our cell lines. As 
previously mentioned loss of mitochondrial membrane potential is believed to be 
one of the early steps in mitophagy. In addition to this it is also a marker of 
mitochondrial health. Utilizing the mitochondrial membrane potential sensitivity 
of tetramethyrhodamine ethyl ester (TMRE, discussed in Chapter 1 section 
1.1.8), a fluorescent dye which localises to and fluoresces in the mitochondria 
when the membrane potential is intact but disassociates from the mitochondria 
and ceases to fluoresce when membrane potential is lost, we measured 
mitochondrial membrane potential of the cells. Cells were stained with both 
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mitotracker green, which maintains its fluorescence even after depolarisation, 
and TMRE. This enabled us to ensure it was loss of potential we observed and not 
loss of mitochondria, as well as enabling us to normalise the TMRE fluorescence 
to mitochondrial mass. As well as measuring basal mitochondrial membrane 
potential CCCP was added to each cell line to ascertain if the mitochondria in 
any cell line were already uncoupled as well as check the response of each cell 
line to CCCP.(Figure 4:6). 
 
Figure 4:6- Mitochondrial membrane potential 
Cells we stained with Mitotracker green and TMRE to measure mitochondrial membrane potential. 
The TMRE fluorescence was normalised to Mitotracker green to account for any variation in 
mitochondrial mass. Base line membrane potential was measured in untreated cells, and then the 
same sample was treated with CCCP and measured again immediately. Each cell line was tested 
three times and ten thousand cells analysed in each test. Error bars represent standard error of 
mean fluorescence intensity. Loss of membrane potential upon CCCP addition was found to be 
significantly different compared to untreated for each cell line based on ANOVA p<0.05. There was 
no significant difference between cell lines at either the untreated of CCCP treated levels. 
It appears from the graph that the TAZMUT cells have slightly higher membrane 
potential than TAZREV and CONTROL cells, however this differences was not 
statistically significant. All cell lines gave untreated TMRE readings which were 
not statistically significant from one another, indicating no difference in basal 
mitochondrial membrane potential. They also all lost membrane potential upon 
CCCP addition and this loss was observed as significant as compared to their 
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untreated level, indicating that no cell line was uncoupled prior to CCCP 
addition. There was no difference in the uncoupled TMRE reading across cell 
lines indicating that ability to become uncoupled or remain polarised was not 
affected by loss of TAZ activity of puCL levels. 
4.2.3.3 Mitochondrial function 
As a final measure of mitochondrial health we looked at cellular respiration. 
How efficiently cells respire is dependent on the health of their mitochondria. 
Malfunctioning mitochondria are less efficient requiring more nutrients and 
oxygen to produce the same quantities of ATP. It is known that cardiolipin is 
required for efficient function of cytochrome C and stability of the complexes 
and supercomplexes they form (39-43). It has also been suggested that CL acts as 
a proton trap during OXPHOS, shuttling protons between the ETC complexes (for 
review see(33)).  
Any disruption to the normal CL profile would be expected to have consequences 
on the efficiency of OXPHOS. To measure this we can monitor oxygen 
consumption of the cells, with oxygen consumption being used as a surrogate for 
the OXPHOS efficiency and mitochondrial function. We use a cell metabolism 
analyser manufactured by Seahorse Bioscience, so named the Seahorse. The 
Seahorse measures the oxygen consumption rate (OCR) and the extra cellular 
acidification rate (ECAR). The oxygen consumption rate relates to mitochondrial 
consumption of oxygen and extracellular acidification rate relates to lactate 
production.  Lactate is produced by glycolysis during the non-mitochondrial 
phase of respiration. Glycolysis usually shuttles its final product, pyruvate, into 
the mitochondria for further processing in the TCA cycle. However, when 
mitochondria malfunction the cell attempts to make ATP through glycolysis 
alone which then results in production of lactate from pyruvate. Lactate is 
acidic in nature and is excreted from cells into the media increasing the acidity 
of the media. This increase is measured by the Seahorse and used to calculate 
ECAR for the cells.  
Due to the function of CL in OXPHOS we anticipated our TAZMUT cells would 
behave differently to the TAZREV or CONTROL cells in terms of OCR and ECAR. 
However this was not observed (Figure 4:7A). 
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Figure 4:7- Seahorse metabolic data for CONTOL, TAZMUT and TAZREV cells 
(A) Oxygen consumption rate per million cells for each cell type either untreated (BASAL) or 
treated with the various drugs identified. (B) Extracellular acidification rate per million cells. Data is 
based on three biological replicates with five technical replicates. Error bars represent standard 
error of the mean. All data is normalised to antimycin levels. 
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Taking oxygen consumption rate first and comparing the basal reading to that of 
all the readings following the various drug treatments, each cell lines responds 
to the drug treatments Figure 4:7A. However the degree to which they respond 
is slight and often not significant. In addition taking these OCR readings along 
with the ECAR readings, it seems that these cells on the whole are not 
responding metabolically to stress as dramatically as other cell types have been 
observed to do. As previously mentioned these cells grow and divide slowly, 
perhaps this slow growth rate is indicative of, or resulting from, low metabolic 
activity in these cells. Such low metabolic activity makes obtaining reliable data 
from the Seahorse an issue. In the Seahorse assay the cells are provided with all 
the nutrients they require; glucose glutamine etc. Perhaps if we placed these 
cells under more physiological conditions where nutrients are limiting they 
would respond more dramatically to other exogenous stressors. 
Differences in OCR and ECAR between the cell lines are observed, but whilst the 
TAZMUT_3 shows consistently higher levels of OCR and ECAR compared to its 
isogenic control TAZREV_3 and CONTROL_2; TAZMUT_1 only shows increased 
OCR and ECAR when compared to CONTROL_2 and not its isogenic control 
TAZREV_1. 
TAZRREV_1cells appear to behave differently to all cell lines in most of the 
cellular and mitochondrial characteristics investigated. In terms of mitochondrial 
mass the flow cytometry data showed TAZREV_1 cells to have the lowest 
mitochondrial mass of all cells (although this was not statistically significant, 
Figure 4:5) and when looking at the mitochondrial morphology in our first images 
of these cells we see the mitochondria are extremely interconnected and form 
large ‘globule’ type mitochondria rather than filaments and spheres as in the 
other cell types, (Figure 4:8). It should be noted that in terms of TAZ protein 
expression TAZREV_1 cells showed the highest levels of all cell types, (Figure 
4:3). This also corresponded to much higher puCL levels observed as compared 
to the other cell lines, including controls CONTROL_1 and CONTROL_2 (Figure 
3:1 and Figure 4:4). Taking all these striking differences together along with the 
OCR and ECAR data it seems TAZREV_1 represents the result of TAZ over 
expression, with highly elevated puCL above those that naturally occur as in 
CONTROL_1 and CONTROL_2. With mitochondrial mass reduced either due to 
increased mitophagy resulting from increased levels of oxi-CL borne out of 
164 
 
 Laura Catherine Avril Galbraith 
elevated levels of puCL available for oxidation. Or perhaps less mitochondria are 
required since those present are highly efficient due to increased OXPHOS 
efficiency (evidenced by the Seahorse data above) resulting from increased puCL 
and its role in OXPHOS efficiency (Chapter 1section 1.3.1). If so this explains the 
observations made regarding this cell line and can help us explain the Seahorse 
data for the other cell types if we focus on the TAZMUT_3 and TAZREV_3 pairing. 
Barth syndrome cells have been shown to have reduced metabolic power, with 
reduced oxygen consumption (153, 168, 169). However, previous work in our lab 
by Francois Gonzalvez has shown Barth’s lymphocytes/lymphoblasts to actually 
have increased oxygen consumption as compared to normal cells. This may 
suggest a cell type effect, in that those cells in which metabolic demand is high 
e.g. cardiomyocytes are affected to a greater extent due to lack of puCL than 
those cells in which metabolic demand is low e.g. skin fibroblasts as used here. 
Essentially skin fibroblasts don’t require as much energy as other cell types like 
cardiomyocytes. Therefore the effect of lower puCL levels on OXPHOS is not as 
detrimental and can be compensated for by increasing the rate of OXPHOS which 
requires higher levels of oxygen and thus increased OCR results. This appears to 
be the case when comparing TAZMUT_3 to TAZREV_3 and CONTROL_1 and 
CONTROL_2, as well as when comparing TAZMUT_1 with CONTROL_1 and 
CONTROL_2. In addition the excess of nutrients in the cell culture media allows 
for this inefficient mode of OXPHOS to be maintained. Cardiomyocytes in 
contrast will be running OXPHOS at maximal capacity due to the high energy 
demand in this cell type with no room to compensate for reduced efficiency 
resulting from lower levels of puCL. As such the oxygen consumption of Barth’s 
cardiomyocytes appears reduced compared to normal cardiomyocytes as OXPHOS 
is impaired. 
4.3 Mitophagy in the revertants 
After completing an initial biochemical characterisation of the mutants and 
various control cells we then returned to mitophagy measurements. Using the 
technique established in Chapter 3; using Mitotracker green, Lysotracker red, 
CCCP and CI’s, we performed imaging of the TAZREV_1 and TAZREV_3. 
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4.3.1 Mitophagy imaging 
As before the images were taken using the NIKON A1R in the same fashion. Both 
Z-stacks were acquired in conjunction with a representative single slice image. 
 
Figure 4:8- TAZREV_1 CCCP induced Mitophagy 
Representative images of TAZREV_1 cells under various treatments. All CCCP treatments were 
three hours at 10µM, whilst all CI treatments were for six hours prior to imaging, with Pepstatin A at 
a concentration of 5µg/ml and E64d at a concentration of 10µM. White arrows highlight highly 
interconnected nature of the mitochondria in this cell line and large mitochondrial “globules”. 
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Figure 4:9- TAZREV_3 CCCP induced mitophagy 
Representative images of TAZREV_3 cells under various treatments. All CCCP treatments were 
three hours at 10µM, whilst all CI treatments were for six hours prior to imaging, with Pepstatin A at 
a concentration of 5µg/ml and E64d at a concentration of 10µM. 
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As discussed in section 4.2.3.3 the mitochondrial morphology observed in the 
TAZREV_1 is particularly striking (Figure 4:8). This is the first visualisation of the 
mitochondria in these revertant cells and it seems comparing them to any of the 
other cell lines CONTROL_1, CONTROL_2, TAZMUT_1 TAZMUT_3 and TAZREV_3 
they have a much altered morphology. The mitochondria of TAZREV_1 appear 
highly interconnected and also oddly shaped- instead of forming spheres, rods 
and filaments as seen in the other cell lines these mitochondria appear in larger 
“globules” which are interconnected in a vast web (Figure 4:8, indicated by 
white arrows). The morphology we are observing here may the result from the 
over expression of TAZ and highly elevated levels of puCL.  
In terms of mitophagy it appears that the CCCP does have the same fragmenting 
effect as observed in the CONTROL_2 cells (Figure 3:11) for both TAZREV cell 
lines. Perinuclear localisation of mitochondria is also evident although perhaps 
more so in TAZREV_3 (Figure 4:8 and Figure 4:9). It seems that both TAZREV cell 
lines have increased levels of mitophagic events, upon CCCP addition, as 
observed by appearance of yellow punctae. However, trying to identify and 
quantify such small events by eye, over several images and through three 
dimensional space is challenging. Indeed it is unlikely that such an analysis 
would not be affected but bias, particularly when trying to compare cell lines; 
TAZREV_3 to TAZMUT_3 (Figure 4:9 and Figure 3:13), and TAZREV_1 and 
TAZMUT_1 (Figure 4:8 and Figure 3:12). Thus an accurate unbiased method of 
quantification was required 
4.3.2 Identification of mitophagy – Macro development 
Identification and quantitation of mitophagic events, as highlighted above, is 
difficult by eye alone. When examining images as the ones above, identifying 
tiny dots of yellow co-localisation is difficult, quantifying them even more so and 
applying this over a Z-stack impossible for the human eye alone to judge. As 
such our next step was to develop a computerized method for quantifying the 
mitophagic events observed in the Z-stack.  
Working closely with David Strachan of the Beatson Advanced Imaging Facility 
(BAIR), we developed an ImageJ macro (based on a previously described macro 
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(162)) that could analyse each image stack and quantify the mitophagic events 
observed. 
 
Figure 4:10- ImageJ Macro explained 
The above figure shows how the ImageJ macro processes the images and identifies areas of 
mitophagy. The white and red boxes in the bottom two images highlight the same mitophagic 
event, showing how this is detected by the macro. This image shows CONTROL_2 cells treated for 
3 Hours with CCCP. 
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The macro has two phases, it begins by analysing each image using the “Co-
localisation colour map macro” described by Jaskolski et al 2005 (162). 
Following this it then runs a modified version of the “grey scale colour map 
macro” (detailed in Chapter 2 section 2.2.19.1). By combining the two macros 
an 8 bit grey scale image is generated in place of the heat map of correlation 
produced from the first macro alone (Figure 4:10). Thus the degree of 
correlation between the two original pixels (green =mitochondria and red = 
lysosome) is represented in the pixel intensity of the generated 8 bit grey scale 
image on a scale of 0-225. Every pixel in every slice in each Z-stack is assigned a 
value between 0-225. Black (‘0’ pixel intensity) equates to no correlation and 
white (‘225’ pixel intensity) equates to a high level of correlation or co-
localisation as highlighted by the white box in the combined image and the red 
box in the grey scale image (Figure 4:10). This pixel intensity scale corresponds 
to the normalized mean deviation product (nMDP) scale defined by the “Co-
localisation colour map macro” of -1 to 1 (162). Within this scale there is a 
defined threshold of ‘0’ above which is considered positive correlation. Similarly 
the pixel intensity of 128 for the grey scale image is considered the threshold 
above which is classed as correlation. However, to confirm this positive and 
negative control images were generated to test the modified macro’s output 
(Figure 4:11). 
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Figure 4:11- Positive and negative controls for ImageJ Macro 
(A) Shows representative images for positive and negative of co-localisation. Positive images have 
co-localisation of two mitochondrial markers Mito-YFP and Mitotracker deep red, effectively two 
markers for the same organelle so should give the highest degree of co-localisation. Negative 
images have Hoechst staining of the nuclei and Farnesylated-GFP for the plasma membrane to 
represent the lowest level of co-localisation possible in a cell. (B) Shows a graph showing pixel 
intensity versus number of pixels, it represents the mean values for four images, with 37 Z-slices 
per image. The 0 pixel intensity has been omitted as it was so large as to make the rest of the 
graph un-readable, and error bars are not shown as this also makes the graph un-readable. (C) 
Shows the percentage co-localisation of each control based on the threshold set. The percentage 
is based on percentage of populated pixels, i.e. percentage of non-black or >‘0’ value pixels in 
each image, not total pixel number. 
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As a positive control, cells were transiently transfected with Mito-YFP (Figure 
4:17) and then dyed with Mitotracker deep red. As a negative control we chose 
to stain the nuclei with Hoechst and transiently transfect cells with 
Farnesylated-GFP to mark the plasma membrane. Whilst it is possible that there 
may be some contact with the nucleus and the plasma membrane it was felt this 
represented the best and most physiological negative control as was possible. 
The images show the co-localisation of the two mitochondrial markers in the 
merged panel by showing the entire mitochondrial network highlighted in 
yellow. Yet the merged panel for the negative image does not show any signs of 
visible co-localisation between the plasma membrane and the nucleus.  
The four images taken for each control type were then processed by the macro; 
the output can be seen in panel B of Figure 4:11. In this graph we see the 
number of pixels at any given intensity value in the grey scale image generated. 
The graph represents the average number of pixels of each intensity over the 
four images. Black pixels or ‘0’ value pixels have been discounted as their 
number is so large that the rest graph is unreadable and we are only interested 
in pixels with values greater than ‘0’. 
The distribution of pixel intensity is relatively similar until we reach values 
above 125, and then there is a sharp incline in the negative control before it 
begins falling away again. Whilst the there is also an incline in the positive 
control above pixel intensity 125 it is not as sharp and does not fall away so 
rapidly. We were interested at the point on the graph at which the number of 
pixels at a given intensity in the positive control is above that of the negative 
control. The black arrow on the graph marks the point at which this change 
occurs. Although the negative control still has pixels of this intensity present we 
believe these represent background levels of co-localisation which would occur 
by random chance. As anticipated the pixel intensity value above which can be 
considered as correlation/co-localisation is 128 confirming that the modified 
macros is functioning as intended and that the 8-bit grey scale of correlation is 
in line with the nMDP scale previously defined (162).  
Based on this threshold we then calculated for our positive and negative controls 
the percentage co-localisation, and this is shown in panel C of Figure 4:11. It 
should be noted that this percent co-localisation refers to a percentage based on 
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the total number of populated pixels, i.e. non ‘0’ value or black pixels, and for 
all future data generated in this way the percentage co-localisation will refer to 
this. The positive control images have on average 31.42% co-localisation whilst 
the negative control images have 7.84% co-localisation.  
To re-cap, the macro combines the two channel Z-stacks to form one merged Z-
stack. It then converts this Z-stack to an 8 bit grey scale image in which the 
correlation of mitochondria and lysosome is defined for every pixel and the 
degree of correlation is represented by the pixel intensity value, with low values 
equating to little or no correlation whilst high pixel intensity values equate to 
high correlation or co-localisation. We can then interpret this data firstly by 
removing the ‘0’ value or black pixels and secondly based on the threshold set 
using positive and negative control images we can calculate the percentage co-
localisation for every three dimensional image. We have also fully automated 
this macro, it will analyse all images automatically provided they are all in the 
same folder, creating large spreadsheets of data which the user then processes 
to calculate the percentage intensity.  
4.3.3 Reduced mitophagy levels under CCCP induction 
Having now developed a method for quantifying the imaging data amassed, all of 
the previously acquired images represented in Figure 3:11, Figure 3:12, Figure 
3:13, Figure 4:8 and Figure 4:9  were processed using the macro. 
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Figure 4:12- Macro derived quantification of CCCP induced mitophagy 
The above graph shows the quantification of all the images taken of CCCP induced mitophagy in 
all cell lines. The positive and negative controls are also shown in green as a reference. Black * 
indicate a significant difference between CONTROL_1 and the cell line it is above. Red * indicate a 
significant difference between TAZREV_3 and TAZMUT_3. Blue * indicate a significant difference 
between TAZREV_1 and TAZMUT_1. Error bars are based on standard error of mean and 
statistics were generated by two-way ANOVA. 
The first point to note is that there is an overall trend in the data of increased 
co-localisation as moving left to right across the graph- indicating the 
treatments are inducing mitophagy or increasing the likelihood of observing 
mitophagic events. Taking first untreated cells we can see that the two TAZMUT 
cell lines have the lowest incidence of co-localisation whilst the TAZREV cells 
have the highest, at this baseline only the difference between TAZREV_1 and 
TAZMUT_1 is significantly different. This is the base line of co-localisation for 
each of the cell lines suggesting that background levels of mitophagy are 
relatively similar across all cell types.  
With the addition of CI’s TAZREV cells show a slight increase in co-localisation. 
This results in a significant difference in co-localisation between TAZMUT and 
TAZREV cells. The increase of co-localisation in TAZREV cells can be explained 
by the fact these CI’s will block the action of the lysosomal cathepsins and so 
the basal mitophagy observed in untreated cells will be on-going but blocked by 
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inhibition of cathepsins resulting in an accumulation of autolysosomes increasing 
the co-localisation observed.  
The most significant change comes with the addition of CCCP. As a known 
mitophagy inducer and from the images, we expected to see an increase in 
mitophagy occurrence. This is certainly the case in CONTROL_1 and TAZREV_1 
cells with both cell lines showing significantly higher levels of mitophagy than 
either of the TAZMUT cell lines. Although TAZREV_3 does not show an increase in 
mitophagy levels it still maintains a higher level of mitophagy than TAZMUT_3. 
There was no significant increase in mitophagy after CCCP treatment in either 
TAZMUT cell line, as compared to untreated or CI treated TAZMUT cells. This 
suggests that even upon highly potent mitophagic stimuli the TAZMUT cells fail 
to induce mitophagy. 
To confirm this and rule out the possibility that the TAZMUT cells are perhaps 
just super-efficient and clearing all damaged mitochondria much faster than the 
CONTROL_1 and TAZREV cells, we added the cathepsins CI’s.  These are added 6 
hours prior to imaging and 3 hours prior to CCCP addition, thus ensuring that any 
mitophagic event taking place as a result of CCCP addition should be blocked at 
the autolysosome stage and therefore captured in the images taken. As such it is 
interesting to see that CONTROL_1, and both TAZREV cell lines show yet further 
increases in mitophagic events compared to CCCP treatment alone. TAZMUT 
cells do not show the same increases. In fact the levels of mitophagy detected in 
the TAZMUT cells remain comparable to the untreated levels. Consequently the 
difference in mitophagy levels between each TAZMUT cell line and its related 
TAZREV cell line along with the CONTROL_1 cell line are statistically significant. 
This confirms that there is a problem with mitophagy in the TAZMUT cells, and 
since the only difference between the TAZMUT and respective TAZREV control 
cells is the activity of TAZ and levels of puCL it suggests that this mitophagic 
failure is most probably related to TAZ function and puCL levels. 
As an aside and adding weight to our previous observation (section 4.2.3.3) it is 
interesting to note that the TAZREV_1 cell line shows the highest levels of 
mitophagy of all cell lines irrespective of treatment. This elevated level of 
mitophagy in TAZREV_1 as compared to all other cell lines may result from the 
previously mentioned characteristics of TAZREV_1 -high TAZ expression and high 
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levels of puCL etc. leading to higher oxi-CL levels amplifying the mitophagic 
signal resulting in and accounting for reduced mitochondrial mass observed 
(Figure 4:5).  
4.3.4 Use of hydrogen peroxide 
Our hypothesis specifically cites oxidation of cardiolipin as the signal for 
mitophagy. CCCP is a known inducer of mitophagy and causes increased levels of 
ROS due to uncoupling of the ETC. These elevated levels of ROS will induce 
oxidation of puCL, however puCL is not directly oxidized by CCCP. For our study 
we required a direct link between oxidation of puCL and mitophagy. Therefore 
we needed an inducer of mitophagy which relied on oxidative stress for its mode 
of action. Hydrogen peroxide (H2O2) is one type of ROS produced by 
damaged/malfunctioning mitochondria, and it in turn causes further oxidative 
damage to the mitochondria (as well as other cellular components). In addition 
to this there is rising concern over the effects of CCCP upon the specificity of 
the mitotracker and lysotracker probes (100, 102). Therefore we decided adding 
H2O2 exogenously could act as a physiological relevant oxidative inducer of 
mitophagy, whilst also allaying any concerns over the use of CCCP. As with CCCP 
we had to identify the conditions under which H2O2 could induce mitophagy. As 
previously mentioned (Chapter 1) loss of mitochondrial membrane potential is a 
known preliminary step in mitophagy so we decided to establish under what 
conditions H2O2 caused mitochondrial depolarisation, as this would lead to 
mitophagy induction.  
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Figure 4:13- Effect of Hydrogen peroxide treatment on mitochondrial membrane potential 
and cell number 
All cells were dual stained with TMRE and Mitotracker green. TMRE data was then normalised to 
Mitotracker green to account for any variation in mitochondrial mass. All cells were treated every 
thirty minutes with 500µM (final) H2O2 for the time frames shown. Each cell line was tested three 
times and where possible ten thousand cells analysed for each time point. At some time points not 
enough cells were available to count ten thousand. (A) Shows the effect of hydrogen peroxide on 
mitochondrial membrane potential over time. Error bars represent standard error of mean 
fluorescence intensity. (B) Shows the effect of hydrogen peroxide on cell number over time. Error 
bars represent the standard error of mean number of cells counted.  
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Following addition of H2O2 for various timeframes all cell types were analysed 
for mitochondrial membrane potential using TMRE and flow cytometry. Figure 
4:13 shows the effect of H2O2 both mitochondrial membrane potential (based on 
TMRE fluorescence) and cell number. From panel A we can see that 
mitochondrial membrane potential gradually decreases with time with full 
depolarisation occurring between 1.5 and 2 hours, with all cells types 
completely depolarised at 2 hours. Panel B obtained from the same experiments 
shows the decrease in cell number counted by flow cytometry with the 
treatments. This decrease results from H2O2 induced cell death as all 
experiments began with the same cell number. Therefore what the panel 
actually shows is cell death with H2O2 treatment. As such we can see that cells 
begin to die after 2 hours of treatment. Taking these two panels together it 
suggests that whilst 2 hours of treatment give complete mitochondrial 
depolarisation in all cell types it also results in cell death. Cell death is not the 
goal of this treatment; we require a treatment that induces mitophagy without 
causing cell death. As such although a 1.5 hour treatment does not cause full 
depolarisation in all cell types it does cause a degree of depolarisation without 
the cell death observed at 2 hours of treatment.  
We also investigated the effect of H2O2 on LC3; LC3 is a protein that becomes 
lipidated and binds the autophagosomal membrane upon autophagy/mitophagy 
induction. We wanted to ascertain whether the conditions we have identified 
above as causing mitochondrial depolarisation also induced formation of 
autophagosomes and thereby induction of autophagy/mitophagy. Therefore we 
treated cells three times at 30 minute intervals over 1.5 hours with 500µM H2O2 
and then lysed the cells and through western blot examined the levels of 
LC3,Figure 4:14.  
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Figure 4:14- LC3 western blot 
Western blot of all cell lines plus/minus treatment with hydrogen peroxide every 30 minutes for 1.5 
hours with 500µM H2O2. Whole cell lysate was loaded and ACTIN used as the loading control. The 
top band of the LC3 bands represents the un-lipidated LC3I and second lower band represents the 
lipidated form LC3II. 
From the western blot we can clearly see an increase in lipidated LC3 upon H2O2 
treatment indicating the induction of autophagosome formation and hence 
autophagy/mitophagy. In conjunction with the flow cytometry data this data 
indicates that this treatment regime is not only depolarizing mitochondria but 
also inducing autophagosome formation. Therefore we decided on a treatment 
schedule of three treatments of 500µM H2O2 over a 1.5 hour period to induce 
mitophagy. 
Using the same method employed to acquire images of the cells following CCCP 
treatment i.e. staining with Mitotracker green and Lysotracker red, imaging was 
performed upon H2O2 treated cells. However we were unable to analyse these 
images using the ImageJ macro, due to the poor quality of the images obtained 
following H2O2 treatment (Figure 4:15). 
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Figure 4:15- Effect of H2O2 on Mitotracker green 
The above figure shows CONTROL_1 cells dyed with Mitotracker green and Lysotracker red. The 
column on the right shows untreated cells and those on the left cells treated with H2O2.  
As seen above the H2O2 treatment has a dramatic effect on the specificity of 
Mitotracker green. Mitotracker green is the only version of the mitotrackers 
which its manufactures state is not subject to mitochondrial membrane potential 
and certainly it retained its specificity under CCCP treatment, however here it 
appears that specificity is lost. This appears similar to the evidence of others 
who saw upon CCCP induced loss of mitochondrial membrane potential increased 
mitotracker green fluorescence, accompanied by loss mitochondrial specific 
localisation (100, 102).  Whilst this was not observed here upon addition of CCCP 
it seems that H2O2 induced mitochondrial depolarisation is having an effect on 
mitotracker fluorescence and specificity. Perhaps the oxidizing effect of H2O2 on 
the mitochondria results in loss of mitotracker specificity which is not due to 
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effects on mitochondrial membrane potential. In any case it is not possible to 
use any mitotracker in conjunction with H2O2 for imaging. Although the 
mitochondria are still definable in the treated images they are in no-way as 
clear as in the untreated images. There is a greatly increased level of 
background staining of the cell. This level of background is not compatible with 
the ImageJ macro and would result in a high occurrence of false positives as 
green fluorescence can be observed practically everywhere in the cell. As such 
an alternative to the Mitotracker/lysotracker combination is required. 
4.4 Expression of Fluorescent proteins for mitophagy 
measurement 
Although the use of mitotracker green and lysotracker red proved useful tools in 
to study CCCP induced mitophagy it proved to be of little use in studying H2O2 
induced mitophagy. For this a more stable marker for mitochondria was 
required. In addition whilst mitochondrial/lysosomal co-localisation had been 
used as a surrogate to measure mitophagy it in fact only measures lysosomal 
degradation of mitochondria, whilst all mitophagy finishes with fusion of 
lysosomes with the mitochondria containing autophagosome and its degradation, 
it is not the only process by which mitochondria can be observed as co-localising 
with the lysosome. Recent work shows that mitochondria can be shuttled to and 
directly degraded by lysosomes without the need for the autophagosome (84). As 
such when measuring purely lysosomal co-localisation with the mitochondria we 
are not only measuring the end stage in mitophagy but also this other form of 
mitochondrial degradation. Therefore as well as establishing a H2O2 stable 
mitochondrial marker it was also important to establish a way of measuring pure 
mitophagy, as defined by the engulfment of mitochondria by the 
autophagosome, which required a marker for the autophagosome. The most 
well-known and well used marker of the autophagosomes is LC3. LC3, as 
mentioned in Chapter 1 and briefly in section 4.3.4, is the protein present in the 
cytosol (LC3 I) whose expression upon autophagic/mitophagic stimuli is up 
regulated. LC3I then becomes lipidated by binding PE at glycine 116, becoming 
LC3II. LC3II then becomes attached to the developing autophagosomal 
membrane by virtue of this conjugation to PE moiety which is incorporated into 
the emerging membrane. It remains on the autophagosomal membrane until 
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fusion with the lysosome where upon the change in pH causes the disassociation 
of the protein from the outer membrane, whilst that inside the vesicle is 
degraded by the lysosomal enzymes along with contents of the autophagosome. 
Upon attaching a fluorescent tag to the LC3 protein it can be detected by 
fluorescent microscopy as either a dull cytosolic haze relating to its unlipidated 
state LC3I or as distinct punctae representing its lipidated state LC3II on the 
surface of the autophagosomal membrane and as such represents a viable 
marker for the autophagosome.  
We attempted to develop a stable fluorescent marker for the mitochondria and 
also to use LC3 as a marker for the autophagosome. However, as mentioned 
previously (section 4.2), infection of the fibroblast cell lines with retrovirus is 
difficult due to the slow cell division rate. Lipofectamine had also been used in 
the past by others in the lab, but with no success. Thus we explored three other 
methods.  
4.4.1 Nucleofection 
Working on the principal of electroporation, Lonza manufacture a range of 
devices and kits which enable electroporation or nucleofection as they call it, to 
be tailored to a specific cell type. The contents of each kit is optimized for the 
cell type specified and the nucleofector device, the machine used to carry out 
the electroporation, has a number of pre-defined programs which can be used 
depending on the cell type in question. 
Given that these cells are derived from primary fibroblasts we used a kit 
specifically tailored for this cell type. With this kit five protocols are 
recommended, to determine the best protocol to use we tested each program by 
using the same GFP containing plasmid (provided with the kit) and measuring the 
efficiency of electroporation by flow cytometry for GFP expression. Using flow 
cytometry we first identified the whole population of cells in any given sample, 
based on forward and side scattering of the light, then from that measured the 
GFP Fluorescence of this population and calculated the percentage of GFP 
expressing cell in the whole cell population. The program which gave the highest 
percentage was the best suited to these fibroblasts (Figure 4:16- Optimizing 
protocols for nucleofection). 
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Figure 4:16- Optimizing protocols for nucleofection 
TAZMUT_3 cells were used for this optimization. The same cell numbers were used for every 
program as was the concentration of DNA.  The first graph shows the negative control, 
untransfected. The Marker imposed upon each graph is based on the negative control and 
indicates the region in which GFP positive cells will be present if the transfection has been a 
success. The percentage given indicates the percentage of cells from the whole population that lie 
within this defined region and as such are positive for GFP.   
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As we can see the first program A024 shows little increase in GFP expression 
above that of the negative control. The T016 and U012 programs show slight 
increases but are still very low. However U023 and V013 showed a very large 
increase in GFP expressing cells as compare to control, indicating that these two 
programs are best suited to our fibroblasts. Unfortunately despite V013 giving 
the best efficiency of electroporation many of the cells died, perhaps indicating 
this program was too harsh for these particular cells to handle. Therefore U023 
represented the best overall program to use. 
Having established the best protocol to use we then set about transfecting the 
cells with the markers we required: LC3-cherry, using plasmid derived from the 
pmCherry vector commercially available from Clontech, into which was cloned 
cDNA for Rat LC3 (Figure 4:17B); Mito-YFP, derived from the Clontech vector 
pEYFP-N1, into which was cloned the mitochondrial targeting sequence of 
cytochrome C to give mitochondrial localisation to YFP protein (Figure 4:17A). 
Despite choosing the best protocol for our cell type a few problems arose- firstly 
the high level of cell death associated with nucleofection meant large numbers 
of cells were required for each reaction to ensure enough survived to be useful. 
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Figure 4:17- Mito-YFP and LC3-Cherry, with images showing varying expression levels 
(A) Shows the plasmid pEYFP-Mito_N1 (B) Shows the plasmid pmCherry_LC3_C1 (C) Results of 
pmCherry-LC3-C1 nucelofection. Two images show same field of view, Setting 1 with gain set high 
so as to detect the low expressing cells, and setting 2 with gain set low so as to show LC3 punctae 
in high expressing cells. 
Again due to the slow rate of cell division in these cells, getting enough cells to 
begin with each time was challenging. However more importantly was the fact 
that nucelofection unlike viral infection allowed for more than one copy of the 
construct to enter any given cell such that the number of constructs entering 
cells can vary cell to cell. The number of constructs entering the cells will affect 
the level of expression observed, i.e. more constructs higher expression level. 
This created a heterogeneous population in terms of fluorescent protein 
expression levels, as seen for LC3-Cherry in Figure 4:17C (the same is also true 
of Mito-YFP). This figure shows the same field of view taken under different 
settings on the microscope. The first field shows the image taken with a high 
level of PMT (photomultiplier tube) voltage, this allows for the punctate in the 
lower expressing cells to be observed (at the top and bottom of the field). 
However, having to adjust the of PMT voltage to enable the visualisation of the 
lower expressing cells results in the LC3 punctae of the higher expressing cells 
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appearing as one large mass instead of distinct punctae. By lowering the PMT 
voltage, as seen in the second image, the punctae in the high expressing cells 
become distinct but we lose almost completely the fluorescence from the lower 
expressing cells. When trying to compare cell lines to one another it is 
imperative that all conditions, including the settings on the microscope, are kept 
constant so that any differences observed can be solely attributed to differences 
between cell lines rather than differences in image acquisition. So switching 
between microscope settings to obtain images is not acceptable. In an attempt 
to generate a more homogenous population from nucleofection we applied 
selection to the cells in the hopes of generating clones from each cell line which 
expressed the construct at comparable levels. However it would appear that 
nucleofection of these cell lines did not result in incorporation of the 
transfected DNA into the cell genome. After selection was applied most of the 
cells died resulting from lack of antibiotic resistance. Those that did survive 
appeared to have lost expression of the Fluorescent protein. So whilst 
nucleofection represents a useful transient transfection method, in this context 
where homogenous expression of the transfected construct is required it is not.  
4.4.2 Lentivirus 
Lentiviral infection represents one of the most reliable ways of generating stable 
cell lines. As with retroviral infection it works by using the virus as the delivery 
system to get the desired DNA into the target cells. As with all viruses, lentivirus 
has a highly efficient delivery system and in contrast to retrovirus it does not 
require that a cell is dividing to infect. This key difference between lentivirus 
and retrovirus makes lentivirus the preferred system to use in our cells, which do 
not divide regularly. Lentivirus is also not species specific and can infect a 
variety of cell types including human cells. However we do not want or require 
the lentivirus to replicate in our target cell (or indeed our own cells should we 
be inadvertently infected), as such the construct used to produce the lentivirus 
is a modified version of the naturally occurring lentiviral genome. It does not 
contain the genes for the packaging and envelope proteins required for viral 
particle production. This means that upon infection the Lentivirus will 
incorporate into the host genome  and will be transcribed and replicated along 
with the host genome, but due to lack of packaging and envelope protein genes 
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it will be unable to form and release new viral particles. Unfortunately no 
lentiviral construct containing the gene of interest, LC3-Cherry, existed so a 
cloning strategy was derived to generate one. 
4.4.2.1 Cloning strategy for pLenti6_LC3-cherry.13 
The strategy began with the excision of the LC3-Cherry sequence from the 
previously mentioned pmCherry-LC3 plasmid (Figure 4:17) and insert it into a 
lentiviral vector backbone pLenti6_puro (Figure 2:1 Chapter 2). This Lentiviral 
vector has limited restriction enzyme recognition sequences present at its 
multiple cloning site (MCS) and as such we had a limited choice for cloning. In 
addition to excise LC3-cherry from the pmCherry backbone meant identifying a 
site out with the MCS of pmCherry to use in order to remove not just the 
inserted gene LC3 but also the gene for the fused fluorescent protein mCherry. 
Two sites were identified in pLenti MCS that were also present in the pmCherry-
LC3 MCS. However, we still needed a second restriction site to excise the whole 
LC3-Cherry fragment. With the limited sites available in the pLenti6 vector for 
insertion of this excised fragment we decided to use the same restriction 
enzyme to cut both ends of the LC3-cherry fragment, from pmcherry-LC3, which 
meant only one restriction site was required in the pLenti_6 vector for insertion. 
A BAMHI restriction site was present in both the MCS of plenti_6 and pmCherry-
LC3; in addition a site just upstream of the mcherry gene in pmCherry-LC 
differed in only three base pairs from a BAMHI restriction site. We therefore 
modified this site using site directed mutagenesis (details of mutagenesis etc. 
can be found in Chapter 2 section 2.2.6 Figure 2:1)to change these three base 
pairs, thereby creating a second BAMHI site just upstream of the mCherry gene. 
Twenty three colonies were generated from the transformation pmCherry-LC3 
following mutagenesis. The plasmid DNA was extracted from each and tested to 
determine if the mutagenesis had been successful by restriction digest with 
BAMHI. Those that represented a modified pmCherry-LC3 with two BAMHI sites 
gave two bands on the agrose gel those that had not been changed by the site 
directed mutagenesis gave only one band (Figure 4:18A). We could now use 
BAMHI restriction enzyme to excise the LC3-Cherry fragment from the pmCherry-
LC3 plasmid and separate this from the vector backbone by agrose gel 
electrophoresis. We then preformed the same restriction digest on the pLenti-6 
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vector to enable insertion of the fragment, followed by bacterial transformation 
to amplify the production of the ligation.  
 
Figure 4:18-pLenti_LC3-Cherry cloning confirmation 
(A) Shows restriction digest with BAMHI of pmCherry_LC3 following mutagenesis. Blue arrows 
indicate the empty vector control digest. White arrows indicate the clones in which the mutagenesis 
has been successful, evidenced by the two bands highlighted by the two yellow arrows. (B) Shows 
the plasmid generated from the cloning approach. 
188 
 
 Laura Catherine Avril Galbraith 
Due to the fact the same enzyme was used to excise both ends of the LC3-Cherry 
fragment from the original pmCherry vector, it is possible that upon insertion 
the fragment may have ligated into the pLenti6 vector in the wrong orientation 
(Chapter 2 section 2.2.6 Figure 2:1). As such a restriction digest would not be 
sufficient to confirm a success. Plasmid DNA generated following ligation 
(Chapter 2 section 2.2.6) underwent sequencing to confirm the success of 
ligation and the orientation of the insert. Of all the original plasmids tested only 
two returned results of correct orientation. Both were tested for expression by 
transient transfection into HEK293 cells and both plasmids produced red 
fluorescence as observed by fluorescence microscopy. Both plasmids were 
amplified up and stocks made, but only one pLenti6_LC3-Cherry.13 was used 
further. 
4.4.2.2 LC3-Cherry Lentiviral infection and selection 
Using the plasmid above we then went on to generate Lentiviral particles with 
which to infect our fibroblast cells. As mentioned above the lentiviral construct 
used has been modified to make it replication incompetent, therefore to 
generate viral particles from it we had to supply it with the envelope and 
packaging genes required and cells in which to replicate. The standard 
procedure for lentiviral infection was applied; HEK293T cells were co-
transfected with our lentiviral construct pLenti6_LC3-Cherry.13 and two 
packaging plasmids pPAX2 and pLPVSVG supplying the packaging and envelope 
genes respectively (Figure 4:20). The HEK293T cells are packaging cells allowing 
the viral construct to replicate and with the help of the packaging and envelope 
plasmids produce viral particles which can then leave their host cell to infect 
other cells- however these particles are still replication incompetent as their 
viral genome only contains the pLenti6_LC3-Cherry.13 DNA with no packaging or 
envelope genes.  
To infect the fibroblasts we removed the media from the HEK293T cells and 
applied it to the fibroblasts. The viral particles in the media infected the 
fibroblasts and the viral genome integrates into the cellular genome. After two 
days of infection and one day of recover in full non-viral containing media the 
fibroblasts were imaged to determine the success of the infection (Figure 4:19). 
189 
 
 Laura Catherine Avril Galbraith 
 
Figure 4:19- LC3-Cherry expressing fibroblasts pre and post FACS sorting 
The above images show firstly the fibroblast cells newly infected with pLenti6_LC3-cherry.13 prior 
to FACS. The second set of images show the fibroblasts of the lowest expression fraction shortly 
after FACS sorting. 
 As with other techniques the expression level from cell to cell was variable. As 
previously mentioned this would prove an issue when imaging. Therefore it was 
determined that some form of selection was required to separate high 
expressing cells from low expressing cells. Instead of using the conventional 
method of antibiotic selection, to generate clones we opted to use Fluorescence 
assisted cell sorting (FACS) to separate cells based purely on fluorescence.  This 
method had a twofold advantage for us over traditional antibiotic selection: 
firstly we were selecting our cells based on their fluorescent read out which, 
meant we could chose the cells which expressed the fluorescent protein at 
levels we felt would be best for imaging; secondly we were not picking clones 
derived from one cell, which could result in clonal variation affecting the 
resulting data, selecting cells this way means that a pool is generated and so any 
clonal variation will be balanced out. We were able to split our total population 
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of infected cells into four sub populations based on fluorescence intensity of 
mCherry as seen below, Figure 4:20. 
 
Figure 4:20- Lentiviral infection Schematic 
Above shows the approach used to generate LC3-cherry stable cell lines from the fibroblast cells. 
Cells not exhibiting mCherry fluorescence were discarded, the other three 
expression levels; low, medium and high were maintained and stocks kept of all. 
The expression levels in each fraction were observed to be more homogenous 
than that observed in the pre-sorted population (Figure 4:19), although in the 
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end it was decided that only the lowest expressing fraction of each cell type 
would be used for further imaging as it gave the most distinct LC3 punctae.   
4.5 Discussion 
In this chapter functional TAZ was successfully re-introduced into the TAZMUT 
cells thereby creating the isogenic control cells TAZREV_1 and TAZREV_3 
required for further work. We fully characterized these cells showing the 
expression of TAZ protein and restoration of the CL profile as compared to 
TAZMUT cells, and as such confirmed not only the expression of TAZ but also its 
activity. 
Further Characterization of all six cell lines was then undertaken identified 
similar in mitochondrial mass and membrane potential across all cell lines. In 
terms of mitochondrial function as measured by oxygen consumption and 
extracellular acidification using the Seahorse, TAZMUT cells had higher oxygen 
consumption in all cases compared to TAZREV_3 and CONTROL cells. This was in 
direct contrast to results from other groups working with cells from Barth’s 
syndrome patients. A possible explanation for this is that fibroblasts have low 
energy demand and so are not running OXPHOS at its maximal rate, therefore in 
our fibroblasts where low puCL levels decrease the efficiency of OXPHOS the 
cells are able to increase the rate of OXPHOS to compensate, giving the 
increased OCR observed. Cells that ordinarily have higher energy demands 
compared to fibroblasts, e.g. cardiomyocytes are already running OXPHOS at its 
maximal rate, and as such in cardiomyocytes with low puCL levels, as in Barth 
syndrome, these cells can not compensate for the decrease in efficiency and as 
such appear to have a reduced OCR as compared to control cells of the same 
type. 
A second observation from the Seahorse data pertaining to TAZREV_1 highlighted 
the significant differences between this cell line and all other cell lines. 
TAZREV_1 had elevated levels of oxygen consumption more reduced 
mitochondrial mass and aberrant mitochondrial morphology. All these 
differences are the result of clonal variation with the TAZREV_1 cells having 
significantly higher levels of TAZ expression and puCL levels as compared to any 
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other cell type studied here giving the resulting functional and morphological 
differences observed.  
We also sought to characterize mitophagy levels in all cell lines using the same 
mitotracker green lysotracker red system as in Chapter 3, with CCCP being used 
to induce mitophagy. Images were previously analysed by eye, however it was 
felt that this was not accurate enough and did not account for the three 
dimensional nature of the images. As such a computerized method was 
developed to quantify mitophagy by interrogating and analysing the images. The 
method was based on an IMAGEJ macro and was used to analyse images of five 
of the six cell lines (162). From this analysis it appeared there was indeed a 
defect in mitophagy in the TAZMUT cells. The level of mitophagy in these cells 
was consistently lower than the TAZREV and CONTROL_1 cells and did not 
increase with CCCP or CCCP and CI treatment. In addition measurements relating 
to TAZREV_1 cells showed these cells to have the highest level of mitophagy of 
all the cell types adding credence to our previous observations and conclusions 
regarding this cell line. 
Despite this positive result for mitophagy measurement it was felt a more direct 
oxidative inducer of mitophagy was required to strengthen the link between oxi-
CL and mitophagy. We developed a treatment regime using H2O2, (a reactive 
oxygen species produced by mitochondria) that we felt induced mitophagy based 
on mitochondrial depolarisation and LC3II induction. However the use of H2O2 
prevented us using mitotracker green and lysotracker red due to the effect H2O2 
had on mitotracker green. We therefore began developing stable markers for the 
mitochondria; in addition it was felt that whilst mitochondrial/lysosomal co-
localisation represented a good grounding for measuring mitophagy it was not 
specific for mitophagy. Mitophagy is defined as the engulfment of the 
mitochondria by the autophagosome, and although co-localisation with the 
lysosome represented the end stage of mitophagy, autophagosomal engulfment 
of mitochondria is not the only mechanism by which mitochondria can be found 
inside lysosomes. Therefore it was important that what we measured as 
mitophagy was actually mitophagy as defined by the engulfment of the 
mitochondria by the autophagosome. Therefore we developed a stable 
fluorescent marker of the autophagosome in the form of the stable expression of 
LC3-cherry in five of our six cell lines; TAZMUT_ 1, TAZMUT_3, TAZREV_1, 
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TAZREV_3 and CONTROL_2. We successfully generated a LC3-cherry lentivirus 
which we used to infect our fibroblasts and select cells using FACS sorting for 
fluorescence intensity, such that each cell line expressed LC3-cherry to the same 
level, making future imaging easier. 
We were unsuccessful in generation of a stable mitochondrial marker but 
decided that by fixing our cells we could use mitochondria specific antibodies to 
stain mitochondria and this would also enable us to stain lysosomes using 
lysosome specific antibodies. This would enable us to monitor the interaction of 
all three components of mitophagy in each of our cell lines. However the IMAGEJ 
macro developed in this chapter can only analyse images which represent two 
Fluorescent signals. Future images will be based on three Fluorescent images 
and therefore a new method of analysis was required.  
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Chapter 5 Oxidation of Cardiolipin is the initiating 
signal for mitophagy 
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5.1 Introduction 
Having generated LC3-cherry expressing cells in previous chapter we now 
required a method of fluorescently labelling the mitochondria that is not 
affected by H2O2 treatment. Mitotracker green as seen in Chapter 4 is affected 
by H2O2. We attempted to make Mito-YFP stable cell lines but this was 
unsuccessful. Therefore we decided to fix the cells and use antibodies to stain 
the mitochondria. We also stained the lysosomes with antibodies allowing us to 
monitor all three components involved in mitophagy. This chapter details the 
imaging technique applied and the software used to analyse the images taken, 
and the results it generated.   
5.2 Imaging of LC3-Cherry 
With the generation of the isogenic control cells (TAZREV_1 and TAZREV_3) and 
then the subsequent expression of LC3-cherry in all cell lines we could now move 
forward and look at the direct effect of oxidation of puCL on mitophagy. As 
previously, we used confocal imaging and then subsequent analysis of those 
images to examine the levels of mitophagy. 
However we did not yet have a suitable mitochondrial marker, and we also 
wanted to continue to image the lysosomes in our cells. Since none of the 
mitotracker probes were suitable for the task and generating stable cell lines 
expressing the mitochondrial marker mito-YFP had been unsuccessful. We moved 
away from live cell imaging and used fixed cells instead. This allowed us to use 
antibodies for the mitochondria (TOM20) and the lysosomes (LAMP2); instead of 
fluorescent proteins we used fluorescent secondary antibodies, Alexa 488 for the 
mitochondria and Alexa 405 for the lysosomes. We next set about optimizing our 
fixation technique to give the best possible image, initially we only used the 
mitochondrial antibody as it was only later that we decided to include the 
lysosomes in our imaging and analysis, Figure 5:1. 
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Figure 5:1- Optimization of fixation technique 
Images above show TAZREV_3 cells fixed using paraformaldehyde and glutaraldehyde, methanol 
or acetone. The cells were stained in each case with TOM20/Alexa 488 to detect mitochondria, and 
LAMP2/Alexa405 to detect lysosomes (with the exception of the paraformaldehyde/glutaraldehyde 
fixation where lysosomes were not imaged). 
Whilst the mitochondrial staining and lysosomal staining were not affected by 
the type of fixation used the LC3-cherry appeared disrupted in both the 
paraformaldehyde/glutaraldehyde and methanol fixed cells, when comparing the 
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same cells prior to fixation. However the acetone fixed cells did not suffer from 
this same disruption and this method preserved the LC3-Cherry signal observed 
in the live cells. Therefore this method of fixation along with the combination of 
antibodies for the mitochondria and lysosomes were used in the following images 
and analysis.  
5.3 A new image analysis approach 
Although we had already established a very useful method of image analysis, as 
detailed in Chapter 4 section 4.3.2, it was not sufficient for the imaging data we 
were about to produce. Each new image would be as before a three dimensional 
Z-stacks taken with the NIKON A1R confocal using the Piezo stage, however since 
the cells were fixed there was no need to use the fast resonant scanner as with 
the previous live cell imaging. Therefore we could use the slower and more 
precise galvano scanner consequently higher quality images were generated.  
Previous image data sets were obtained using mitotracker green, lysotracker red 
and thus were only two channel images. The ImageJ macro, described in the 
previous chapter (section 4.3.2) could only analyse two channel images, the new 
images are composed of three channels, green for mitochondria, red for LC3 and 
blue for lysosomes. Therefore these new images could not be analysed using the 
ImageJ macro, and a new image analysis approach was sought. Two software 
packages stood out as possible solutions to this problem; IMARIS and VOLOCITY. 
5.3.1 IMARIS 
IMARIS is a commercially available software package licenced by Bitplane. It 
takes microscope generated Z-stacks and allows the user to build a three 
dimensional representation of that image by creating a volume based view of 
each component in the image. The software can be applied to structures as large 
as whole tissues and organs or as small as the internal structures of individual 
cells. It is possible to aesthetically alter the volumes created thereby improving 
the visualisation of the image. It is also possible to slice through the three 
dimensional space of an image to interrogate the spatial interactions of various 
three dimensional structures. Also of great importance, and relevance when 
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measuring mitophagy, it is possible to measure the co-localisation of objects in 
the image.  
This is achieved by first creating 3D surfaces for each object of interest. Objects 
are defined based on the fluorescent channel, i.e. all mitochondria are one type 
of objects because they are imaged in the green channel. There are various user 
defined parameters than can be changed during this process: allowing for 
example background fluorescence to be discounted; minimum and maximum 
sizes of objects can be defined; where objects are touching and may otherwise 
be identified as one object they can be split by maximum size constraints to be 
correctly identified as two objects. All of these parameters are set during a 
wizard directed process for each channel/object, and are user defined to give 
the best possible 3D representation (Figure 5:2).These wizard led parameter 
settings can be saved and therefore applied to every image in a data set. Once 
the 3D representation is generated it can be tilted rotated flipped magnified and 
examined from every angle, as seen in Figure 5:2. This allows for easier 
identification and examination of structures of interest. In Figure 5:2 we see the 
engulfment of a mitochondrion by the autophagosome along with the fusion of 
lysosomes with this autophagosome. We can cut through the Z-plane of this 
section to reveal in more detail the exact interactions between these three 
organelles, and highlight effectively the type of event which we are seeking to 
measure. Whilst it is important to be able to readily observe these events 
clearly, as in this case, it is also of great importance to be able to quantify them 
and IMARIS is also capable of this. 
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Figure 5:2- IMARIS generated 3D reconstruction from Z-stack image 
These images are of a TAZREV_3 cell treated with CCCP, green is TOM20/Alexa 488 indicating 
mitochondria, blue is LAMP2/Alexa 405 indicating lysosomes and red is LC3-Cherry indicating the 
autophagosome. The first image shows the original fluorescent image obtained from the 
microscope. The second image shows the three dimensional reconstruction of the first image using 
the original Z-stack to generate a volume view representation with IMARIS. On this image a small 
area has been highlighted by a white box, this area is then magnified in the image below. It shows 
a mitophagic event, highlighted by the engulfment of the mitochondrial sphere (green) by the 
autophagosome (red) with lysosomes (blue) fusing with the autophagosome to allow the 
completion of the process by digestion. The final two images show sectioning of this magnified 
area, through the Z-plane, clearly showing the interactions between mitochondria, autophagosome 
and lysosome. 
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IMARIS can identify the mitochondrial surfaces that are being engulfed by 
autophagosomes. This is done by asking IMARIS to highlight all autophagosomal 
surfaces containing mitochondria, (based on green fluorescence intensity). We 
can then measure the mitochondrial volume contained within these 
autophagosomes and by also measuring the total mitochondrial volume in the 
image we can determine the percentage of mitochondria in the image being 
engulfed by autophagosomes; effectively measuring percentage mitophagy. We 
can then proceed further by looking at how lysosomes are involved. Using the 
surfaces already built for the lysosomes we can ask IMARIS to identify where 
these surfaces are in contact with the previously defined “mitophagy surfaces”. 
This again will give us a volume measure for mitochondria that are not only 
engulfed by autophagosomes but also interacting with lysosomes, i.e. just prior 
to the final stage of mitophagy, which can be converted to a percentage as 
IMARIS also provides us with the measure of the total volume of mitochondria.  
IMARIS not only gives very clear 3D reconstructions of Z-stack confocal images, 
but the method described above is clearly traceable at every step and very 
accurate. However it has one major downfall, other than the protocol 
parameters to build the surfaces for fluorescent signal, (mitochondria, 
lysosomes, autophagosomes) no other part of this protocol can be saved or 
automated, every image must be analysed manually individually - there is no 
option to batch process a number of images all under the same setting at the 
same time; as previously achieved by our IMAGEJ macro. As we have a large data 
set of images, processing each image individually in this way would have been 
extremely time-consuming. Therefore we decided against using IMARIS for image 
analysis, but its superior 3D rendering of our images meant its continued use for 
presentation purposes.  
5.3.2 Volocity 
For our image analysis we turned instead to Volocity. Volocity like IMARIS is 
capable of taking a Z-stack and generating a 3D volume rendering of the image. 
However there is less user input to the rendering of the 3D surfaces and so the 
visual presentation of the rendering I feel is less impressive. However in terms of 
image analysis Volocity has one distinct advantage over IMARIS, it can batch 
process images, protocols for analysis can be saved and applied to other data 
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sets later. Meaning that once a protocol is designed and all thresholds and 
parameters are set these can then be applied to any and all images in all data 
sets, without the user having to apply the each step in the protocol to each 
image manually- as in IMARIS. All images and all data sets are analysed in the 
same manner and therefore the data returned is comparable. As stated above 
due to the large number of the images we obtained for each cell line under each 
condition (26 images per condition per cell line), batch processing was a 
necessity, and as such made Volocity the software of choice over IMARIS for this 
analysis. 
5.3.3 Final protocol 
After testing both versions of software and identifying Volocity as the method by 
which we would analyse our imaging data we next set up the protocol for 
analysis based on images from untreated CONTROL_2 cells. A description of this 
protocol is provided in Chapter 2 section 2.2.19.4. 
The first key stage of the protocol is to identify and measure the number of the 
three types of organelle in each image (mitochondria, autophagosomes and 
lysosomes). Each is defined based on fluorescence intensity and size thresholds 
which are set by the user (details in Chapter 2 section 2.2.19.4). Once each type 
of organelle is identified by Volocity it can then count the number of occasions 
when the different types of organelles interact with one another in three 
dimensional spaces, i.e. when autophagosomes and mitochondria are interacting 
during mitophagy. Using these two key functions we designed a Volocity protocol 
that enabled us to not only count the number of mitochondria, autophagosomes 
and lysosomes in every image but also the number of mitophagic events in every 
image. This protocol can be applied to many images within an image library 
simultaneously, therefore allowing for the batch processing function that was 
lacking in IMARIS.   
Volocity was key to obtaining the information required from the imaging data, 
and represented a more in depth way of analysing the data as compared to the 
original ImageJ macro used previously. As with the previous method it relies on a 
whole Z-stack image of the cell to build its 3D dimensional representation, from 
which it can quantify co-localisation of the organelles. This co-localisation data 
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can then be interpreted as a measure of mitophagy and additionally a number of 
other elements which add to the interpretation and understanding of the data it 
generates regarding mitophagy. Its one downfall is in the visual aspect, the way 
in which it generates its 3D representations are not as intuitive as IMARIS with 
less user input and room for artistic adaption (for presentation purposes) as in 
IMARIS. Therefore it was decided that both packages would be used. IMARIS to 
generate the artistic 3D representations for descriptive understanding of what 
was being identified and measured and Volocity to actually measure, analyse 
and produce numerical data from the images using the protocol detailed above. 
5.4 Mitophagy levels are reduced with reduced TAZ 
activity and polyunsaturated Cardiolipin levels 
5.4.1 Imaging data 
Five cell lines were imaged: CONTROL_2, TAZMUT1, TAZMUT_3, TAZREV_1 and 
TAZREV_3. For each condition tested in each cell line twenty six images were 
taken, each image was obtained in Z-stack form as well as a representative 
single plane image from each stack to be used for visual representation but not 
analysis. Statistical analysis of the data generated by Volocity was performed by 
Gabriela Kalna, using generalized linear method. The statistics that correspond 
to each data set can be found in the tables indicated. It was decided not to 
include any statistical data on the graphs themselves as this would result in a 
very crowded confusing presentation of the statistics. All data were normalised 
to cell number, the number of cells imaged in each frame varies from cell type 
to cell type and treatment to treatment, so to compensate for this all data were 
normalised to cell number.  
5.4.2 Mitophagy in CONTROL_2 cells 
CONTROL_2 cells were subject to five different treatment regimes: untreated, 
as a basal measure; H2O2 treated, the oxidative stress inducer of mitophagy; 
H2O2 and CI treated, to induce mitophagy and then block, with the lysosomal 
enzyme inhibitors E64d and pepstatin A, the digestion of the damaged 
mitochondria thereby amplifying any mitophagic signal; CI alone, as a control for 
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the effects of CI’s upon the cells and finally CCCP treated, to act as a control 
due to its known role in inducing mitophagy. The images for CONTROL_2 cells 
were then used to optimize the Volocity protocol (section 5.3.3) as well as give a 
general control for the measurements being made in other cell lines. Figure 5:3 
presents representative images for this cell line under all conditions; Figure 5:4 
and Figure 5:5 present the analysis. 
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Figure 5:3- CONTROL_2 representative images 
Above are representative images of the CONTROL_2 cells taken under the five different treatment 
regimes. LC3-Cherry represents the autophagosomes, LAMP2/Alexa405 the lysosomes, 
TOM20/Alexa488 the mitochondria. The first merged image is of mitochondria and 
autophagosomes only to focus mitophagy. The second merged image is of all three channels, 
mitochondria lysosomes and autophagosomes. 
205 
 
 Laura Catherine Avril Galbraith 
 
Figure 5:4- Count of Organelles for CONTROL_2 
(A) Graph of mean number of autophagosomes per cell under each treatment regime. (B) Graph of 
mean number of lysosomes per cell under each treatment regime. (C) Graph of the mean number 
of mitochondria per cell under each treatment regime. Error bars represent standard error of mean; 
(D) Gives the statistics for each graph comparing each treatment to all other treatments. Red p-
values indicate that the data is classed as significant, significant p-values are considered to be 
those equal to or less than 0.05. Statistical testing performed using generalized linear model. 
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Figure 5:5- Count of events for CONTROL_2 
(A) Graph of mean count of mitophagy events per 100 cells. (B) Graph of mean count of late stage 
mitophagy (co-localisation of mitochondria, autophagosomes and lysosomes) events per 100 cells. 
(D) Error bars represent standard error of mean. (D)  Gives the statistics for each graph comparing 
each treatment to all other treatments. Red p-values indicate that the data is classed as significant, 
significant p-values are considered to be those equal to or less than 0.05. Statistical testing 
performed using generalized linear model. 
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The first striking observation was the increasing number of autophagosomes with 
the treatments given, this was observed in the images and then confirmed by 
Volocity analysis (Figure 5:3 and Figure 5:4A). Compared to untreated cells each 
treatment induced a statistically significant increase in autophagosome number. 
It is not surprising however given the inducing effect of H2O2 on LC3 as seen in 
Figure 4:14.  
Lysosome number is most difficult to judge by eye since they are the most 
prolific organelle we are measuring. They appear most abundant in the 
untreated and H2O2 and CI treated cells Figure 5:3. However on analysis it seems 
that untreated and CCCP treated cells have similarly high numbers of lysosomes, 
while treatment with H2O2 alone shows a reduction number of lysosomes number 
compared to untreated, this is slightly increased when CI’s are also added, 
Figure 5:4 C. The difference between H2O2 treated and untreated cells is 
significant Figure 5:4D; perhaps indicating that H2O2 treatment induces a faster 
clearance of damaged mitochondria than CCCP treatment resulting in reduced 
lysosome levels following successful mitochondrial degradation. Under all 
conditions except untreated the lysosomes appear perinuclear, this localisation 
of lysosomes ties in with the perinuclear localisation of the mitochondria also 
seen here. Perinuclear localisation of mitochondria is an indicator of imminent 
mitophagy therefore observing this indicates that mitophagy has been initialised 
(75).  
The mitochondria appear fragmented upon H2O2 treatment and CCCP treatment 
as compared to untreated cells (Figure 5:3). Analysis of mitochondrial number 
shows slight fluctuations under H2O2 treatment and CCCP treatment consistent 
with induction of mitophagy (Figure 5:4 B). However the effect of CI upon 
mitochondrial number is dramatic, perhaps resulting from some unknown off 
target effect of the compounds. As such it was decided that for all other cell 
types analysed the use of CI’s would be omitted as we are unsure of the effect 
these compounds are actually having on our cells.   
The untreated cells show little or no co-localisation of mitochondria with 
autophagosomes, as identified by the appearance of yellow punctae suggesting 
low basal levels of mitophagy in these cells Figure 5:3 and Figure 5:5A . There is 
an increase in mitophagy observed upon H2O2 treatment and further increases 
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upon CI and H2O2 and CCCP treatment showing how each of the treatments 
clearly induces mitophagy and this is accurately reflected in the analysis, Figure 
5:5A. As CONTROL_2 represent healthy individuals with normal puCL profiles and 
TAZ activity, it was expected that this kind of result would be observed. These 
results therefore confirmed our treatments were inducing mitophagy as 
expected and our method for quantitation was accurate; the results it returned 
were as expected as well as matching for the most part the observations made 
by eye.  
To further investigate mitophagy in these cells we also investigated the late 
stage of mitophagy; co-localisation of lysosomes autophagosomes and 
mitochondria (observed in the images as white punctae in the three channel 
merged image Figure 5:5B). Untreated cells show little or no white punctae 
confirming the low basal levels of mitophagy under these conditions and as with 
mitophagy, we see increasing levels of late stage mitophagy events (co-
localisation of mitochondria, autophagosomes and lysosomes) with each of the 
treatments, in almost exactly the same pattern. As these two stages represent 
consecutive stages of mitochondrial degradation they should and do emulate 
each other in this way.  
The analysis of these images confirms to us that our treatment regime has the 
desired effect of inducing mitophagy in cells, with healthy levels of puCL 
allowing mitophagy to proceed as normal. These images and analysis represent 
the normal progression of mitophagy and tests the accuracy and robustness of 
our analysis method. The difference seen here between observations made from 
the images and software analysis of the images highlights the importance of 
software analysis in deriving quantitative data from images, as it is very difficult 
to judge by eye the levels of one organelle or event in each image let alone 
compare across images, cell lines and different treatments. Software analysis is 
simply more accurate as well as less biased. H2O2 treatment induces 
autophagosome formation, mitochondrial fragmentation, mitophagy and fusion 
of the lysosome with the autophagosome containing mitochondria as compared 
to untreated. We had hoped that with the addition of lysosomal CI’s this effect 
would be amplified, however although this seems to be the case we also 
observed an unexpected effect of the CI’s upon mitochondrial number. In every 
case where CI’s were added to cells the mitochondrial number was significantly 
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decreased as compared to untreated cells (Figure 5:4 A and D).With the role of 
the CI’s in inhibiting the lysosomal degradative enzymes we would have in fact 
expected mitochondrial number to remain constant or increase due to a block in 
their degradation. This unexpected result leads us to believe that in our cells the 
CI’s are having some off target effect on mitochondria, which lead to our 
decision to omit the use of CI’s in the imaging and analysis of the following data 
regarding the TAZMUT and TAZREV cells as we could not be sure what effect the 
CI’s were actually having on our cells.   
5.4.3 Effects of oxidative stress upon mitophagy in TAZMUT and 
TAZREV cells. 
Having developed and validated the analysis protocol in CONTROL_2 cells it was 
then applied it to our TAZMUT and TAZREV cells to determine what effect if any 
loss of TAZ activity and reduced puCL levels have on the cells response to 
mitophagy inducing treatments. 
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Figure 5:6- TAZMUT_1 and TAZREV_1  
Above are representative images of untreated and H2O2 treated TAZMUT_1 and TAZREV_1 cells. 
LC3-Cherry represents the autophagosomes, LAMP2/Alexa405 the lysosomes, TOM20/Alexa488 
the mitochondria. The first merged image is of mitochondria and autophagosomes only to focus on 
mitophagy. The second merged image is of all three channels, mitochondria lysosomes and 
autophagosomes. 
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Figure 5:7- TAZMUT_3 and TAZREV_3  
Above are representative images of untreated and H2O2 treated TAZMUT_3 and TAZREV_3 cells. 
LC3-Cherry represents the autophagosomes, LAMP2/Alexa405 the lysosomes, TOM20/Alexa488 
the mitochondria. The first merged image is of mitochondria and autophagosomes only to focus on 
mitophagy. The second merged image is of all three channels, mitochondria lysosomes and 
autophagosomes. 
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Figure 5:8- TAZMUT_1 and TAZREV_1 data analysis 
(A) Graph of number of autophagosomes, based on LC3-cherry punctae, per cell, with error bars 
representing standard error of mean, for both untreated and H2O2 treated cells. (B) Graph of 
number of mitophagy events per 100 cells with error bars representing standard error of mean, for 
both untreated and H2O2 treated cells. (C) Graph of number of late stage mitophagy (co-localisation 
of mitochondria, lysosome and autophagosome) events per 100 cells with error bars representing 
standard error of mean, for both untreated and H2O2 treated cells. (D) Tables giving statistical 
significance of the effect of each treatment on each cell type, details of statistical significance 
between cell lines can be found in Table 8. 
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Figure 5:9- TAZMUT_3 and TAZREV_3 data analysis 
(A) Graph of number of autophagosomes, based on LC3-cherry punctae, per cell, with error bars 
representing standard error of mean, for both untreated and H2O2 treated cells. (B) Graph of 
number of mitophagy events per 100 cells with error bars representing standard error of mean, for 
both untreated and H2O2 treated cells. (C) Graph of number of late stage mitophagy (co-localisation 
of mitochondria, lysosome and autophagosome) events per 100 cells with error bars representing 
standard error of mean, for both untreated and H2O2 treated cells. (D) Tables giving statistical 
significance of the effect of each treatment on each cell type, details of statistical significance 
between cell lines can be found in Table 8. 
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TAZREV_1 cells have high basal levels of autophagosomes and as such although 
there is an increase of autophagosome number upon H2O2 treatment this 
increase is not statistically significant. However the induction of mitophagy in 
H2O2 treated TAZREV_1 cell is obvious from the increase in yellow punctae (co-
localisation of mitochondria, green, and autophagosomes, red) in the images and 
which is quantified by Volocity and shown to be statistically significantly 
different from basal mitophagy levels in untreated cells (Figure 5:6 and Figure 
5:8). A similarly significant increase in the number of late stage mitophagy 
events is observed upon H2O2 treatment as compared to untreated, evidenced by 
the dramatic increase in white punctae (co-localisation of mitochondria, green, 
autophagosomes, red, and lysosomes, blue) in the images and this is reflected in 
the quantitation by Volocity (Figure 5:6 and Figure 5:8). As these cells express 
functional TAZ and have healthy levels of puCL we expected to see this 
induction of mitophagy upon H2O2 treatment. 
By contrast TAZMUT_1 lacks functional TAZ and has significantly decreased 
levels of puCL and indeed this affects the induction of mitophagy in these cells 
upon H2O2 treatment. In terms of Autophagosome number there is almost no 
induction of autophagosome formation upon H2O2 treatment, this is also true of 
the induction of mitophagy and number of mitochondria containing 
autophagosomes, as observed from the images and quantified by Volocity (Figure 
5:6 and Figure 5:8 A-C). For all measurements there is no significant change in 
the cells between detection in untreated cells and the levels detected in cells 
treated with H2O2 (Figure 5:8D). This suggests that the lack of functional TAZ and 
reduced puCL levels affects the induction of mitophagy upon H2O2 treatment. 
A similar effect is observed in the TAZREV_3 and TAZMUT_3 pairing. In this case 
TAZREV_3 has lower basal levels of autophagosomes in untreated cells as 
compared to TAZREV_1 (Figure 5:6 and Figure 5:7) which means that upon H2O2 
treatment a statistically significant induction of autophagosome formation is 
observed (Figure 5:7 and Figure 5:9). This induction is emulated in terms of 
mitophagy and number of late stage mitophagy events, which is observed in the 
images as an increase in the number of yellow and white punctae, respectively 
(Figure 5:7). Volocity analysis reveals this induction to be statistically 
significantly as compared to untreated levels in the TAZREV_3 cells (Figure 5:9). 
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Again as with TAZREV_1 this was to be expected in these cells which have active 
TAZ and healthy levels of puCL.  
Yet once again the TAZMUT_3, which lack functional TAZ and have decreased 
puCL levels, have abrogated induction of autophagosome number, mitophagy 
and number of late stage mitophagy events. There is a slight induction in these 
cells of autophagosome number, mitophagy and number of late stage mitophagy 
events upon H2O2 treatment as observed in the images by a slight increase in 
red, yellow and white punctae (Figure 5:7) however this increase is by no means 
statistically significant as identified by the Volocity analysis (Figure 5:9). This 
slight induction may relate to some residual activity of the mutant TAZ protein 
expressed in these cells. TAZMUT_1 cells harbour a mutation in the TAZ gene 
leading to an insertion of a pre-mature stop codon and as observed by western 
blot (Figure 4:3 Chapter four) this leads to no detectable expression of TAZ 
protein. By contrast TAZMUT_3 cells harbour a point mutation resulting in an 
amino acid change in the TAZ protein and as observed by western blot these 
cells do express TAZ protein (Figure 4:3 Chapter four). This expressed mutant 
protein may still have some residual activity, which is lacking in TAZMUT_1 
which does not express any protein. Indeed the CL mass spectrometry data 
(Figure 3:1 Chapter 3) shows that TAZMUT_3 have a less severe loss of puCL as 
compared to TAZMUT_1 cells which could be attributed to residual activity of 
mutant protein and account for the slight induction observed in autophagosome 
formation, mitophagy and late stage mitophagy.  
Despite this slight difference between the two TAZMUT cell lines induction of 
mitophagy upon H2O2 treatment was observed to be impaired in each case. 
These cells fail to induce autophagosome formation upon H2O2 treatment, which 
leads to reduced levels of mitophagy and late stage mitophagy; suggesting a 
failure in the initiation of this quality control system. To further understand this 
we also compared these measurements in the TAZMUT cells upon H2O2 treatment 
to the measurements derived from their isogenic matched control and 
CONTROL_2 cells (Table 8).  
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5.4.4 Mitophagy is reduced in TAZMUT cells 
 
Table 8- Statistics for lysosomal degradation of mitochondria 
(A) Three tables giving the statistical significance (p-values) of the differences between cell lines in 
autophagosome number, number of mitophagy events and late stage mitophagy events in 
untreated cells. (B) Three tables giving the statistical significance (p-values) of the differences 
between cell lines in autophagosome number, number of mitophagy events and late stage 
mitophagy events in H2O2 treated cells. Red p-values indicate that the data is classed as 
significant, significant p-values are considered to be those equal to or less than 0.05. Statistical 
testing performed using generalized linear model. 
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The above table gives the statistical data for comparisons in autophagosome 
number, mitophagy and late stage mitophagy events across all cell lines 
untreated and also upon H2O2 treatment. 
In comparing cell types under untreated conditions we can see that for the 
differences between TAZMUT_3 and TAZREV_3 are not statistically significant. 
This is probably because under basal conditions the need for mitophagy is low. In 
contrast, even at basal levels in untreated cells the TAZMUT_1 cells have 
significantly lower levels of autophagosomes, mitophagy and late stage 
mitophagy events than the TAZREV_1 cells. However the most striking effect is 
observed upon H2O2 treatment. In both of the mutant-revertant pairings the 
levels of autophagosomes, mitophagy and late stage mitophagy events are 
significantly lower in the mutant cells as compared to their isogenic revertant 
controls. This evidence suggests an effect of low puCL levels upon mitophagy. 
The TAZMUT cells have lower levels of puCL compared to their isogenic controls, 
an observation that supports the original hypothesis regarding a role for puCL in 
mitophagy; my data shows that cells with low levels of puCL have significantly 
abrogated levels of mitophagy and autophagosome induction. The observation of 
this effect upon oxidative stress induced by the addition of H2O2 indicates that 
the oxidation of puCL may be the initiating signal for mitophagy, and that lack of 
puCL in TAZMUT cells results in decreased levels of oxi-CL and lower levels of 
mitophagy.  
5.5 Cardiolipin oxidation 
To pursue the role of oxi-CL in mitophagy further, we decided to measure the 
levels of oxi-CL in both TAZMUT and TAZREV cells under the same mitophagy 
inducing conditions used for the imaging above. Firstly we investigated 4HNE 
levels in our cells. 4HNE is α,β-unsaturated hydroxyalkenal that is produced upon 
oxidation of lipids in cells and forms adducts with proteins. 4HNE is not specific 
for CL oxidation but has been shown to be produced upon CL oxidation (170); 
however we reasoned that in the TAZMUT cells the loss of oxidation of CL would 
cause a noticeable reduction in 4HNE levels compared to TAZREV cells. 4HNE 
forms protein adducts which are immunogenic, therefore we performed a 
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western blot of whole cell lysate from cells treated with H2O2, probing for 4HNE 
protein adducts (Figure 5:10). 
 
Figure 5:10- Western blot for 4HNE 
Western blot for 4HNE, whole cell lysates derived from cells treated with H2O2 at 500µM every 30 
minutes for 1.5 hours. ACTIN was used as a loading control.  
As expected 4HNE is detected in all cell types since 4HNE is not specific to 
oxidation of CL and we would expect other lipids to be oxidized under H2O2 
treatment. However, looking at the TAZMUT_1 and TAZREV_1 cell types we can 
see that TAZREV_1 does indeed have elevated levels of 4HNE compared to 
TAZMUT_1, with more bands and bands of higher intensity seen in TAZREV_1 as 
compared to TAZMUT_1. This suggests TAZREV_1 has higher levels of oxidized 
lipids compared to TAZMUT_1 and this is highly likely to result from the 
oxidation of puCL in TAZREV_1 which does not occur in TAZMUT_1. For 
TAZREV_3 we also see higher levels of 4HNE compared to TAZMUT_3 although it 
is not as obvious as observed in the TAZMUT_1, TAZREV_1 pairing. Together 
these the two pairings suggests higher levels of oxidized lipid in TAZREV cells 
than TAZMUT cells. This is most likely resulting from the oxidation of puCL in 
TAZREV cells which is lacking in TAZMUT cells since the only difference between 
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these isogenic pairs is the function of TAZ and consequently levels of puCL 
available for oxidation. 
Whilst monitoring 4HNE levels is a good indicator of oxidation of puCL, it is not 
as mentioned specific for oxidation of puCL. As such we attempted to measure 
oxidized CL by mass spectrometry. We produced lipid extracts from CONTROL_2, 
TAZMUT_1, TAZMUT_3, TAZREV_1 and TAZREV_3 and sent them for analysis at 
the Babraham Institute, Cambridge to be analysed by Mike Wakelam and Qifeng 
Zhang. Lipid extracts from untreated, H2O2, and H2O2 and CI treated cells were 
sent for analysis from each cell type, along with an oxi-CL standard generated by 
in-vitro oxidation of CL. Oxi-CL species of various types were detected from the 
oxi-CL standard, however we were unable to detect any oxi-CL in any of the lipid 
extracts from cells. This was very disappointing, however we feel that the 
reason for this may be that the concentration of the CL from whole cell extracts 
is significantly lower than the concentration of the CL used to generated the oxi-
CL standard, meaning the concentration of oxi-CL in the cell derived lipid 
extracts is so low that it cannot be detected. Moving forward we will be looking 
at repeating this experiment with isolated mitochondria from each cell type to 
enable us to concentrate the CL in each sample and then extract the lipids from 
the isolated mitochondria rather than whole cells. We hope this will increase the 
concentration of CL enough that we will be able to detect oxi-CL and compare 
the levels across cell lines. 
In the meantime the data derived from the 4HNE western blot strongly suggests 
that TAZMUT cells have lower levels of lipid oxidation than TAZREV cells. As the 
primary difference in lipid composition between these cells is that TAZMUT cells 
lack puCL, it stands to reason that this reduced level of lipid oxidation results 
from loss of puCL oxidation, which in turn causes the reduced mitophagy we see 
in our imaging data.  
5.6 Discussion 
In this chapter I have developed a microscopy based approach for the 
quantitative analysis of mitophagy events. I used this method to image and 
analyse five cell lines under various different to study the effects of loss of 
220 
 
 Laura Catherine Avril Galbraith 
Tafazzin activity and reduced puCL levels on mitophagy. The CONTROL_2 cells 
were used as a tool to test, evaluate and design the analysis protocol using 
Volocity. The parameters and thresholds set for this cell line were then applied 
to the isogenic paired cell lines of Tafazzin mutant and revertant cells.  
Interrogating the images obtained for these cell lines with the Volocity protocol I 
was able to show that mitophagy and other related events were affected 
differently across the different cell lines. I showed that the TAZREV cells 
responded to H2O2 treatment, as expected, by induction of autophagosome 
formation and up-regulation of mitophagy. In direct contrast to this the TAZMUT 
cells showed no significant induction of autophagosome formation or up-
regulation of mitophagy upon H2O2 treatment. Indeed even in untreated cells the 
basal levels of autophagosome formation and mitophagy in TAZMUT cells was 
lower than that of their respective TAZREV control.  
This indicates that mitophagy is negatively affected in the TAZMUT cells as 
compared to the TAZREV cells. The fundamental difference between these cell 
lines lies within the activity of TAZ which results in the different levels of puCL 
in each cell line. Thus the data presented in this chapter supports a role for 
puCL in induction of mitophagy.  
My hypothesis is that oxidation of CL acts as an initiating signal to the 
mitophagic machinery conveying that mitochondria are damaged and require 
removal. Formation of oxidized CL requires puCL which is oxidized via 
nucleophilic attack on the double bonds of the fatty acid chain. If, as in TAZMUT 
cells, puCL is levels are decreased then the abundance of oxi-CL will be lower as 
a consequence. This will result in reduced signalling to the mitophagic 
machinery, causing reduced levels of mitophagy as observed above.  
To try and determine if indeed oxi-CL is the initiating signal for mitophagy we 
attempted to quantify the oxidation of CL in each of our cell types, under the 
mitophagy inducing conditions used for imaging. We initially investigated the 
levels of 4HNE, a product of lipid oxidation, as a read out for CL oxidation. 4HNE 
is produced upon oxidation of lipids within a cell; it is not specific for oxidation 
of CL, but a product of peroxidation of any lipid. Protein adducts of 4HNE can be 
detected by western blot, with increased levels of adducts indicating increased 
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lipid oxidation. Although not specific to oxidation of puCL, oxidation of puCL 
contributes to the levels of 4HNE. Therefore where oxidation of puCL does not 
occur we would expect 4HNE levels to be reduced compared to incidences were 
it is oxidized. We observed the presence of 4HNE in all our cell lines; however 
the levels of 4HNE did appear lower in protein extracts taken from TAZMUT cells 
as compared to TAZREV cells. This reduction can most probably be attributed to 
loss of puCL oxidation, as in all aspects (except TAZ function and puCL levels) 
these cells are genetically identical to one another (within their matched pair). 
Given therefore that oxidation of CL is absent or decreased in the TAZMUT cells 
compared to TAZREV cells, and mitophagy fails to occur in the TAZMUT cells 
upon oxidative damage, it is likely that removal of damaged mitochondria upon 
oxidative stress requires the oxidation of puCL to act as the initiation signal for 
mitophagy. As this signal is lacking in the TAZMUT cells mitophagy fails to be 
induced yet in the TAZREV cells were puCL can be effectively oxidized upon 
oxidative stress (H2O2 treatment) mitophagy is initiated and the damaged 
mitochondria degraded.   
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Chapter 6 Conclusions, Discussion and Future 
work. 
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6.1 Final Conclusions 
The field of mitophagy is relatively young, given that the term mitophagy was 
only first back in 2005 (8). Since then a wealth of progress has been made 
mapping the different stages of mitophagy, the triggers of mitophagy, the 
regulatory proteins involved and diseases where mitophagy has a significant 
impact. Recently there have been tentative forays into the role of lipids in 
mitophagy (section 1.1.6) for autophagosomal membrane development and for 
the direct regulation of the mitophagic machinery (124, 155, 156). Although 
research focusing on the role of lipids in mitophagy is sparse, we considered that 
lipids within the mitochondrial membranes were likely to be instrumental in 
mitophagy; perhaps as initiating signals or binding platforms. More specifically I 
predicted that cardiolipin, the mitochondrial specific phospholipid, would be 
involved in this process. Having previously been implicated in mitochondrial 
processes such as cell death, mitochondrial dynamics and ATP production it 
made perfect sense to me that it could also be involved in mitophagy (Sections 
1.1.4 and 1.3.1).  Indeed the chemical structure of CL lends it to a role as a 
marker of mitochondrial health. By virtue of its polyunsaturated acyl chains, CL 
is a prime target for oxidative attack forming oxi-CL. As mitochondria become 
dysfunctional or damaged the levels of ROS they generate through the ETC is 
increased. The resulting generation of oxi-CL would therefore serve as an 
indicator of mitochondrial health and activate the mitophagy machinery to 
degrade the mitochondria in question (Figure 6:1).  
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Figure 6:1- Oxi-CL is the initiating signal for mitophagy 
The above scheme shows two mitochondria, one healthy and one damaged/dysfunctional. The 
lipid shown represents cardiolipin; those with yellow circle attached represent oxidized CL. The 
healthy mitochondria have low ROS levels inside and outside of the mitochondria because the 
mitochondria are functioning as required with low ROS generation. However this will still have 
some oxidizing effect on CL as indicated, but at a low level. Upon mitochondrial 
dysfunction/damage the ROS levels inside the mitochondria are increased, which will also serve to 
increase ROS levels outside the mitochondria, (exogenous sources of ROS will have similar 
effects). This increased ROS level will increase the level of oxidized CL as shown and this will 
identify the damaged/dysfunctional mitochondria to the mitophagic machinery stimulating them into 
action. 
  
This thesis focused on assessing if CL did indeed act in this way as a functional 
indicator of mitochondrial health resulting in the induction of mitophagy upon 
mitochondrial damage and dysfunction. 
We generated a model system utilizing primary cells derived from Barth’s 
syndrome patients. Barth’s syndrome patients lack the enzyme TAZ which 
enables remodelling of immature CL to mature puCL, the form which can be 
readily oxidized. I generated isogenic control cell lines from the Barth’s cells by 
re-introducing functional TAZ, enabling the cells to generate puCL. This enabled 
us to compare mitophagy under conditions were CL could not be oxidized 
(Barth’s syndrome cells referred to as TAZMUT) with conditions where it could 
(Revertant cells referred to as TAZREV and non-isogenic controls referred to as 
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CONTROL). To check success of re-introduction of TAZ we ran mass spectrometry 
analysis for CL. The classic loss of puCL and concurrent increase in MLCL 
observed in the TAZMUT cells was rescued effectively in our TAZREV cells giving 
near similar levels of puCL and MLCL as observed in the CONTROL cells. In 
addition we also created a revertant cell line expressing a different spliceform 
of TAZ, TAZΔexon 7. This isoform actually caused a worsening of the TAZMUT CL 
profile suggesting this isoform of TAZ may work in reverse catalysing conversion 
of puCL to MLCL or inhibit further any residual activity of endogenous TAZ in the 
TAZMUT cells. 
Having established our model system we began to investigate specific processes 
where CL is known to have a functional role or processes occur during 
mitophagy. It was quickly established that the mitochondria of TAZMUT cells 
were appeared significantly longer than CONTROL cells. The length of 
mitochondria has been shown to affect their ability to be engulfed by the 
autophagosome (6, 82). Increased length of mitochondria in TAZMUT cells could 
prevent the engulfment of the mitochondria during mitophagy due to size 
constraints. To understand why the mitochondria appeared longer mitochondria 
dynamics in the cells was briefly examined. The TAZMUT cells showed reduced 
network connectivity and dynamics as compared to CONTROL. Rare fission and 
possible fusion events were observed, and whilst the fusion events appeared to 
proceed unhindered, in some cases fission progressed strangely (Figure 3:8 and 
Figure 3:9 in Section 3.2.3). A mitochondrial filament would appear to undergo 
several fission events concurrently forming a string of mitochondrial spheres, 
only for these spheres to re-form into the original filament a short time later. 
This may be indicative of failure of the mitochondria to complete the fission 
process. The mitochondria were labelled with matrix targeted fluorescent tags, 
which would allow effective observation of the inner membrane fission. However 
if fission of the outer membrane are affected this would not be observed, we 
would still see the inner membrane fission but for lack of outer membrane 
marker we could not determine if the outer membrane had undergone fission. If 
the outer membrane fails to ‘Fis’ while the inner is successful, small spherical 
inner membrane compartments would be observed captured inside an ‘invisible’ 
singular outer membrane. This is reminiscent of the events we observed for 
TAZMUT cells and indicated that perhaps the increased mitochondrial length is 
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not due to an active up-regulation of fusion but in fact reduced capacity for 
mitochondrial fission, alongside reduced levels of interconnection, fusion and 
mitochondrial movement. Since fission of damaged/dysfunctional mitochondria 
from the mitochondrial network is a key stage in mitophagy, this suggested along 
with increased mitochondrial length that mitophagy may be abrogated in the 
TAZMUT cells. 
Two key stimuli for mitophagy are loss of mitochondrial membrane potential and 
reduced mitochondrial function. The mitochondrial membrane potential in all 
cell types was examined along with the ability of each to depolarise upon CCCP 
treatment. There was no difference in basal or CCCP treated mitochondrial 
membrane potential. Mitochondrial function was examined using the Seahorse 
flux analyser, this proved less than conclusive. For one isogenic pairing the 
expected reduction in mitochondrial function often observed in Barth’s 
syndrome derived cells resulting from the reduced CL levels affecting the 
activity, stability and formation of the complexes and supercomplexes of the 
ETC (TAZMUT_1 and TAZREV_1), was observed. However the second isogenic 
pairing gave the reverse result, with the TAZMUT_3 cells having increased 
mitochondrial function compared to the TAZREV_3. Such a result contradicts all 
previous findings regarding loss of TAZ function and reduced CL levels. One 
possible explanation could be that in the majority of research investigating the 
effects of loss of TAZ and CL reduction on mitochondrial function has been 
performed in cells and tissues with high energy demand, such as cardiomyocytes. 
The cells being used to generate this data are fibroblast cells derived for the 
skin of Barth’s patients. Skin fibroblasts are by far less energy demanding than 
cardiomyocytes. Therefore this inconclusive and inconsistent result could be due 
to these cells having enough reserve capacity within their mitochondria to 
compensate for the inefficiency, whilst in cardiomyocytes there is little or no 
reserve capacity. 
Mitochondrial mass was also examined as an indicator of occurrence of 
mitophagy. No significant difference in mitochondrial mass  was observed in any 
of the cell lines. This was surprising because defects in mitophagy are expected 
to cause increased mitochondrial mass in the TAZMUT cells. However these 
measurements were taken under basal conditions, (i.e. no stress stimuli) and 
given the low metabolic nature of these fibroblasts it is likely that basal levels of 
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mitophagy would be low in all cell lines.  However of note, although not 
statistically significant, was the much reduced mitochondrial mass in the 
TAZREV_1 cells. These cells had also given the highest results for mitochondrial 
function and the best recovery of the Barth’s CL profile, and later it was noticed 
that the mitochondrial morphology of these cells was odd; instead of forming 
long filaments, as the other cells did, they formed large globule like 
mitochondria. In every parameter measured this cell line differed from all 
others. When looking at the expression level of TAZ and the CL profile of these 
cells together an explanation comes to mind. The cells have the highest 
expression of TAZ of all the cell lines, and also have the highest levels of mature 
CL. Thus this cell line appears to be the polar opposite phenotype to that of a 
Barth’s syndrome cell. The exceedingly high levels of mature CL perhaps enable 
mitochondrial function to be drastically improved due to enhanced ETC complex 
and supercomplex formation, function and stability. The strange morphology 
observed later in imaging could result from the enhanced function of the 
mitochondrial fusion machinery due to increased CL levels. Finally, 
mitochondrial mass could be low simply because of the enhanced functionality 
of the mitochondria; hence less mitochondria are required to maintain their 
functions. Alternatively (or in addition), since we have shown here that 
oxidation of CL is the initiating signal for mitophagy, increased levels of CL 
would also result in increased levels of oxi-CL, which would amplify the 
mitophagy signal resulting in higher levels of mitophagy and the resultant lower 
mitochondrial mass observed. With this in mind it is hardly surprising that 
TAZREV_1 cells also had the highest levels of mitophagy in all the cell types             
To be able to measure mitophagy in the cells an imaging technique had to be 
developed along with a method of image analysis that would enable the 
quantification of mitophagic events. Initially we utilized the commercially 
available mitotracker green and lysotracker red dyes to identify the 
mitochondria and lysosome respectively. In conjunction with this we designed 
and built a macro to run in ImageJ based on an already published macro (162), 
which processed three dimensional (Z-stack) images of our cells, identifying and 
quantifying co-localisation between mitochondria and lysosomes i.e. mitophagy. 
This was an invaluable development in the early stages of this project allowing 
us to image live cells and quantify the occurrence of mitophagy at basal levels 
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and following addition of CCCP, a known inducer of mitophagy. We were able to 
reliably show that mitophagy was abrogated in TAZMUT cells as compared to 
TAZREV and CONTROL cells, suggesting that mature puCL has a role to play in 
mitophagy. To further elucidate the role of puCL in mitophagy we reasoned that 
we should instigate an oxidative stress on the cells and monitor mitophagy 
following this, as that would help us determine if our hypothesis about oxidized 
CL as the signal for mitophagy was correct. 
Unfortunately we could not extend our findings using the 
mitotracker/lysotracker approach as mitotracker green appeared to lose 
specificity for mitochondria upon oxidative stress. Although the lysotracker 
identification represents a good surrogate for measuring mitophagy, the most 
widely accepted definition of mitophagy is the specific engulfment of 
mitochondria by the autophagosome. Therefore, we developed a new imaging 
technique; using our TAZMUT, TAZREV and CONTROL cells which were stably 
transfected with LC3-cherry (as a fluorescent marker for the autophagosome). 
Cells were fixed and co-stained for TOM20 (identifying the mitochondria) and 
LAMP2 (identifying the lysosome) and as such we could now image the whole 
process of mitophagy in our cells under oxidative conditions. As we had now 
developed a different imaging technique our original ImageJ macro was of no 
use, instead we turned to commercially available image analysis packages, 
Volocity and IMARIS, in order to analyse our imaging data. Whilst IMARIS 
represented the most comprehensive package in terms of 3D image rendering for 
presentation quality and ability to analyse images, it was lacking in its ability to 
batch process numerous images using one analysis protocol all at the same time. 
Volocity in contrast was capable of undertaking the batch processing required 
for such a large data set; however its 3D rendering of images was sorely lacking. 
As such, a combined approach was employed; IMARIS utilized to generate 3D 
renderings for presentation and explanatory purposes whilst Volocity undertook 
the actual image analysis and number crunching. Finally statistical analysis was 
performed in house by Gabriela Kalna, due to the size of the data set and the 
complexity of comparing several measurements, across all cell lines under each 
treatment condition. The final conclusion confirmed our original result based on 
the ImageJ data analysis, that mitophagy was significantly reduced in the 
TAZMUT cells as compared to TAZREV and Control cells. From this we could 
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suggest that the lack of puCL in the TAZMUT cells appeared to adversely affect 
the ability of these cells to undertake mitophagy in response to oxidative stress. 
Indeed, the increased levels of mitophagy in TAZREV and CONTROL cells upon 
oxidative stress indicated that puCL had a definite effect in the up-regulation of 
the mitophagy response. However further work was required to determine if this 
was due to the oxidation state of puCL. Whilst writing this thesis an article has 
been published suggesting CL externalisation as the initiation signal for 
mitophagy. Persuasive evidence is presented implicating CL externalisation as 
the signal for mitophagy; although they do not specify puCL, it does support the 
findings of this thesis in relation to a role for CL in mitophagy (171). However, 
they also state they found no evidence to suggest oxi-CL was involved; this is in 
contrast to our preliminary findings regarding oxi-CL (section 5.5).     
Initially we sought to quantify oxi-CL levels through measurement of the 
surrogate 4HNE by immunoblot. 4HNE is α,β-unsaturated hydroxyalkenal that is 
produced upon oxidation of lipids in cells and forms proteins adducts that are 
detectable by western blot (170). Production 4HNE is not specific for CL 
oxidation but CL oxidation will contribute to the levels of 4HNE within the cells. 
As such where oxidation of CL is absent i.e. in the TAZMUT cells we would 
expect reduced levels of 4HNE. This indeed was the case when TAZMUT cells 
were compared to TAZREV. We then attempted to measure the levels of oxi-CL 
by mass spectrometry under basal and oxidative stress conditions. Unfortunately 
it proved impossible to detect any oxi-CL from lipid extracts from any cell type, 
most probably due to the low concentration of CL in terms of total cellular lipid 
in the extract. We hope to repeat this in the future using more cells and isolated 
mitochondria in order to concentrate the oxi-CL in each sample such that it is at 
detectable levels for the mass spectrometer.  
6.2 Future work 
The data herein firstly suggests a role for puCL in mitophagy. It is possible that it 
is the oxidation of puCL that acts as the initiating signal for mitophagy, as 
observed through measurement of 4HNE levels. Unfortunately we have not 
shown conclusively that under the mitophagy inducing conditions used here, oxi-
CL levels are high in TAZREV and CONTROL cells whilst non-existent in TAZMUT 
cells. As such it is our plan to repeat the mass spectrometry analysis described 
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above to measure oxi-CL. However the approach will be modified by isolating 
mitochondria and combining samples to increase the abundance of CL in our 
starting material. We will then directly treat the mitochondria from the 
different cell types with our oxidizing agent (H2O2) and promptly extract the 
lipids from the mitochondria and analyse by mass spectrometry. It is our hope 
that this method will increase the levels of oxi-CL in our samples to detectable 
levels and from that we will be able to ascertain if differences do exist between 
our cell types under mitophagy inducing conditions. 
We also hope to look at the recovery of cells following oxidative stress, to show 
mitophagy as a pro-survival mechanism under these conditions. We plan to apply 
oxidative stress to our cells instigating mitophagy as we have observed from our 
imaging data, and then remove the oxidative stress and allow cells to recover, 
monitoring their recovery using mitochondrial membrane potential and 
mitochondrial function on the Seahorse. We anticipate that whilst TAZREV and 
CONTROL cells will recover effectively as they are able to utilize mitophagy to 
remove damaged mitochondria, TAZMUT cells will not recover, or have reduced 
recovery, displaying reduced mitochondrial membrane potential and function 
indicative of their retention of damaged and dysfunctional mitochondria 
following oxidative stress.  We hope to then develop these investigations to 
determine if rapamycin, a known inducer of macroautophagy, could rescue the 
recovery effect lacking in TAZMUT cells by removing these damaged 
mitochondria through a non-specific autophagic response to rapamycin.  
We will also attempt to flood the TAZMUT cells with exogenous polyunsaturated 
fatty acids (PUFA’s), thus forcing them to synthesise immature CL using PUFA’s. 
Hopefully this will raise the level of puCL’s in the TAZMUT cells to levels 
comparable to TAZREV and CONTROL cells. We would determine if this was the 
case by mass spectrometry and measure mitophagy levels and recovery from 
oxidative stress to determine if the phenotype observed for each in the TAZMUT 
cells could be rescued by addition of PUFA’s. 
Finally we would like to explore to a greater level an effect upon mitochondrial 
dynamics and morphology observed early on in this project. I would like to 
determine if a quantifiable deficiency in fission and fusion is present in the 
TAZMUT cells, as well as ascertain if the defect in fission lies within the inability 
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of the outer mitochondrial membrane to Fis as suspected. To this end we would 
propose using two fluorescent markers for the mitochondria, one specifically 
matrix/inner membrane localised and the other exclusively outer membrane 
localised. With this approach we would be able to monitor the dynamics of each 
membrane separately and thus determine if, as we suspect, the outer membrane 
has difficulties in fission when puCL levels are reduced.    
6.3 Clinical relevance 
Mitophagy has been implicated in several diseases as highlighted in section 1.2 
and 1.3.3. Therefore the increased understanding of the role of CL in mitophagy 
as evidenced here may aid in the treatment for these conditions. With direct 
relevance to Barth’s syndrome, the disease upon which our model system was 
built, it seems that mitophagy is markedly reduced under Barth’s syndrome 
conditions of low levels of puCL. This may account for some of the disease 
pathology observed and the effects this condition has on patients. If we show, as 
we plan to, that forcing mitophagy in Barth’s syndrome cells can cause a 
reduction in the molecular presentation of the disease (in terms of 
mitochondrial function) then perhaps up-regulation of mitophagy in patients 
with Barth’s syndrome could be viewed as an effective treatment. Indeed our 
plans to test rapamycin, a clinically approved drug, to increase mitochondrial 
clearance by macroautophagy may represent a viable treatment plan. In addition 
the supplementation of Barth’s cells with PUFA to increase mitophagy may also 
represent a second approach for treatment through dietary supplementation, an 
approach that has already been investigated in Barth syndrome patients (108, 
111, 172, 173).      
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